Diagnostic antibodies and antigens for functional ELISA assay kit, lateral flow and other immunoassays in diagnostics
Diagnostic antibodies and antigens list
In vitro diagnostic (IVD) testing has become an indispensable tool in clinical practice for diagnosing and monitoring of diseases, as well as providing prognosis and predicting treatment response, In vitro tests may be done in laboratories, health care facilities or even in the home. The tests themselves can be performed on a variety of instruments ranging from small, handheld tests to complex laboratory instruments. They allow doctors to diagnose patients effectively and work to provide appropriate treatments.
IVDs are used to analyze human samples such as blood and saliva, either by measuring the concentration of specific substances, or analytes (such as sodium and cholesterol), or by detecting the presence or absence of a particular marker or set of markers, such as a genetic mutation or an immune response to infection. Clinicians regularly use IVDs to diagnose conditions, guide treatment decisions, and even mitigate or prevent future disease (for example, through screening tests that indicate a patient’s risk of developing a given condition in the future). There are over 40,000 different IVD products available that provide information to doctors and patients on a huge range of conditions. These comprise markers for inorganic chemistry (electrolytes, toxins, and heavy metals), markers for organic chemistry/biochemistry (proteins, lipids, and carbohydrates), as well as molecular biologic procedures (sequencing and polymerase chain reaction).
In recent years, the value of IVDs has gained further recognition because of their potential to save lives through earlier diagnosis of medical conditions. In the case of an infectious disease, early detection can ensure that patients receive timely care to help slow or stop the progression of disease. Further, knowledge of infection can help promote self-isolation to prevent further spread of the disease to the community. This has been particularly important in containing the spread of highly infectious agents during an active outbreak. Using IVDs to predict underlying genetic conditions in addition to diagnostic screening can also prevent unnecessary suffering by a patient as well as reduce the scale of treatment required.
As the ease-of-use and reliability of IVDs has improved, some IVDs have moved out of the laboratory setting and into the patient’s home. Consumers can now perform simple tests to monitor blood glucose levels, identify urinary tract infections, track ovulation, and confirm pregnancy. These tests not only empower individuals to take charge of their own health but can provide quick results that help guide further medical actions. Genemedi provides diagnostic antibodies and antigens for the in vitro diagnosis of diseases such as infectious disease, inflammation/autoimmune/inflammatory disease, kidney function (renal damages), liver diseases, lung injury, metabolic diseases, multiple disease, neurodegenerative diseases, pain, thyroid diseases, vitamin deficiency and so on.
Evidence has shown plasma biomarkers (p-tau181, p-tau217, p-tau231, GFAP, NfL, and Aβ42/40) were significantly changed in preclinical Alzheimer's Disease (AD). Recently, our R&D department demonstrated that our GMP-h-p-tau217-Ab01 has a large linear range and good sensitivity against the GMP-h-p-tau217-Ag01. Below is the result of GeneMedi's GMP-h-p-tau217-Ab01 (Anti-human p-tau217 antibody) validation with GMP-h-p-tau217-Ag01 (p-tau217 antigen) in ELISA. We highly recommend the Ab&Ag to you.
Figure 1. GeneMedi's GMP-h-p-tau217-Ab01 (Anti-human p-tau217 antibody) is validated to detect the GMP-h-p-tau217-Ag01 (p-tau217 antigen) in ELISA. EC50 = 25.85ng/ml.
Classification of IVD Disease:
Cancer
Infectious Disease
Inflammation/Autoimmune/Inflammatory Disease
Cardiovascular Disease
Liver Diseases
Lung Injury
Kidney Function (renal damages)
Gastric Disease
Thyroid Diseases
Bowel Disease
Fertility
Diabetes Diseases
Metabolic Diseases
Hormone Disorders
Vitamin Deficiency
Fibrinogen Disorders
Neurodegenerative Diseases
Epilepsy
Pain
Multiple Disease
Biology
Diagnostic antibodies and antigens for cancer detection - TG, CA-125, SCC Ag, PIVKA-Ⅱ, ProGRP, Calcitonin, NSE, CA-724, HE4, CA15-3, FER, CYFRA21-1, HER2, HSP90α, S100B, CEA, AFP, sFlt-1, PSA, hEGF, TFF2, TFF3, CA199, CA50, TK1
Regardless of the advances in the cancer therapy, delayed symptoms and lack of successful diagnosis of cancer at early stage increased the death rate. Tumor-associated antigens (TAAs) and their antibodies have been identified as potential markers in cancer diagnosis and determination. TAAs and their antibodies-based detection of cancer have the advantages such as low-cost, and simple access, which attracted much attention for early cancer detection. For several reasons, tumor marker itself is typically insufficient to analyze disease conditions. Because, maximum number of markers have been produced by both normal and cancer cells. Several cancers such as anal, breast, ovaries, testicles, colon, endometrial, peritoneal, fallopian tube, gallbladder, gastric, liver, lung, neuroendocrine, pancreatic, prostate, renal, cervix, stomach and thyroid cancer, bronchopulmonary dysplasia, hepatitis, hematological malignancies, hemochromatosis, hypercalcemia, osteoporosis, Parget's diseases and so on have been identified using specific marker. Detecting the quantity of marker proteins from different samples may benefit from ELISA, Lateral flow immunoassay (LFIA), colloidal gold immunochromatographic assay, Chemiluminescent immunoassay (CLIA), turbidimetric inhibition immuno assay (TINIA), immunonephelometry and POCT.
Classification:
TG
CA-125
SCC Ag
PIVKA-Ⅱ
ProGRP
Calcitonin
NSE
CA-724
HE4
CA15-3
FER
CYFRA21-1
HER2
HSP90α
S100B
CEA
AFP
sFlt-1
PSA
hEGF
TFF2
TFF3
CA199
CA50
TK1
Thyroglobulin (TG)
Cat No. | Species | Biomarker | Disease | Cat No.of Antigen | Bioactivity validation of Antigen | Cat No.of Antibodies | Bioactivity validation of Antibodies | Order |
GMP-h-TG | Human | Thyroglobulin (TG) | thyroid nodules, thyroid adenomas, multinodular goiters, thyrotoxicosis, thyroid cancer | GMP-h-TG-Ag01: Recombinant human TG Protein |
Thyroglobulin (TG) antibodies, Immunogen in Sandwich Elisa, lateral-flow tests,and other immunoassays as control material in TG level test of Cancer(thyroid nodules, thyroid adenomas, multinodular goiters, thyrotoxicosis, thyroid cancer) and related syndrome evaluation. | GMP-h-TG-Ab01; GMP-h-TG-Ab02: Anti-human TG mouse monoclonal antibody(mAb) |
Human Thyroglobulin (TG) antigen binding, ELISA validated as capture antibody and detection antibody. Pair recommendation with other Thyroglobulin (TG) antibodies in TG level test of Cancer (thyroid nodules, thyroid adenomas, multinodular goiters, thyrotoxicosis, thyroid cancer) and related syndrome evaluation. | ![]() |
cancer antigen 125 (CA-125)
Cat No. | Species | Biomarker | Disease | Cat No.of Antigen | Bioactivity validation of Antigen | Cat No.of Antibodies | Bioactivity validation of Antibodies | Order |
GMP-h-CA-125 | Human | cancer antigen 125 (CA-125) | ovarian, endometrial, peritoneal and fallopian tube cancers. | GMP-h-CA-125-Ag01: Recombinant human CA-125 Protein |
cancer antigen 125 (CA-125) antibodies, Immunogen in Sandwich Elisa, lateral-flow tests,and other immunoassays as control material in CA-125 level test of Cancer(ovarian, endometrial, peritoneal and fallopian tube cancers.) and related syndrome evaluation. | GMP-h-CA-125-Ab01; GMP-h-CA-125-Ab02: Anti-human CA-125 mouse monoclonal antibody(mAb) |
Human cancer antigen 125 (CA-125) antigen binding, ELISA validated as capture antibody and detection antibody. Pair recommendation with other cancer antigen 125 (CA-125) antibodies in CA-125 level test of Cancer (ovarian, endometrial, peritoneal and fallopian tube cancers.) and related syndrome evaluation. | ![]() |
squamous cell carcinoma antigen (SCC Ag)
Cat No. | Species | Biomarker | Disease | Cat No.of Antigen | Bioactivity validation of Antigen | Cat No.of Antibodies | Bioactivity validation of Antibodies | Order |
GMP-h-SCC-Ag | Human | squamous cell carcinoma antigen (SCC Ag) | squamous cancers of the cervix, head, neck, and lung | GMP-h-SCC-Ag-Ag01: Recombinant human SCC Ag Protein |
squamous cell carcinoma antigen (SCC Ag) antibodies, Immunogen in Sandwich Elisa, lateral-flow tests,and other immunoassays as control material in SCC Ag level test of Cancer(squamous cancers of the cervix, head, neck, and lung) and related syndrome evaluation. | GMP-h-SCC-Ag-Ab01; GMP-h-SCC-Ag-Ab02: Anti-human SCC Ag mouse monoclonal antibody(mAb) |
Human squamous cell carcinoma antigen (SCC Ag) antigen binding, ELISA validated as capture antibody and detection antibody. Pair recommendation with other squamous cell carcinoma antigen (SCC Ag) antibodies in SCC Ag level test of Cancer (squamous cancers of the cervix, head, neck, and lung) and related syndrome evaluation. | ![]() |
Protein induced by vitamin K absence-II (PIVKA-Ⅱ)
Cat No. | Species | Biomarker | Disease | Cat No.of Antigen | Bioactivity validation of Antigen | Cat No.of Antibodies | Bioactivity validation of Antibodies | Order |
GMP-h-PIVKA-Ⅱ | Human | Protein induced by vitamin K absence-II (PIVKA-Ⅱ) | hepatocellular carcinoma | GMP-h-PIVKA-Ⅱ-Ag01: Recombinant human PIVKA-Ⅱ Protein |
Protein induced by vitamin K absence-II (PIVKA-Ⅱ) antibodies, Immunogen in Sandwich Elisa, lateral-flow tests,and other immunoassays as control material in PIVKA-Ⅱ level test of Cancer(hepatocellular carcinoma) and related syndrome evaluation. | GMP-h-PIVKA-Ⅱ-Ab01; GMP-h-PIVKA-Ⅱ-Ab02: Anti-human PIVKA-Ⅱ mouse monoclonal antibody(mAb) |
Human Protein induced by vitamin K absence-II (PIVKA-Ⅱ) antigen binding, ELISA validated as capture antibody and detection antibody. Pair recommendation with other Protein induced by vitamin K absence-II (PIVKA-Ⅱ) antibodies in PIVKA-Ⅱ level test of Cancer (hepatocellular carcinoma) and related syndrome evaluation. | ![]() |
Gastrin-releasing peptide (ProGRP)
Cat No. | Species | Biomarker | Disease | Cat No.of Antigen | Bioactivity validation of Antigen | Cat No.of Antibodies | Bioactivity validation of Antibodies | Order |
GMP-h-ProGRP | Human | Gastrin-releasing peptide (ProGRP) | cancer | GMP-h-ProGRP-Ag01: Recombinant human ProGRP Protein |
Gastrin-releasing peptide (ProGRP) antibodies, Immunogen in Sandwich Elisa, lateral-flow tests,and other immunoassays as control material in ProGRP level test of Cancer(cancer) and related syndrome evaluation. | GMP-h-ProGRP-Ab01; GMP-h-ProGRP-Ab02: Anti-human ProGRP mouse monoclonal antibody(mAb) |
Human Gastrin-releasing peptide (ProGRP) antigen binding, ELISA validated as capture antibody and detection antibody. Pair recommendation with other Gastrin-releasing peptide (ProGRP) antibodies in ProGRP level test of Cancer () and related syndrome evaluation. | ![]() |
Calcitonin (Calcitonin)
Cat No. | Species | Biomarker | Disease | Cat No.of Antigen | Bioactivity validation of Antigen | Cat No.of Antibodies | Bioactivity validation of Antibodies | Order |
GMP-h-Calcitonin | Human | Calcitonin (Calcitonin) | osteoporosis, hypercalcemia and Parget's diseases | GMP-h-Calcitonin-Ag01: Recombinant human Calcitonin Protein |
Calcitonin (Calcitonin) antibodies, Immunogen in Sandwich Elisa, lateral-flow tests,and other immunoassays as control material in Calcitonin level test of Cancer(osteoporosis, hypercalcemia and Parget's diseases) and related syndrome evaluation. | GMP-h-Calcitonin-Ab01; GMP-h-Calcitonin-Ab02: Anti-human Calcitonin mouse monoclonal antibody(mAb) |
Human Calcitonin (Calcitonin) antigen binding, ELISA validated as capture antibody and detection antibody. Pair recommendation with other Calcitonin (Calcitonin) antibodies in Calcitonin level test of Cancer (osteoporosis, hypercalcemia and Parget's diseases) and related syndrome evaluation. | ![]() |
Neuron specific enolase (NSE)
Cat No. | Species | Biomarker | Disease | Cat No.of Antigen | Bioactivity validation of Antigen | Cat No.of Antibodies | Bioactivity validation of Antibodies | Order |
GMP-h-NSE | Human | Neuron specific enolase (NSE) | neuroendocrine tumors | GMP-h-NSE-Ag01: Recombinant human NSE Protein |
Neuron specific enolase (NSE) antibodies, Immunogen in Sandwich Elisa, lateral-flow tests,and other immunoassays as control material in NSE level test of Cancer(neuroendocrine tumors) and related syndrome evaluation. | GMP-h-NSE-Ab01; GMP-h-NSE-Ab02: Anti-human NSE mouse monoclonal antibody(mAb) |
Human Neuron specific enolase (NSE) antigen binding, ELISA validated as capture antibody and detection antibody. Pair recommendation with other Neuron specific enolase (NSE) antibodies in NSE level test of Cancer (neuroendocrine tumors) and related syndrome evaluation. | ![]() |
Cancer Antigen 72-4 (CA-724)
Cat No. | Species | Biomarker | Disease | Cat No.of Antigen | Bioactivity validation of Antigen | Cat No.of Antibodies | Bioactivity validation of Antibodies | Order |
GMP-h-CA-724 | Human | Cancer Antigen 72-4 (CA-724) | carcinomas of pancreas, stomach, gallbladder, colon, ovaries, cervix and endometrium | GMP-h-CA-724-Ag01: Recombinant human CA-724 Protein |
Cancer Antigen 72-4 (CA-724) antibodies, Immunogen in Sandwich Elisa, lateral-flow tests,and other immunoassays as control material in CA-724 level test of Cancer(carcinomas of pancreas, stomach, gallbladder, colon, ovaries, cervix and endometrium) and related syndrome evaluation. | GMP-h-CA-724-Ab01; GMP-h-CA-724-Ab02: Anti-human CA-724 mouse monoclonal antibody(mAb) |
Human Cancer Antigen 72-4 (CA-724) antigen binding, ELISA validated as capture antibody and detection antibody. Pair recommendation with other Cancer Antigen 72-4 (CA-724) antibodies in CA-724 level test of Cancer (carcinomas of pancreas, stomach, gallbladder, colon, ovaries, cervix and endometrium) and related syndrome evaluation. | ![]() |
epididymis protein 4 (HE4)
Cat No. | Species | Biomarker | Disease | Cat No.of Antigen | Bioactivity validation of Antigen | Cat No.of Antibodies | Bioactivity validation of Antibodies | Order |
GMP-h-HE4 | Human | epididymis protein 4 (HE4) | ovarian cancer | GMP-h-HE4-Ag01: Recombinant human HE4 Protein |
epididymis protein 4 (HE4) antibodies, Immunogen in Sandwich Elisa, lateral-flow tests,and other immunoassays as control material in HE4 level test of Cancer(ovarian cancer) and related syndrome evaluation. | GMP-h-HE4-Ab01; GMP-h-HE4-Ab02: Anti-human HE4 mouse monoclonal antibody(mAb) |
Human Human epididymis protein 4 (HE4) antigen binding, ELISA validated as capture antibody and detection antibody. Pair recommendation with other Human epididymis protein 4 (HE4) antibodies in HE4 level test of Cancer (ovarian cancer) and related syndrome evaluation. | ![]() |
Cancer antigen 15-3 (CA15-3)
Cat No. | Species | Biomarker | Disease | Cat No.of Antigen | Bioactivity validation of Antigen | Cat No.of Antibodies | Bioactivity validation of Antibodies | Order |
GMP-h-CA15-3 | Human | Cancer antigen 15-3 (CA15-3) | breast cancer | GMP-h-CA15-3-Ag01: Recombinant human CA15-3 Protein |
Cancer antigen 15-3 (CA15-3) antibodies, Immunogen in Sandwich Elisa, lateral-flow tests,and other immunoassays as control material in CA15-3 level test of Cancer( breast cancer ) and related syndrome evaluation. | GMP-h-CA15-3-Ab01; GMP-h-CA15-3-Ab02: Anti-human CA15-3 mouse monoclonal antibody(mAb) |
Human Cancer antigen 15-3 (CA15-3) antigen binding, ELISA validated as capture antibody and detection antibody. Pair recommendation with other Cancer antigen 15-3 (CA15-3) antibodies in CA15-3 level test of Cancer ( breast cancer ) and related syndrome evaluation. | ![]() |
Ferritin (FER)
Cat No. | Species | Biomarker | Disease | Cat No.of Antigen | Bioactivity validation of Antigen | Cat No.of Antibodies | Bioactivity validation of Antibodies | Order |
GMP-h-FER | Human | Ferritin (FER) | hemochromatosis | GMP-h-FER-Ag01: Recombinant human FER Protein |
Ferritin (FER) antibodies, Immunogen in Sandwich Elisa, lateral-flow tests,and other immunoassays as control material in FER level test of Cancer(hemochromatosis) and related syndrome evaluation. | GMP-h-FER-Ab01; GMP-h-FER-Ab02: Anti-human FER mouse monoclonal antibody(mAb) |
Human Ferritin (FER) antigen binding, ELISA validated as capture antibody and detection antibody. Pair recommendation with other Ferritin (FER) antibodies in FER level test of Cancer (hemochromatosis) and related syndrome evaluation. | ![]() |
soluble fragment of cytokeratin-19 (CYFRA21-1)
Cat No. | Species | Biomarker | Disease | Cat No.of Antigen | Bioactivity validation of Antigen | Cat No.of Antibodies | Bioactivity validation of Antibodies | Order |
GMP-h-CYFRA21-1 | Human | soluble fragment of cytokeratin-19 (CYFRA21-1) | bronchopulmonary dysplasia | GMP-h-CYFRA21-1-Ag01: Recombinant human CYFRA21-1 Protein |
soluble fragment of cytokeratin-19 (CYFRA21-1) antibodies, Immunogen in Sandwich Elisa, lateral-flow tests,and other immunoassays as control material in CYFRA21-1 level test of Cancer(bronchopulmonary dysplasia) and related syndrome evaluation. | GMP-h-CYFRA21-1-Ab01; GMP-h-CYFRA21-1-Ab02: Anti-human CYFRA21-1 mouse monoclonal antibody(mAb) |
Human soluble fragment of cytokeratin-19 (CYFRA21-1) antigen binding, ELISA validated as capture antibody and detection antibody. Pair recommendation with other soluble fragment of cytokeratin-19 (CYFRA21-1) antibodies in CYFRA21-1 level test of Cancer (bronchopulmonary dysplasia) and related syndrome evaluation. | ![]() |
epidermal growth factor receptor 2 (HER2)
Cat No. | Species | Biomarker | Disease | Cat No.of Antigen | Bioactivity validation of Antigen | Cat No.of Antibodies | Bioactivity validation of Antibodies | Order |
GMP-h-HER2 | Human | epidermal growth factor receptor 2 (HER2) | breast cancer | GMP-h-HER2-Ag01: Recombinant human HER2 Protein |
epidermal growth factor receptor 2 (HER2) antibodies, Immunogen in Sandwich Elisa, lateral-flow tests,and other immunoassays as control material in HER2 level test of Cancer(breast cancer) and related syndrome evaluation. | GMP-h-HER2-Ab01; GMP-h-HER2-Ab02: Anti-human HER2 mouse monoclonal antibody(mAb) |
Human human epidermal growth factor receptor 2 (HER2) antigen binding, ELISA validated as capture antibody and detection antibody. Pair recommendation with other human epidermal growth factor receptor 2 (HER2) antibodies in HER2 level test of Cancer (breast cancer) and related syndrome evaluation. | ![]() |
epidermal growth factor receptor 2 (HER2)
Cat No. | Species | Biomarker | Disease | Cat No.of Antigen | Bioactivity validation of Antigen | Cat No.of Antibodies | Bioactivity validation of Antibodies | Order |
GMP-h-HSP90α | Human | epidermal growth factor receptor 2 (HER2) | breast cancer | GMP-h-HSP90α-Ag01: Recombinant human HSP90α Protein |
epidermal growth factor receptor 2 (HSP90α) antibodies, Immunogen in Sandwich Elisa, lateral-flow tests,and other immunoassays as control material in HSP90α level test of Cancer(breast cancer) and related syndrome evaluation. | GMP-h-HSP90α-Ab01; GMP-h-HSP90α-Ab02: Anti-human HSP90α mouse monoclonal antibody(mAb) |
Human Heat shock proteins 90-alpha (HSP90α) antigen binding, ELISA validated as capture antibody and detection antibody. Pair recommendation with other Heat shock proteins 90-alpha (HSP90α) antibodies in HSP90α level test of Cancer ( renal cancer, liver cancer and breast cancer) and related syndrome evaluation. | ![]() |
S100 proteins (S100B)
Cat No. | Species | Biomarker | Disease | Cat No.of Antigen | Bioactivity validation of Antigen | Cat No.of Antibodies | Bioactivity validation of Antibodies | Order |
GMP-h-S100B | Human | S100 proteins (S100B) | Alzheimer disease, cancer and inflammatory disorders (such as rheumatoid arthritis (RA) | GMP-h-S100B-Ag01: Recombinant human S100B Protein |
S100 proteins (S100B) antibodies, Immunogen in Sandwich Elisa, lateral-flow tests,and other immunoassays as control material in S100B level test of Cancer(Alzheimer disease, cancer and inflammatory disorders (such as rheumatoid arthritis (RA)) and related syndrome evaluation. | GMP-h-S100B-Ab01; GMP-h-S100B-Ab02: Anti-human S100B mouse monoclonal antibody(mAb) |
Human S100 proteins (S100B) antigen binding, ELISA validated as capture antibody and detection antibody. Pair recommendation with other S100 proteins (S100B) antibodies in S100B level test of Cancer (Alzheimer disease, cancer and inflammatory disorders (such as rheumatoid arthritis (RA)) and related syndrome evaluation. | ![]() |
carcinoembryonic antigen (CEA)
Cat No. | Species | Biomarker | Disease | Cat No.of Antigen | Bioactivity validation of Antigen | Cat No.of Antibodies | Bioactivity validation of Antibodies | Order |
GMP-h-CEA | Human | carcinoembryonic antigen (CEA) | breast cancer, lung cancer, breast cancer, liver cancer, pancreatic cancer, stomach cancer, ovarian cancer | GMP-h-CEA-Ag01: Recombinant human CEA Protein |
carcinoembryonic antigen (CEA) antibodies, Immunogen in Sandwich Elisa, lateral-flow tests,and other immunoassays as control material in CEA level test of Cancer(breast cancer, lung cancer, breast cancer, liver cancer, pancreatic cancer, stomach cancer, ovarian cancer) and related syndrome evaluation. | GMP-h-CEA-Ab01; GMP-h-CEA-Ab02: Anti-human CEA mouse monoclonal antibody(mAb) |
Human Carcinoembryonic antigen (CEA) antigen binding, ELISA validated as capture antibody and detection antibody. Pair recommendation with other Carcinoembryonic antigen (CEA) antibodies in CEA level test of Cancer (breast cancer, lung cancer, breast cancer, liver cancer, pancreatic cancer, stomach cancer, ovarian cancer) and related syndrome evaluation. | ![]() |
Alpha-fetoprotein (AFP)
Cat No. | Species | Biomarker | Disease | Cat No.of Antigen | Bioactivity validation of Antigen | Cat No.of Antibodies | Bioactivity validation of Antibodies | Order |
GMP-h-AFP | Human | Alpha-fetoprotein (AFP) | liver cancer, cancer of the ovaries or testicles, liver cirrhosis and hepatitis | GMP-h-AFP-Ag01: Recombinant human AFP Protein |
Alpha-fetoprotein (AFP) antibodies, Immunogen in Sandwich Elisa, lateral-flow tests,and other immunoassays as control material in AFP level test of Cancer(liver cancer, cancer of the ovaries or testicles, liver cirrhosis and hepatitis) and related syndrome evaluation. | GMP-h-AFP-Ab01; GMP-h-AFP-Ab02: Anti-human AFP mouse monoclonal antibody(mAb) |
Human Alpha-fetoprotein (AFP) antigen binding, ELISA validated as capture antibody and detection antibody. Pair recommendation with other Alpha-fetoprotein (AFP) antibodies in AFP level test of Cancer (liver cancer, cancer of the ovaries or testicles, liver cirrhosis and hepatitis) and related syndrome evaluation. | ![]() |
soluble vascular endothelial growth factor receptor-1 (sFlt-1)
Cat No. | Species | Biomarker | Disease | Cat No.of Antigen | Bioactivity validation of Antigen | Cat No.of Antibodies | Bioactivity validation of Antibodies | Order |
GMP-h-sFlt-1 | Human | soluble vascular endothelial growth factor receptor-1 (sFlt-1) | ascular diseases and cancer | GMP-h-sFlt-1-Ag01: Recombinant human sFlt-1 Protein |
soluble vascular endothelial growth factor receptor-1 (sFlt-1) antibodies, Immunogen in Sandwich Elisa, lateral-flow tests,and other immunoassays as control material in sFlt-1 level test of Cancer(ascular diseases and cancer) and related syndrome evaluation. | GMP-h-sFlt-1-Ab01; GMP-h-sFlt-1-Ab02: Anti-human sFlt-1 mouse monoclonal antibody(mAb) |
Human soluble vascular endothelial growth factor receptor-2 (sFlt-1) antigen binding, ELISA validated as capture antibody and detection antibody. Pair recommendation with other soluble vascular endothelial growth factor receptor-2 (sFlt-1) antibodies in sFlt-1 level test of Cancer (ascular diseases and cancer) and related syndrome evaluation. | ![]() |
Prostate-specific antigen (PSA)
Cat No. | Species | Biomarker | Disease | Cat No.of Antigen | Bioactivity validation of Antigen | Cat No.of Antibodies | Bioactivity validation of Antibodies | Order |
GMP-h-PSA | Human | Prostate-specific antigen (PSA) | prostate cancer | GMP-h-PSA-Ag01: Recombinant human PSA Protein |
Prostate-specific antigen (PSA) antibodies, Immunogen in Sandwich Elisa, lateral-flow tests,and other immunoassays as control material in PSA level test of Cancer(prostate cancer) and related syndrome evaluation. | GMP-h-PSA-Ab01; GMP-h-PSA-Ab02: Anti-human PSA mouse monoclonal antibody(mAb) |
Human Prostate-specific antigen (PSA) antigen binding, ELISA validated as capture antibody and detection antibody. Pair recommendation with other Prostate-specific antigen (PSA) antibodies in PSA level test of Cancer (prostate cancer) and related syndrome evaluation. | ![]() |
Human epidermal growth factor (hEGF)
Cat No. | Species | Biomarker | Disease | Cat No.of Antigen | Bioactivity validation of Antigen | Cat No.of Antibodies | Bioactivity validation of Antibodies | Order |
GMP-h-hEGF | Human | Human epidermal growth factor (hEGF) | lung cancer, anal cancers, glioblastoma and epithelian tumors of the head and neck | GMP-h-hEGF-Ag01: Recombinant human hEGF Protein |
Human epidermal growth factor (hEGF) antibodies, Immunogen in Sandwich Elisa, lateral-flow tests,and other immunoassays as control material in hEGF level test of Cancer(lung cancer, anal cancers, glioblastoma and epithelian tumors of the head and neck) and related syndrome evaluation. | GMP-h-hEGF-Ab01; GMP-h-hEGF-Ab02: Anti-human hEGF mouse monoclonal antibody(mAb) |
Human Human epidermal growth factor (hEGF) antigen binding, ELISA validated as capture antibody and detection antibody. Pair recommendation with other Human epidermal growth factor (hEGF) antibodies in hEGF level test of Cancer (lung cancer, anal cancers, glioblastoma and epithelian tumors of the head and neck) and related syndrome evaluation. | ![]() |
trefoil factor 2 (TFF2)
Cat No. | Species | Biomarker | Disease | Cat No.of Antigen | Bioactivity validation of Antigen | Cat No.of Antibodies | Bioactivity validation of Antibodies | Order |
GMP-SMT-TFF2 | Human | trefoil factor 2 (TFF2) | Crohn´s disease and inflammatory bowel disease prostate breast, colon and ovarian cancer | GMP-SMT-TFF2-Ag01: BSA-trefoil factor 2 (TFF2) GMP-SMT-TFF2-Ag02: OVA-trefoil factor 2 (TFF2) |
Competitive immunoassay-validated hapten-carrier conjugates [BSA-&OVA-trefoil factor 2 (TFF2)], trefoil factor 2 (TFF2) antibodies binding, Immunogen in Competitive immunoassay validation, Elisa, lateral-flow tests,and other immunoassays as control material in TFF2 level test of Cancer (Crohn´s disease and inflammatory bowel disease prostate breast, colon and ovarian cancer) and related syndrome evaluation. | GMP-SMT-TFF2-Ab01: Anti-trefoil factor 2 (TFF2) mouse monoclonal antibody(mAb) |
Human Carbohydrate antigen 19-9 (CA199) antigen binding, ELISA validated as capture antibody and detection antibody. Pair recommendation with other Carbohydrate antigen 19-9 (CA199) antibodies in CA199 level test of Cancer (pancreatic and biliary tract tumors) and related syndrome evaluation. | ![]() |
trefoil factor 3 (TFF3)
Cat No. | Species | Biomarker | Disease | Cat No.of Antigen | Bioactivity validation of Antigen | Cat No.of Antibodies | Bioactivity validation of Antibodies | Order |
GMP-SMT-TFF3 | Human | trefoil factor 3 (TFF3) | gastric cancer | GMP-SMT-TFF3-Ag01: BSA-trefoil factor 3 (TFF3) GMP-SMT-TFF3-Ag02: OVA-trefoil factor 3 (TFF3) |
Competitive immunoassay-validated hapten-carrier conjugates [BSA-&OVA-trefoil factor 3 (TFF3)], trefoil factor 3 (TFF3) antibodies binding, Immunogen in Competitive immunoassay validation, Elisa, lateral-flow tests,and other immunoassays as control material in TFF3 level test of Cancer (gastric cancer) and related syndrome evaluation. | GMP-SMT-TFF3-Ab01: Anti-trefoil factor 3 (TFF3) mouse monoclonal antibody(mAb) |
Human Carbohydrate Antigen 50 (CA50) antigen binding, ELISA validated as capture antibody and detection antibody. Pair recommendation with other Carbohydrate Antigen 50 (CA50) antibodies in CA50 level test of Cancer (pancreatic and colorectal cancer) and related syndrome evaluation. | ![]() |
Carbohydrate antigen 19-9 (CA199)
Cat No. | Species | Biomarker | Disease | Cat No.of Antigen | Bioactivity validation of Antigen | Cat No.of Antibodies | Bioactivity validation of Antibodies | Order |
GMP-h-CA199 | Human | Carbohydrate antigen 19-9 (CA199) | pancreatic and biliary tract tumors | GMP-h-CA199-Ag01: Recombinant human CA199 Protein |
Carbohydrate antigen 19-9 (CA199) antibodies, Immunogen in Sandwich Elisa, lateral-flow tests,and other immunoassays as control material in CA199 level test of Cancer(pancreatic and biliary tract tumors) and related syndrome evaluation. | GMP-h-CA199-Ab01; GMP-h-CA199-Ab02: Anti-human CA199 mouse monoclonal antibody(mAb) |
Human Thymidine Kinase 1 (TK1) antigen binding, ELISA validated as capture antibody and detection antibody. Pair recommendation with other Thymidine Kinase 1 (TK1) antibodies in TK1 level test of Cancer (hematological malignancies) and related syndrome evaluation. | ![]() |
Carbohydrate Antigen 50 (CA50)
Cat No. | Species | Biomarker | Disease | Cat No.of Antigen | Bioactivity validation of Antigen | Cat No.of Antibodies | Bioactivity validation of Antibodies | Order |
GMP-h-CA50 | Human | Carbohydrate Antigen 50 (CA50) | pancreatic and colorectal cancer | GMP-h-CA50-Ag01: Recombinant human CA50 Protein |
Carbohydrate Antigen 50 (CA50) antibodies, Immunogen in Sandwich Elisa, lateral-flow tests,and other immunoassays as control material in CA50 level test of Cancer(pancreatic and colorectal cancer) and related syndrome evaluation. | GMP-h-CA50-Ab01; GMP-h-CA50-Ab02: Anti-human CA50 mouse monoclonal antibody(mAb) |
Antibody Binding, Immunogen in Sandwich Elisa, tteral-flow tests,and other immunoassays in Carbohydrate Antigen 50 (CA50) level test in human infectious disease diagnositcs-for West Nile fever. | ![]() |
Thymidine Kinase 1 (TK1)
Cat No. | Species | Biomarker | Disease | Cat No.of Antigen | Bioactivity validation of Antigen | Cat No.of Antibodies | Bioactivity validation of Antibodies | Order |
GMP-h-TK1 | Human | Thymidine Kinase 1 (TK1) | hematological malignancies | GMP-h-TK1-Ag01: Recombinant human TK1 Protein |
Thymidine Kinase 1 (TK1) antibodies, Immunogen in Sandwich Elisa, lateral-flow tests,and other immunoassays as control material in TK1 level test of Cancer(hematological malignancies) and related syndrome evaluation. | GMP-h-TK1-Ab01; GMP-h-TK1-Ab02: Anti-human TK1 mouse monoclonal antibody(mAb) |
Antibody Binding, Immunogen in Sandwich Elisa, tteral-flow tests,and other immunoassays in Thymidine Kinase 1 (TK1) level test in human infectious disease diagnositcs-for West Nile fever. | ![]() |
Diagnostic antibodies and antigens for infectious disease detection
It is important to diagnose the infectious disease even before it becomes serious. The traditional pathogen-detection methods, such as culture, have established their credibility over time, they are often slow and relatively insensitive. In addition, there are several emerging infectious diseases (ID) such as dengue fever, zika virus, corona virus and so on are need to be diagnosed immediately to prevent the outbreak. Immunodiagnostics show great promise than the traditional methods used in clinical diagnosis. GENEMEDI developed the antigens and antibodies for rapid kit such as competitive immunoassay validation (Competitive ELISA) with hapten-carrier conjugates and anti-Hapten antibody, and Lateral flow immunoassay (LFIA) ELISA, Lateral flow immunoassay (LFIA), colloidal gold immunochromatographic assay, Chemiluminescent immunoassay (CLIA), turbidimetric inhibition immuno assay (TINIA), immunonephelometry and POCT to detect the different types of infectious disease.
Classification:
Flu A
Flu B
HIV-1
HIV-2
HIV1/2
HIV-O
HCV
Treponema Pallidum
T. gondii
rubella virus
Cytomegalovirus
HSV
HSV-1
HSV-2
B. anthracis
Ebola virus
Vaccinia virus (cowpox virus)
West Nile virus
Adenovirus
Plasmodium vivax; Plasmodium falciparum
Astrovirus
Norovirus
C. jejuni
L. monocytogenes
Rotavirus
Salmonella typhi
C. albicans
HPV
HBV
HBV-PreS1
Food source pathogenic bacteria resistant
Rift Valley Fever
EBV
EBV-IgA
V. cholerae
M. tuberculosis
Cryptosporidium parvum (Cp23 )
RSV
Rhinoviruses
dengue nonstructural 1 (DEN-NS1)
Enterovirus
streptolysin O
Mycoplasma pneumoniae
Helicobacter pylori
PrP
STDs
ARTI
Nucleocapsid
Influenza A (flu A)
Cat No. | Pathogen | Target | Disease | Cat No.of Antigen | Bioactivity validation of Antigen | Cat No.of Antibodies | Bioactivity validation of Antibodies | Order |
GMP-IVD-P001-Tg001 | Influenza A (flu A) | nucleoprotein (NP) | Flu | GMP-IVD-P001-Tg001-Ag01: Recombinant Influenza A (flu A) nucleoprotein (NP) Protein |
Influenza A (nucleoprotein (NP)) antibodies binding, Immunogen in Sandwich Elisa, lateral-flow tests, and other immunoassays as control material in nucleoprotein (NP) level test of Infectious disease (Flu) and related syndrome evaluation. | GMP-IVD-P001-Tg001-Ab01; GMP-IVD-P001-Tg001-Ab02: Anti-Influenza A (flu A) nucleoprotein (NP) mouse monoclonal antibody (mAb) |
Influenza A (nucleoprotein (NP)) antigen binding, ELISA validated as capture antibody and detection antibody. Pair recommendation with other Influenza A (nucleoprotein (NP)) antibodies in nucleoprotein (NP) level test of Infectious disease (Flu) and related syndrome evaluation. | ![]() |
Influenza B (Flu B)
Cat No. | Pathogen | Target | Disease | Cat No.of Antigen | Bioactivity validation of Antigen | Cat No.of Antibodies | Bioactivity validation of Antibodies | Order |
GMP-IVD-P002-Tg001 | Influenza B (Flu B) | nucleoprotein (NP) | Flu | GMP-IVD-P002-Tg001-Ag01: Recombinant Influenza B (Flu B) nucleoprotein (NP) Protein |
Influenza B (nucleoprotein (NP)) antibodies binding, Immunogen in Sandwich Elisa, lateral-flow tests, and other immunoassays as control material in nucleoprotein (NP) level test of Infectious disease (Flu) and related syndrome evaluation. | GMP-IVD-P002-Tg001-Ab01; GMP-IVD-P002-Tg001-Ab02: Anti-Influenza B (Flu B) nucleoprotein (NP) mouse monoclonal antibody (mAb) |
Influenza B (nucleoprotein (NP)) antigen binding, ELISA validated as capture antibody and detection antibody. Pair recommendation with other Influenza B (nucleoprotein (NP)) antibodies in nucleoprotein (NP) level test of Infectious disease (Flu) and related syndrome evaluation. | ![]() |
Human immunodeficiency virus 1 (HIV-1)
Cat No. | Pathogen | Target | Disease | Cat No.of Antigen | Bioactivity validation of Antigen | Cat No.of Antibodies | Bioactivity validation of Antibodies | Order |
GMP-IVD-P003-Tg001 | Human immunodeficiency virus 1 (HIV-1) | GP41 Protein | Acquired immunodeficiency syndrome(AIDS) | GMP-IVD-P003-Tg001-Ag01: Recombinant Human immunodeficiency virus 1 (HIV-1) GP41 Protein Protein |
Human immunodeficiency virus 1 (GP41 Protein) antibodies binding, Immunogen in Sandwich Elisa, lateral-flow tests, and other immunoassays as control material in GP41 Protein level test of Infectious disease (Acquired immunodeficiency syndrome(AIDS)) and related syndrome evaluation. | GMP-IVD-P003-Tg001-Ab01; GMP-IVD-P003-Tg001-Ab02: Anti-Human immunodeficiency virus 1 (HIV-1) GP41 Protein mouse monoclonal antibody (mAb) |
Human immunodeficiency virus 1 (GP41 Protein) antigen binding, ELISA validated as capture antibody and detection antibody. Pair recommendation with other Human immunodeficiency virus 1 (GP41 Protein) antibodies in GP41 Protein level test of Infectious disease (Acquired immunodeficiency syndrome(AIDS)) and related syndrome evaluation. | ![]() |
Human immunodeficiency virus 2 (HIV-2)
Cat No. | Pathogen | Target | Disease | Cat No.of Antigen | Bioactivity validation of Antigen | Cat No.of Antibodies | Bioactivity validation of Antibodies | Order |
GMP-IVD-P004-Tg001 | Human immunodeficiency virus 2 (HIV-2) | GP36 Protein | Acquired immunodeficiency syndrome(AIDS) | GMP-IVD-P004-Tg001-Ag01: Recombinant Human immunodeficiency virus 2 (HIV-2) GP36 Protein Protein |
Human immunodeficiency virus 2 (GP36 Protein) antibodies binding, Immunogen in Sandwich Elisa, lateral-flow tests, and other immunoassays as control material in GP36 Protein level test of Infectious disease (Acquired immunodeficiency syndrome(AIDS)) and related syndrome evaluation. | GMP-IVD-P004-Tg001-Ab01; GMP-IVD-P004-Tg001-Ab02: Anti-Human immunodeficiency virus 2 (HIV-2) GP36 Protein mouse monoclonal antibody (mAb) |
Human immunodeficiency virus 2 (GP36 Protein) antigen binding, ELISA validated as capture antibody and detection antibody. Pair recommendation with other Human immunodeficiency virus 2 (GP36 Protein) antibodies in GP36 Protein level test of Infectious disease (Acquired immunodeficiency syndrome(AIDS)) and related syndrome evaluation. | ![]() |
immunodeficiency virus 1/2 (HIV1/2)
Cat No. | Pathogen | Target | Disease | Cat No.of Antigen | Bioactivity validation of Antigen | Cat No.of Antibodies | Bioactivity validation of Antibodies | Order |
GMP-IVD-P005-Tg001 | immunodeficiency virus 1/2 (HIV1/2) | HIV p24 antigen | AIDS | GMP-IVD-P005-Tg001-Ag01: Recombinant immunodeficiency virus 1/2 (HIV1/2) HIV p24 antigen Protein |
immunodeficiency virus 1/2 (HIV p24 antigen) antibodies binding, Immunogen in Sandwich Elisa, lateral-flow tests, and other immunoassays as control material in HIV p24 antigen level test of Infectious disease (AIDS) and related syndrome evaluation. | GMP-IVD-P005-Tg001-Ab01; GMP-IVD-P005-Tg001-Ab02: Anti-immunodeficiency virus 1/2 (HIV1/2) HIV p24 antigen mouse monoclonal antibody (mAb) |
immunodeficiency virus 1/2 (HIV p24 antigen) antigen binding, ELISA validated as capture antibody and detection antibody. Pair recommendation with other immunodeficiency virus 1/2 (HIV p24 antigen) antibodies in HIV p24 antigen level test of Infectious disease (AIDS) and related syndrome evaluation. | ![]() |
immunodeficiency virus-O antigen (HIV-O)
Cat No. | Pathogen | Target | Disease | Cat No.of Antigen | Bioactivity validation of Antigen | Cat No.of Antibodies | Bioactivity validation of Antibodies | Order |
GMP-IVD-P006-Tg001 | immunodeficiency virus-O antigen (HIV-O) | O-antigen | AIDS | GMP-IVD-P006-Tg001-Ag01: Recombinant immunodeficiency virus-O antigen (HIV-O) O-antigen Protein |
immunodeficiency virus-O antigen (O-antigen) antibodies binding, Immunogen in Sandwich Elisa, lateral-flow tests, and other immunoassays as control material in O-antigen level test of Infectious disease (AIDS) and related syndrome evaluation. | GMP-IVD-P006-Tg001-Ab01; GMP-IVD-P006-Tg001-Ab02: Anti-immunodeficiency virus-O antigen (HIV-O) O-antigen mouse monoclonal antibody (mAb) |
immunodeficiency virus-O antigen (O-antigen) antigen binding, ELISA validated as capture antibody and detection antibody. Pair recommendation with other immunodeficiency virus-O antigen (O-antigen) antibodies in O-antigen level test of Infectious disease (AIDS) and related syndrome evaluation. | ![]() |
hepatitis C virus (HCV)
Cat No. | Pathogen | Target | Disease | Cat No.of Antigen | Bioactivity validation of Antigen | Cat No.of Antibodies | Bioactivity validation of Antibodies | Order |
GMP-IVD-P007-Tg001 | hepatitis C virus (HCV) | Recombinant HCV NS3-NS4-NS5 fusion Protein (His Tag) | Hepatitis C | GMP-IVD-P007-Tg001-Ag01: Recombinant hepatitis C virus (HCV) Recombinant HCV NS3-NS4-NS5 fusion Protein (His Tag) Protein |
HCV core antigen (Recombinant HCV NS3-NS4-NS5 fusion Protein (His Tag)) antibodies binding, Immunogen in Sandwich Elisa, lateral-flow tests, and other immunoassays as control material in Recombinant HCV NS3-NS4-NS5 fusion Protein (His Tag) level test of Infectious disease (Hepatitis C) and related syndrome evaluation. | GMP-IVD-P007-Tg001-Ab01; GMP-IVD-P007-Tg001-Ab02: Anti-hepatitis C virus (HCV) Recombinant HCV NS3-NS4-NS5 fusion Protein (His Tag) mouse monoclonal antibody (mAb) |
HCV core antigen (Recombinant HCV NS3-NS4-NS5 fusion Protein (His Tag)) antigen binding, ELISA validated as capture antibody and detection antibody. Pair recommendation with other HCV core antigen (Recombinant HCV NS3-NS4-NS5 fusion Protein (His Tag)) antibodies in Recombinant HCV NS3-NS4-NS5 fusion Protein (His Tag) level test of Infectious disease (Hepatitis C) and related syndrome evaluation. | ![]() |
GMP-IVD-P007-Tg002 | hepatitis C virus (HCV) | HCV core antigen | Hepatitis C | GMP-IVD-P007-Tg002-Ag01: Recombinant hepatitis C virus (HCV) core protein |
Hepatitis C virus core protein (HCV core protein) antibodies binding, Immunogen in Sandwich Elisa, lateral-flow tests, and other immunoassays as control material in core protein level test of Infectious disease (Hepatitis C) and related syndrome evaluation | GMP-IVD-P007-Tg002-Ab01; GMP-IVD-P007-Tg002-Ab02: Anti-hepatitis C virus (HCV) core protein mouse monoclonal antibody (mAb) |
Hepatitis C virus core antigen (HCV core antigen) antigen binding, ELISA validated as capture antibody and detection antibody. Pair recommendation with other Hepatitis C virus core antigen (HCV core antigen) antibodies in HCV core antigen level test of Infectious disease (Hepatitis C) and related syndrome evaluation. | ![]() |
Treponema Pallidum (TP)
Cat No. | Pathogen | Target | Disease | Cat No.of Antigen | Bioactivity validation of Antigen | Cat No.of Antibodies | Bioactivity validation of Antibodies | Order |
GMP-IVD-P008-Tg001 | Treponema Pallidum (TP) | Recombinant TP P15-P17-P47 fusion Protein (His Tag) | syphilis | GMP-IVD-P008-Tg001-Ag01: Recombinant Treponema Pallidum (TP) Recombinant TP P15-P17-P47 fusion Protein (His Tag) Protein |
Treponema Pallidum (Recombinant TP P15-P17-P47 fusion Protein (His Tag)) antibodies binding, Immunogen in Sandwich Elisa, lateral-flow tests, and other immunoassays as control material in Recombinant TP P15-P17-P47 fusion Protein (His Tag) level test of Infectious disease (syphilis) and related syndrome evaluation. | GMP-IVD-P008-Tg001-Ab01; GMP-IVD-P008-Tg001-Ab02: Anti-Treponema Pallidum (TP) Recombinant TP P15-P17-P47 fusion Protein (His Tag) mouse monoclonal antibody (mAb) |
Treponema Pallidum (Recombinant TP P15-P17-P47 fusion Protein (His Tag)) antigen binding, ELISA validated as capture antibody and detection antibody. Pair recommendation with other Treponema Pallidum (Recombinant TP P15-P17-P47 fusion Protein (His Tag)) antibodies in Recombinant TP P15-P17-P47 fusion Protein (His Tag) level test of Infectious disease (syphilis) and related syndrome evaluation. | ![]() |
Toxoplasma gondii (T. gondii)
Cat No. | Pathogen | Target | Disease | Cat No.of Antigen | Bioactivity validation of Antigen | Cat No.of Antibodies | Bioactivity validation of Antibodies | Order |
GMP-IVD-P009-Tg001 | Toxoplasma gondii (T. gondii) | P30 | Toxoplasmosis | GMP-IVD-P009-Tg001-Ag01: Recombinant Toxoplasma gondii (T. gondii) P30 Protein |
toxoplasma gondii (P30) antibodies binding, Immunogen in Sandwich Elisa, lateral-flow tests, and other immunoassays as control material in P30 level test of Infectious disease (Toxoplasmosis) and related syndrome evaluation. | GMP-IVD-P009-Tg001-Ab01; GMP-IVD-P009-Tg001-Ab02: Anti-Toxoplasma gondii (T. gondii) P30 mouse monoclonal antibody (mAb) |
toxoplasma gondii (P30) antigen binding, ELISA validated as capture antibody and detection antibody. Pair recommendation with other toxoplasma gondii (P30) antibodies in P30 level test of Infectious disease (Toxoplasmosis) and related syndrome evaluation. | ![]() |
rubella virus
Cat No. | Pathogen | Target | Disease | Cat No.of Antigen | Bioactivity validation of Antigen | Cat No.of Antibodies | Bioactivity validation of Antibodies | Order |
GMP-IVD-P010-Tg001 | rubella virus | CAPSID (C) | Rubella or German measles or three-day measlesis | GMP-IVD-P010-Tg001-Ag01: Recombinant rubella virus CAPSID (C) Protein |
rubella virus (CAPSID (C)) antibodies binding, Immunogen in Sandwich Elisa, lateral-flow tests, and other immunoassays as control material in CAPSID (C) level test of Infectious disease (Rubella or German measles or three-day measlesis) and related syndrome evaluation. | GMP-IVD-P010-Tg001-Ab01; GMP-IVD-P010-Tg001-Ab02: Anti-rubella virus CAPSID (C) mouse monoclonal antibody (mAb) |
rubella virus (CAPSID (C)) antigen binding, ELISA validated as capture antibody and detection antibody. Pair recommendation with other rubella virus (CAPSID (C)) antibodies in CAPSID (C) level test of Infectious disease (Rubella or German measles or three-day measlesis) and related syndrome evaluation. | ![]() |
GMP-IVD-P010-Tg002 | rubella virus | capsid protein; Nucleoprotein | Rubella | GMP-IVD-P010-Tg002-Ag01: Recombinant rubella virus capsid protein; Nucleoprotein Protein |
rubella virus (capsid protein; Nucleoprotein) antibodies binding, Immunogen in Sandwich Elisa, lateral-flow tests, and other immunoassays as control material in capsid protein; Nucleoprotein level test of Infectious disease (Rubella) and related syndrome evaluation. | GMP-IVD-P010-Tg002-Ab01; GMP-IVD-P010-Tg002-Ab02: Anti-rubella virus capsid protein; Nucleoprotein mouse monoclonal antibody (mAb) |
rubella virus (capsid protein; Nucleoprotein) antigen binding, ELISA validated as capture antibody and detection antibody. Pair recommendation with other rubella virus (capsid protein; Nucleoprotein) antibodies in capsid protein; Nucleoprotein level test of Infectious disease (Rubella) and related syndrome evaluation. | ![]() |
Cytomegalovirus (CMV)
Cat No. | Pathogen | Target | Disease | Cat No.of Antigen | Bioactivity validation of Antigen | Cat No.of Antibodies | Bioactivity validation of Antibodies | Order |
GMP-IVD-P011-Tg001 | Cytomegalovirus (CMV) | pp65 | chickenpox, herpes simplex and mononucleosis | GMP-IVD-P011-Tg001-Ag01: Recombinant Cytomegalovirus (CMV) pp65 Protein |
Cytomegalovirus (pp65) antibodies binding, Immunogen in Sandwich Elisa, lateral-flow tests, and other immunoassays as control material in pp65 level test of Infectious disease (chickenpox, herpes simplex and mononucleosis) and related syndrome evaluation. | GMP-IVD-P011-Tg001-Ab01; GMP-IVD-P011-Tg001-Ab02: Anti-Cytomegalovirus (CMV) pp65 mouse monoclonal antibody (mAb) |
Cytomegalovirus (pp65) antigen binding, ELISA validated as capture antibody and detection antibody. Pair recommendation with other Cytomegalovirus (pp65) antibodies in pp65 level test of Infectious disease (chickenpox, herpes simplex and mononucleosis) and related syndrome evaluation. | ![]() |
herpes simplex virus (HSV)
Cat No. | Pathogen | Target | Disease | Cat No.of Antigen | Bioactivity validation of Antigen | Cat No.of Antibodies | Bioactivity validation of Antibodies | Order |
GMP-IVD-P012-Tg001 | herpes simplex virus (HSV) | glycoprotein G | HSV-1 and HSV-2, can cause oral or genital infection. Most often, HSV-1 causes gingivostomatitis, herpes labialis, and herpes keratitis. HSV-2 usually causes genital lesions. Generally, recurrent eruptions are less severe and occur less frequently over time. | GMP-IVD-P012-Tg001-Ag01: Recombinant herpes simplex virus (HSV) glycoprotein G Protein |
herpes simplex virus (glycoprotein G (gG)) antibodies binding, Immunogen in Sandwich Elisa, lateral-flow tests, and other immunoassays as control material in herpes simplex virus (glycoprotein G (gG)) level test of Infectious disease(HSV-1 and HSV-2, can cause oral or genital infection. Most often, HSV-1 causes gingivostomatitis, herpes labialis, and herpes keratitis. HSV-2 usually causes genital lesions. Generally, recurrent eruptions are less severe and occur less frequently over time.) and related syndrome evaluation. | GMP-IVD-P012-Tg001-Ab01; GMP-IVD-P012-Tg001-Ab02: Anti-herpes simplex virus (HSV) glycoprotein G mouse monoclonal antibody (mAb) |
herpes simplex virus (HSV) (glycoprotein G (gG)) antigen binding, ELISA validated as capture antibody and detection antibody. Pair recommendation with other herpes simplex virus (glycoprotein G (gG)) antibodies in level test of Infectious disease (HSV-1 and HSV-2, can cause oral or genital infection. Most often, HSV-1 causes gingivostomatitis, herpes labialis, and herpes keratitis. HSV-2 usually causes genital lesions. Generally, recurrent eruptions are less severe and occur less frequently over time.) and related syndrome evaluation. | ![]() |
Herpes simplex virus 1 (HSV-1)
Cat No. | Pathogen | Target | Disease | Cat No.of Antigen | Bioactivity validation of Antigen | Cat No.of Antibodies | Bioactivity validation of Antibodies | Order |
GMP-IVD-P013-Tg001 | Herpes simplex virus 1 (HSV-1) | glycoprotein G (gG-1) | oral herpes | GMP-IVD-P013-Tg001-Ag01: Recombinant Herpes simplex virus 1 (HSV-1) glycoprotein G (gG-1) Protein |
Herpes simplex virus 1 (glycoprotein G (gG-1)) antibodies binding, Immunogen in Sandwich Elisa, lateral-flow tests, and other immunoassays as control material in glycoprotein G (gG-1) level test of Infectious disease (oral herpes) and related syndrome evaluation. | GMP-IVD-P013-Tg001-Ab01; GMP-IVD-P013-Tg001-Ab02: Anti-Herpes simplex virus 1 (HSV-1) glycoprotein G (gG-1) mouse monoclonal antibody (mAb) |
Herpes simplex virus 1 (glycoprotein G (gG-1)) antigen binding, ELISA validated as capture antibody and detection antibody. Pair recommendation with other Herpes simplex virus 1 (glycoprotein G (gG-1)) antibodies in glycoprotein G (gG-1) level test of Infectious disease (oral herpes) and related syndrome evaluation. | ![]() |
Herpes simplex virus 2 (HSV-2)
Cat No. | Pathogen | Target | Disease | Cat No.of Antigen | Bioactivity validation of Antigen | Cat No.of Antibodies | Bioactivity validation of Antibodies | Order |
GMP-IVD-P014-Tg001 | Herpes simplex virus 2 (HSV-2) | glycoprotein G (gG-2) | genital herpes | GMP-IVD-P014-Tg001-Ag01: Recombinant Herpes simplex virus 2 (HSV-2) glycoprotein G (gG-2) Protein |
Herpes simplex virus 2 (glycoprotein G (gG-2)) antibodies binding, Immunogen in Sandwich Elisa, lateral-flow tests, and other immunoassays as control material in glycoprotein G (gG-2) level test of Infectious disease (genital herpes) and related syndrome evaluation. | GMP-IVD-P014-Tg001-Ab01; GMP-IVD-P014-Tg001-Ab02: Anti-Herpes simplex virus 2 (HSV-2) glycoprotein G (gG-2) mouse monoclonal antibody (mAb) |
Herpes simplex virus 2 (glycoprotein G (gG-2)) antigen binding, ELISA validated as capture antibody and detection antibody. Pair recommendation with other Herpes simplex virus 2 (glycoprotein G (gG-2)) antibodies in glycoprotein G (gG-2) level test of Infectious disease (genital herpes) and related syndrome evaluation. | ![]() |
Bacillus anthracis (B. anthracis)
Cat No. | Pathogen | Target | Disease | Cat No.of Antigen | Bioactivity validation of Antigen | Cat No.of Antibodies | Bioactivity validation of Antibodies | Order |
GMP-IVD-P015-Tg001 | Bacillus anthracis (B. anthracis) | protective antigen (PA) | Anthrax | GMP-IVD-P015-Tg001-Ag01: Recombinant Bacillus anthracis (B. anthracis) protective antigen (PA) Protein |
anthrax bacillus (protective antigen (PA)) antibodies binding, Immunogen in Sandwich Elisa, lateral-flow tests, and other immunoassays as control material in protective antigen (PA) level test of Infectious disease (Anthrax) and related syndrome evaluation. | GMP-IVD-P015-Tg001-Ab01; GMP-IVD-P015-Tg001-Ab02: Anti-Bacillus anthracis (B. anthracis) protective antigen (PA) mouse monoclonal antibody (mAb) |
anthrax bacillus (protective antigen (PA)) antigen binding, ELISA validated as capture antibody and detection antibody. Pair recommendation with other anthrax bacillus (protective antigen (PA)) antibodies in protective antigen (PA) level test of Infectious disease (Anthrax) and related syndrome evaluation. | ![]() |
Ebola virus (EV)
Cat No. | Pathogen | Target | Disease | Cat No.of Antigen | Bioactivity validation of Antigen | Cat No.of Antibodies | Bioactivity validation of Antibodies | Order |
GMP-IVD-P016-Tg001 | ebola virus (EV) | nucleoprotein (NP) | Ebola Virus Disease | GMP-IVD-P016-Tg001-Ag01: Recombinant ebola virus (EV) nucleoprotein (NP) Protein |
ebola virus (nucleoprotein (NP)) antibodies binding, Immunogen in Sandwich Elisa, lateral-flow tests, and other immunoassays as control material in nucleoprotein (NP) level test of Infectious disease (Ebola Virus Disease) and related syndrome evaluation. | GMP-IVD-P016-Tg001-Ab01; GMP-IVD-P016-Tg001-Ab02: Anti-ebola virus (EV) nucleoprotein (NP) mouse monoclonal antibody (mAb) |
ebola virus (nucleoprotein (NP)) antigen binding, ELISA validated as capture antibody and detection antibody. Pair recommendation with other ebola virus (nucleoprotein (NP)) antibodies in nucleoprotein (NP) level test of Infectious disease (Ebola Virus Disease) and related syndrome evaluation. | ![]() |
Vaccinia virus (cowpox virus)
Cat No. | Pathogen | Target | Disease | Cat No.of Antigen | Bioactivity validation of Antigen | Cat No.of Antibodies | Bioactivity validation of Antibodies | Order |
GMP-IVD-P017-Tg001 | Vaccinia virus (cowpox virus) | A27L | Cowpox | GMP-IVD-P017-Tg001-Ag01: Recombinant Vaccinia virus (cowpox virus) A27L Protein |
Vaccinia virus (cowpox virus) A27L antibodies binding, Immunogen in Sandwich Elisa, lateral-flow tests, and other immunoassays as control material in Vaccinia virus (cowpox virus) level test of Infectious disease (Cowpox) and related syndrome evaluation. | GMP-IVD-P017-Tg001-Ab01; GMP-IVD-P017-Tg001-Ab02: Anti-Vaccinia virus (cowpox virus) A27L mouse monoclonal antibody (mAb) |
Vaccinia virus (cowpox virus) A27L antigen binding, ELISA validated as capture antibody and detection antibody. Pair recommendation with other Vaccinia virus (cowpox virus) antibodies in Vaccinia virus (cowpox virus) level test of Infectious disease (Cowpox) and related syndrome evaluation. | ![]() |
GMP-IVD-P017-Tg002 | Vaccinia virus (cowpox virus) | h3l | Cowpox | GMP-IVD-P017-Tg002-Ag01: Recombinant Vaccinia virus (cowpox virus) h3l Protein |
Vaccinia virus (cowpox virus) h3l antibodies binding, Immunogen in Sandwich Elisa, lateral-flow tests, and other immunoassays as control material in Vaccinia virus (cowpox virus) level test of Infectious disease (Cowpox) and related syndrome evaluation. | GMP-IVD-P017-Tg002-Ab01; GMP-IVD-P017-Tg002-Ab02: Anti-Vaccinia virus (cowpox virus) h3l mouse monoclonal antibody (mAb) |
Vaccinia virus (cowpox virus) h3l antigen binding, ELISA validated as capture antibody and detection antibody. Pair recommendation with other Vaccinia virus (cowpox virus) antibodies in Vaccinia virus (cowpox virus) level test of Infectious disease (Cowpox) and related syndrome evaluation. | ![]() |
GMP-IVD-P017-Tg003 | Vaccinia virus (cowpox virus) | b5r | Cowpox | GMP-IVD-P017-Tg003-Ag01: Recombinant Vaccinia virus (cowpox virus) b5r Protein |
Vaccinia virus (cowpox virus) b5r antibodies binding, Immunogen in Sandwich Elisa, lateral-flow tests, and other immunoassays as control material in Vaccinia virus (cowpox virus) level test of Infectious disease (Cowpox) and related syndrome evaluation. | GMP-IVD-P017-Tg003-Ab01; GMP-IVD-P017-Tg003-Ab02: Anti-Vaccinia virus (cowpox virus) b5r mouse monoclonal antibody (mAb) |
Vaccinia virus (cowpox virus) b5r antigen binding, ELISA validated as capture antibody and detection antibody. Pair recommendation with other Vaccinia virus (cowpox virus) antibodies in Vaccinia virus (cowpox virus) level test of Infectious disease (Cowpox) and related syndrome evaluation. | ![]() |
West Nile virus (WNV)
Cat No. | Pathogen | Target | Disease | Cat No.of Antigen | Bioactivity validation of Antigen | Cat No.of Antibodies | Bioactivity validation of Antibodies | Order |
GMP-IVD-P018-Tg001 | West Nile virus (WNV) | envelope (E) | West Nile fever | GMP-IVD-P018-Tg001-Ag01: Recombinant West Nile virus (WNV) envelope (E) Protein |
West Nile virus (envelope (E)) antibodies binding, Immunogen in Sandwich Elisa, lateral-flow tests, and other immunoassays as control material in envelope (E) level test of Infectious disease (West Nile fever) and related syndrome evaluation. | GMP-IVD-P018-Tg001-Ab01; GMP-IVD-P018-Tg001-Ab02: Anti-West Nile virus (WNV) envelope (E) mouse monoclonal antibody (mAb) |
West Nile virus (envelope (E)) antigen binding, ELISA validated as capture antibody and detection antibody. Pair recommendation with other West Nile virus (envelope (E)) antibodies in envelope (E) level test of Infectious disease (West Nile fever) and related syndrome evaluation. | ![]() |
Adenovirus
Cat No. | Pathogen | Target | Disease | Cat No.of Antigen | Bioactivity validation of Antigen | Cat No.of Antibodies | Bioactivity validation of Antibodies | Order |
GMP-IVD-P019-Tg001 | adenovirus | NA | cold-like symptoms, fever, sore throat, bronchitis, pneumonia, diarrhea, and pink eye (conjunctivitis) | GMP-IVD-P019-Tg001-Ag01: Recombinant adenovirus Protein |
adenovirus antibodies binding, Immunogen in Sandwich Elisa, lateral-flow tests, and other immunoassays as control material in adenovirus level test of Infectious disease (cold-like symptoms, fever, sore throat, bronchitis, pneumonia, diarrhea, and pink eye (conjunctivitis)) and related syndrome evaluation. | GMP-IVD-P019-Tg001-Ab01; GMP-IVD-P019-Tg001-Ab02: Anti-adenovirus mouse monoclonal antibody (mAb) |
adenovirus antigen binding, ELISA validated as capture antibody and detection antibody. Pair recommendation with other adenovirus antibodies in adenovirus level test of Infectious disease (cold-like symptoms, fever, sore throat, bronchitis, pneumonia, diarrhea, and pink eye (conjunctivitis)) and related syndrome evaluation. | ![]() |
Plasmodium [Plasmodium falciparum] [Plasmodium knowlesi] [Plasmodium malariae] [Plasmodium ovale] [Plasmodium vivax]
Cat No. | Pathogen | Target | Disease | Cat No.of Antigen | Bioactivity validation of Antigen | Cat No.of Antibodies | Bioactivity validation of Antibodies | Order |
GMP-IVD-P020-Tg001 | Plasmodium [Plasmodium falciparum] [Plasmodium knowlesi] [Plasmodium malariae] [Plasmodium ovale] [Plasmodium vivax] |
merozoite surface protein (MSP) | malaria | GMP-IVD-P020-Tg001-Ag01: Recombinant Plasmodium [Plasmodium falciparum] [Plasmodium knowlesi] [Plasmodium malariae] [Plasmodium ovale] [Plasmodium vivax] merozoite surface protein (MSP) Protein |
Plasmodium [Plasmodium falciparum] [Plasmodium knowlesi] [Plasmodium malariae] [Plasmodium ovale] [Plasmodium vivax] (merozoite surface protein (MSP)) antibodies binding, Immunogen in Sandwich Elisa, lateral-flow tests,and other immunoassays as control material in merozoite surface protein (MSP) level test of Infectious disease(malaria) and related syndrome evaluation. | GMP-IVD-P020-Tg001-Ab01; GMP-IVD-P020-Tg001-Ab02: Anti-Plasmodium [Plasmodium falciparum] [Plasmodium knowlesi] [Plasmodium malariae] [Plasmodium ovale] [Plasmodium vivax] merozoite surface protein (MSP) mouse monoclonal antibody (mAb) |
Plasmodium [Plasmodium falciparum] [Plasmodium knowlesi] [Plasmodium malariae] [Plasmodium ovale] [Plasmodium vivax] malaria (merozoite surface protein (MSP)) antigen binding, ELISA validated as capture antibody and detection antibody. Pair recommendation with other Plasmodium (merozoite surface protein (MSP) ) antibodies in merozoite surface protein (MSP) level test of Infectious disease (malaria) and related syndrome evaluation. | ![]() |
GMP-IVD-P020-Tg002 | Plasmodium [Plasmodium falciparum] [Plasmodium knowlesi] [Plasmodium malariae] [Plasmodium ovale] [Plasmodium vivax] |
Circumsporozoite Protein (CSP) | malaria | GMP-IVD-P020-Tg002-Ag01: Recombinant Plasmodium [Plasmodium falciparum] [Plasmodium knowlesi] [Plasmodium malariae] [Plasmodium ovale] [Plasmodium vivax] Circumsporozoite Protein (CSP) Protein |
Plasmodium [Plasmodium falciparum] [Plasmodium knowlesi] [Plasmodium malariae] [Plasmodium ovale] [Plasmodium vivax] (Circumsporozoite Protein (CSP)) antibodies binding, Immunogen in Sandwich Elisa, lateral-flow tests, and other immunoassays as control material in Circumsporozoite Protein (CSP) level test of Infectious disease(malaria) and related syndrome evaluation. | GMP-IVD-P020-Tg002-Ab01; GMP-IVD-P020-Tg001-Ab02: Anti-Plasmodium [Plasmodium falciparum] [Plasmodium knowlesi] [Plasmodium malariae] [Plasmodium ovale] [Plasmodium vivax] Circumsporozoite Protein (CSP) mouse monoclonal antibody (mAb) |
Plasmodium [Plasmodium falciparum] [Plasmodium knowlesi] [Plasmodium malariae] [Plasmodium ovale] [Plasmodium vivax] malaria (Circumsporozoite Protein (CSP)) antigen binding, ELISA validated as capture antibody and detection antibody. Pair recommendation with other Plasmodium (Circumsporozoite Protein (CSP) ) antibodies in Circumsporozoite Protein (CSP) level test of Infectious disease (malaria) and related syndrome evaluation. | ![]() |
Astrovirus
Cat No. | Pathogen | Target | Disease | Cat No.of Antigen | Bioactivity validation of Antigen | Cat No.of Antibodies | Bioactivity validation of Antibodies | Order |
GMP-IVD-P021-Tg001 | Astrovirus | capsid proteins | gastroenteritis | GMP-IVD-P021-Tg001-Ag01: Recombinant Astrovirus capsid proteins Protein |
Astrovirus (capsid proteins) antibodies binding, Immunogen in Sandwich Elisa, lateral-flow tests, and other immunoassays as control material in capsid proteins level test of Infectious disease (gastroenteritis) and related syndrome evaluation. | GMP-IVD-P021-Tg001-Ab01; GMP-IVD-P021-Tg001-Ab02: Anti-Astrovirus capsid proteins mouse monoclonal antibody (mAb) |
Astrovirus (capsid proteins) antigen binding, ELISA validated as capture antibody and detection antibody. Pair recommendation with other Astrovirus (capsid proteins) antibodies in capsid proteins level test of Infectious disease (gastroenteritis) and related syndrome evaluation. | ![]() |
Norovirus (NV)
Cat No. | Pathogen | Target | Disease | Cat No.of Antigen | Bioactivity validation of Antigen | Cat No.of Antibodies | Bioactivity validation of Antibodies | Order |
GMP-IVD-P022-Tg001 | Norovirus (NV) | VP1 | vomiting and diarrhea | GMP-IVD-P022-Tg001-Ag01: Recombinant Norovirus (NV) VP1 Protein |
Norovirus (VP1) antibodies binding, Immunogen in Sandwich Elisa, lateral-flow tests, and other immunoassays as control material in VP1 level test of Infectious disease (vomiting and diarrhea) and related syndrome evaluation. | GMP-IVD-P022-Tg001-Ab01; GMP-IVD-P022-Tg001-Ab02: Anti-Norovirus (NV) VP1 mouse monoclonal antibody (mAb) |
Norovirus (VP1) antigen binding, ELISA validated as capture antibody and detection antibody. Pair recommendation with other Norovirus (VP1) antibodies in VP1 level test of Infectious disease (vomiting and diarrhea) and related syndrome evaluation. | ![]() |
Campylobacter jejuni (C. jejuni)
Cat No. | Pathogen | Target | Disease | Cat No.of Antigen | Bioactivity validation of Antigen | Cat No.of Antibodies | Bioactivity validation of Antibodies | Order |
GMP-IVD-P023-Tg001 | Campylobacter jejuni (C. jejuni) | Outer Membrane Protein (OMP); Flagellar L-ring protein (FLGH) | gastroenteritis | GMP-IVD-P023-Tg001-Ag01: Recombinant Campylobacter jejuni (C. jejuni) Outer Membrane Protein (OMP); Flagellar L-ring protein (FLGH) Protein |
Campylobacter jejuni (Outer Membrane Protein (OMP); Flagellar L-ring protein (FLGH)) antibodies binding, Immunogen in Sandwich Elisa, lateral-flow tests, and other immunoassays as control material in Outer Membrane Protein (OMP); Flagellar L-ring protein (FLGH) level test of Infectious disease (gastroenteritis) and related syndrome evaluation. | GMP-IVD-P023-Tg001-Ab01; GMP-IVD-P023-Tg001-Ab02: Anti-Campylobacter jejuni (C. jejuni) Outer Membrane Protein (OMP); Flagellar L-ring protein (FLGH) mouse monoclonal antibody (mAb) |
Campylobacter jejuni (Outer Membrane Protein (OMP); Flagellar L-ring protein (FLGH)) antigen binding, ELISA validated as capture antibody and detection antibody. Pair recommendation with other Campylobacter jejuni (Outer Membrane Protein (OMP); Flagellar L-ring protein (FLGH)) antibodies in Outer Membrane Protein (OMP); Flagellar L-ring protein (FLGH) level test of Infectious disease (gastroenteritis) and related syndrome evaluation. | ![]() |
Listeria monocytogenes (L. monocytogenes)
Cat No. | Pathogen | Target | Disease | Cat No.of Antigen | Bioactivity validation of Antigen | Cat No.of Antibodies | Bioactivity validation of Antibodies | Order |
GMP-IVD-P024-Tg001 | Listeria monocytogenes (L. monocytogenes) | Listeriolysin O (LLO) | Listeriosis | GMP-IVD-P024-Tg001-Ag01: Recombinant Listeria monocytogenes (L. monocytogenes) Listeriolysin O (LLO) Protein |
Listeria monocytogenes (Listeriolysin O (LLO)) antibodies binding, Immunogen in Sandwich Elisa, lateral-flow tests, and other immunoassays as control material in Listeriolysin O (LLO) level test of Infectious disease (Listeriosis) and related syndrome evaluation. | GMP-IVD-P024-Tg001-Ab01; GMP-IVD-P024-Tg001-Ab02: Anti-Listeria monocytogenes (L. monocytogenes) Listeriolysin O (LLO) mouse monoclonal antibody (mAb) |
Listeria monocytogenes (Listeriolysin O (LLO)) antigen binding, ELISA validated as capture antibody and detection antibody. Pair recommendation with other Listeria monocytogenes (Listeriolysin O (LLO)) antibodies in Listeriolysin O (LLO) level test of Infectious disease (Listeriosis) and related syndrome evaluation. | ![]() |
Rotavirus
Cat No. | Pathogen | Target | Disease | Cat No.of Antigen | Bioactivity validation of Antigen | Cat No.of Antibodies | Bioactivity validation of Antibodies | Order |
GMP-IVD-P025-Tg001 | rotavirus | VP6 | watery diarrhea and vomiting | GMP-IVD-P025-Tg001-Ag01: Recombinant rotavirus VP6 Protein |
rotavirus (VP6) antibodies binding, Immunogen in Sandwich Elisa, lateral-flow tests, and other immunoassays as control material in VP6 level test of Infectious disease (watery diarrhea and vomiting) and related syndrome evaluation. | GMP-IVD-P025-Tg001-Ab01; GMP-IVD-P025-Tg001-Ab02: Anti-rotavirus VP6 mouse monoclonal antibody (mAb) |
rotavirus (VP6) antigen binding, ELISA validated as capture antibody and detection antibody. Pair recommendation with other rotavirus (VP6) antibodies in VP6 level test of Infectious disease (watery diarrhea and vomiting) and related syndrome evaluation. | ![]() |
Salmonella typhi
Cat No. | Pathogen | Target | Disease | Cat No.of Antigen | Bioactivity validation of Antigen | Cat No.of Antibodies | Bioactivity validation of Antibodies | Order |
GMP-IVD-P026-Tg001 | Salmonella typhi | outer membrane channel protein (Tolc) OMP 50 (Salmonella typhi) | Salmonellosis | GMP-IVD-P026-Tg001-Ag01: Recombinant Salmonella typhi outer membrane channel protein (Tolc) OMP 50 (Salmonella typhi) Protein |
salmonella (outer membrane channel protein (Tolc) OMP 50 (Salmonella typhi)) antibodies binding, Immunogen in Sandwich Elisa, lateral-flow tests, and other immunoassays as control material in outer membrane channel protein (Tolc) OMP 50 (Salmonella typhi) level test of Infectious disease (Salmonellosis) and related syndrome evaluation. | GMP-IVD-P026-Tg001-Ab01; GMP-IVD-P026-Tg001-Ab02: Anti-Salmonella typhi outer membrane channel protein (Tolc) OMP 50 (Salmonella typhi) mouse monoclonal antibody (mAb) |
salmonella (outer membrane channel protein (Tolc) OMP 50 (Salmonella typhi)) antigen binding, ELISA validated as capture antibody and detection antibody. Pair recommendation with other salmonella (outer membrane channel protein (Tolc) OMP 50 (Salmonella typhi)) antibodies in outer membrane channel protein (Tolc) OMP 50 (Salmonella typhi) level test of Infectious disease (Salmonellosis) and related syndrome evaluation. | ![]() |
Candida albicans (C. albicans)
Cat No. | Pathogen | Target | Disease | Cat No.of Antigen | Bioactivity validation of Antigen | Cat No.of Antibodies | Bioactivity validation of Antibodies | Order |
GMP-IVD-P027-Tg001 | Candida albicans (C. albicans) | enolase (Candida albicans) | Candidiasis | GMP-IVD-P027-Tg001-Ag01: Recombinant Candida albicans (C. albicans) enolase (Candida albicans) Protein |
candida (enolase (Candida albicans)) antibodies binding, Immunogen in Sandwich Elisa, lateral-flow tests, and other immunoassays as control material in enolase (Candida albicans) level test of Infectious disease (Candidiasis) and related syndrome evaluation. | GMP-IVD-P027-Tg001-Ab01; GMP-IVD-P027-Tg001-Ab02: Anti-Candida albicans (C. albicans) enolase (Candida albicans) mouse monoclonal antibody (mAb) |
candida (enolase (Candida albicans)) antigen binding, ELISA validated as capture antibody and detection antibody. Pair recommendation with other candida (enolase (Candida albicans)) antibodies in enolase (Candida albicans) level test of Infectious disease (Candidiasis) and related syndrome evaluation. | ![]() |
Human papilloma virus (HPV)
Cat No. | Pathogen | Target | Disease | Cat No.of Antigen | Bioactivity validation of Antigen | Cat No.of Antibodies | Bioactivity validation of Antibodies | Order |
GMP-IVD-P028-Tg001 | Human papilloma virus (HPV) | HPV 16 L1 capsid protein | cervical and other cancers | GMP-IVD-P028-Tg001-Ag01: Recombinant Human papilloma virus (HPV) HPV 16 L1 capsid protein Protein |
papilloma virus (HPV 16 L1 capsid protein) antibodies binding, Immunogen in Sandwich Elisa, lateral-flow tests, and other immunoassays as control material in HPV 16 L1 capsid protein level test of Infectious disease (cervical and other cancers) and related syndrome evaluation. | GMP-IVD-P028-Tg001-Ab01; GMP-IVD-P028-Tg001-Ab02: Anti-Human papilloma virus (HPV) HPV 16 L1 capsid protein mouse monoclonal antibody (mAb) |
papilloma virus (HPV 16 L1 capsid protein) antigen binding, ELISA validated as capture antibody and detection antibody. Pair recommendation with other papilloma virus (HPV 16 L1 capsid protein) antibodies in HPV 16 L1 capsid protein level test of Infectious disease (cervical and other cancers) and related syndrome evaluation. | ![]() |
Hepatitis b virus (HBV)
Cat No. | Pathogen | Target | Disease | Cat No.of Antigen | Bioactivity validation of Antigen | Cat No.of Antibodies | Bioactivity validation of Antibodies | Order |
GMP-IVD-P029-Tg001 | Hepatitis b virus (HBV) | HBsAg (hepatitis B surface antigen) | Hepatitis B | GMP-IVD-P029-Tg001-Ag01: Recombinant Hepatitis b virus (HBV) HBsAg Protein |
Hepatitis B s antigen (HBsAg) antibodies binding, Immunogen in Sandwich Elisa, lateral-flow tests, and other immunoassays as control material in HBsAg level test of Infectious disease (Hepatitis B) and related syndrome evaluation. | GMP-IVD-P029-Tg001-Ab01; GMP-IVD-P029-Tg001-Ab02: Anti-Hepatitis B virus (HBV) HBsAg mouse monoclonal antibody (mAb) |
Hepatitis B s antigen (HBsAg) antigen binding, ELISA validated as capture antibody and detection antibody. Pair recommendation with other Hepatitis B s antigen (HBsAg) antibodies in HBsAg level test of Infectious disease (Hepatitis B) and related syndrome evaluation. | ![]() |
GMP-IVD-P029-Tg002 | Hepatitis B virus (HBV) | HBeAg (hepatitis B e-antigen) | Hepatitis B | GMP-IVD-P029-Tg002-Ag01: Recombinant Hepatitis B virus (HBV) HBeAg Protein |
Hepatitis B e antigen (HBeAg) antibodies binding, Immunogen in Sandwich Elisa, lateral-flow tests, and other immunoassays as control material in HBeAg level test of Infectious disease (Hepatitis B) and related syndrome evaluation. | GMP-IVD-P029-Tg002-Ab01; GMP-IVD-P029-Tg002-Ab02: Anti-Hepatitis B virus (HBV) HBeAg mouse monoclonal antibody (mAb) |
Hepatitis B e antigen (HBeAg) antigen binding, ELISA validated as capture antibody and detection antibody. Pair recommendation with other hepatitis B e antigen (HBeAg) antibodies in HBeAg level test of Infectious disease (Hepatitis B) and related syndrome evaluation. | ![]() |
GMP-IVD-P029-Tg003 | Hepatitis B virus (HBV) | HBcAg (hepatitis B Core antigen) | Hepatitis B | GMP-IVD-P029-Tg003-Ag01: Recombinant Hepatitis B virus (HBV) HBcAg Protein |
Hepatitis B core antigen (HBcAg) antibodies binding, Immunogen in Sandwich Elisa, lateral-flow tests, and other immunoassays as control material in HBcAg level test of Infectious disease (Hepatitis B) and related syndrome evaluation. | GMP-IVD-P029-Tg003-Ab01; GMP-IVD-P029-Tg003-Ab02: Anti-Hepatitis B virus (HBV) HBcAg mouse monoclonal antibody (mAb) |
Hepatitis B core antigen (HBcAg) antigen binding, ELISA validated as capture antibody and detection antibody. Pair recommendation with other hepatitis B core antigen (HBcAg) antibodies in HBcAg level test of Infectious disease (Hepatitis B) and related syndrome evaluation. | ![]() |
Hepatitis B virus-PreS1 (HBV-PreS1)
Cat No. | Pathogen | Target | Disease | Cat No.of Antigen | Bioactivity validation of Antigen | Cat No.of Antibodies | Bioactivity validation of Antibodies | Order |
GMP-IVD-P030-Tg001 | Hepatitis B virus-PreS1 (HBV-PreS1 ) | PreS1 | Hepatitis B | GMP-IVD-P030-Tg001-Ag01: Recombinant Hepatitis B virus-PreS1 (HBV-PreS1 ) PreS1 Protein |
Hepatitis B virus-PreS1 (PreS1) antibodies binding, Immunogen in Sandwich Elisa, lateral-flow tests, and other immunoassays as control material in PreS1 level test of Infectious disease (Hepatitis B) and related syndrome evaluation. | GMP-IVD-P030-Tg001-Ab01; GMP-IVD-P030-Tg001-Ab02: Anti-Hepatitis B virus-PreS1 (HBV-PreS1 ) PreS1 mouse monoclonal antibody (mAb) |
Hepatitis B virus-PreS1 (PreS1) antigen binding, ELISA validated as capture antibody and detection antibody. Pair recommendation with other Hepatitis B virus-PreS1 (PreS1) antibodies in PreS1 level test of Infectious disease (Hepatitis B) and related syndrome evaluation. | ![]() |
Food source pathogenic bacteria resistant
Cat No. | Pathogen | Target | Disease | Cat No.of Antigen | Bioactivity validation of Antigen | Cat No.of Antibodies | Bioactivity validation of Antibodies | Order |
GMP-IVD-P031-Tg001 | NA | NA | Food source pathogenic bacteria resistant | GMP-IVD-P031-Tg001-Ag01: Recombinant Food source pathogenic bacteria resistant Protein |
Food source pathogenic bacteria resistant antibodies binding, Immunogen in Sandwich Elisa, lateral-flow tests, and other immunoassays as control material in Food source pathogenic bacteria resistant level test of Infectious disease (Food source pathogenic bacteria resistant) and related syndrome evaluation. | GMP-IVD-P031-Tg001-Ab01; GMP-IVD-P031-Tg001-Ab02: Anti-Food source pathogenic bacteria resistant mouse monoclonal antibody (mAb) |
Food source pathogenic bacteria resistant antigen binding, ELISA validated as capture antibody and detection antibody. Pair recommendation with other Food source pathogenic bacteria resistant antibodies in Food source pathogenic bacteria resistant level test of Infectious disease (Food source pathogenic bacteria resistant) and related syndrome evaluation. | ![]() |
Rift Valley Fever (RVF)
Cat No. | Pathogen | Target | Disease | Cat No.of Antigen | Bioactivity validation of Antigen | Cat No.of Antibodies | Bioactivity validation of Antibodies | Order |
GMP-IVD-P032-Tg001 | Rift Valley Fever (RVF) | nucleoprotein (NP) | Rift Valley Fever | GMP-IVD-P032-Tg001-Ag01: Recombinant Rift Valley Fever (RVF) nucleoprotein (NP) Protein |
Rift Valley Fever (nucleoprotein (NP)) antibodies binding, Immunogen in Sandwich Elisa, lateral-flow tests,and other immunoassays as control material in nucleoprotein (NP) level test of Infectious disease(Rift Valley Fever) and related syndrome evaluation. | GMP-IVD-P032-Tg001-Ab01; GMP-IVD-P032-Tg001-Ab02: Anti-Rift Valley Fever (RVF) nucleoprotein (NP) mouse monoclonal antibody (mAb) |
Rift Valley Fever (nucleoprotein (NP)) antigen binding, ELISA validated as capture antibody and detection antibody. Pair recommendation with other Rift Valley Fever (nucleoprotein (NP)) antibodies in nucleoprotein (NP) level test of Infectious disease (Rift Valley Fever) and related syndrome evaluation. | ![]() |
Epstein-Barr virus (EBV)
Cat No. | Pathogen | Target | Disease | Cat No.of Antigen | Bioactivity validation of Antigen | Cat No.of Antibodies | Bioactivity validation of Antibodies | Order |
GMP-IVD-P033-Tg001 | Epstein-Barr virus (EBV) | Nuclear Antigen (EBNA1); capsid antigen (EB-VCA) | infectious mononucleosis | GMP-IVD-P033-Tg001-Ag01: Recombinant Epstein-Barr virus (EBV) Nuclear Antigen (EBNA1); capsid antigen (EB-VCA) Protein |
Epstein-Barr virus (Nuclear Antigen (EBNA1); capsid antigen (EB-VCA)) antibodies binding, Immunogen in Sandwich Elisa, lateral-flow tests,and other immunoassays as control material in Nuclear Antigen (EBNA1); capsid antigen (EB-VCA) level test of Infectious disease(infectious mononucleosis) and related syndrome evaluation. | GMP-IVD-P033-Tg001-Ab01; GMP-IVD-P033-Tg001-Ab02: Anti-Epstein-Barr virus (EBV) Nuclear Antigen (EBNA1); capsid antigen (EB-VCA) mouse monoclonal antibody (mAb) |
Epstein-Barr virus (Nuclear Antigen (EBNA1); capsid antigen (EB-VCA)) antigen binding, ELISA validated as capture antibody and detection antibody. Pair recommendation with other Epstein-Barr virus (Nuclear Antigen (EBNA1); capsid antigen (EB-VCA)) antibodies in Nuclear Antigen (EBNA1); capsid antigen (EB-VCA) level test of Infectious disease (infectious mononucleosis) and related syndrome evaluation. | ![]() |
Epstein-Barr virus-IgA (EBV-IgA)
Cat No. | Pathogen | Target | Disease | Cat No.of Antigen | Bioactivity validation of Antigen | Cat No.of Antibodies | Bioactivity validation of Antibodies | Order |
GMP-IVD-P034-Tg001 | Epstein-Barr virus-IgA (EBV-IgA) | NA | infectious mononucleosis | GMP-IVD-P034-Tg001-Ag01: Recombinant Epstein-Barr virus-IgA (EBV-IgA) Protein |
Epstein-Barr virus-IgA () antibodies binding, Immunogen in Sandwich Elisa, lateral-flow tests,and other immunoassays as control material in level test of Infectious disease(infectious mononucleosis) and related syndrome evaluation. | GMP-IVD-P034-Tg001-Ab01; GMP-IVD-P034-Tg001-Ab02: Anti- mouse monoclonal antibody (mAb) |
Epstein-Barr virus-IgA () antigen binding, ELISA validated as capture antibody and detection antibody. Pair recommendation with other Epstein-Barr virus-IgA () antibodies in level test of Infectious disease (infectious mononucleosis) and related syndrome evaluation. | ![]() |
Vibrio cholerae (V. cholerae)
Cat No. | Pathogen | Target | Disease | Cat No.of Antigen | Bioactivity validation of Antigen | Cat No.of Antibodies | Bioactivity validation of Antibodies | Order |
GMP-IVD-P035-Tg001 | Vibrio cholerae (V. cholerae) | cytotoxin B (CtxB) | Cholera | GMP-IVD-P035-Tg001-Ag01: Recombinant Vibrio cholerae (V. cholerae) cytotoxin B (CtxB) Protein |
Vibrio cholerae (cytotoxin B (CtxB)) antibodies binding, Immunogen in Sandwich Elisa, lateral-flow tests,and other immunoassays as control material in cytotoxin B (CtxB) level test of Infectious disease(Cholera) and related syndrome evaluation. | GMP-IVD-P035-Tg001-Ab01; GMP-IVD-P035-Tg001-Ab02: Anti-Vibrio cholerae (V. cholerae) cytotoxin B (CtxB) mouse monoclonal antibody (mAb) |
Vibrio cholerae (cytotoxin B (CtxB)) antigen binding, ELISA validated as capture antibody and detection antibody. Pair recommendation with other Vibrio cholerae (cytotoxin B (CtxB)) antibodies in cytotoxin B (CtxB) level test of Infectious disease (Cholera) and related syndrome evaluation. | ![]() |
Mycobacterium tuberculosis (M. tuberculosis)
Cat No. | Pathogen | Target | Disease | Cat No.of Antigen | Bioactivity validation of Antigen | Cat No.of Antibodies | Bioactivity validation of Antibodies | Order |
GMP-IVD-P036-Tg001 | Mycobacterium tuberculosis (M. tuberculosis) | M. tb | Tuberculosis (TB) | GMP-IVD-P036-Tg001-Ag01: Recombinant Mycobacterium tuberculosis (M. tuberculosis) M. tb Protein |
Mycobacterium tuberculosis (M. tb) antibodies binding, Immunogen in Sandwich Elisa, lateral-flow tests,and other immunoassays as control material in M. tb level test of Infectious disease(Tuberculosis (TB)) and related syndrome evaluation. | GMP-IVD-P036-Tg001-Ab01; GMP-IVD-P036-Tg001-Ab02: Anti-Mycobacterium tuberculosis (M. tuberculosis) M. tb mouse monoclonal antibody (mAb) |
Mycobacterium tuberculosis (M. tb) antigen binding, ELISA validated as capture antibody and detection antibody. Pair recommendation with other Mycobacterium tuberculosis (M. tb) antibodies in M. tb level test of Infectious disease (Tuberculosis (TB)) and related syndrome evaluation. | ![]() |
Cryptosporidium parvum (Cp23 )
Cat No. | Pathogen | Target | Disease | Cat No.of Antigen | Bioactivity validation of Antigen | Cat No.of Antibodies | Bioactivity validation of Antibodies | Order |
GMP-IVD-P037-Tg001 | Cryptosporidium parvum (Cp23 ) | Crypto | cryptosporidiosis | GMP-IVD-P037-Tg001-Ag01: Recombinant Cryptosporidium parvum (Cp23 ) Crypto Protein |
Cryptosporidium (Crypto) antibodies binding, Immunogen in Sandwich Elisa, lateral-flow tests,and other immunoassays as control material in Crypto level test of Infectious disease(cryptosporidiosis) and related syndrome evaluation. | GMP-IVD-P037-Tg001-Ab01; GMP-IVD-P037-Tg001-Ab02: Anti-Cryptosporidium parvum (Cp23 ) Crypto mouse monoclonal antibody (mAb) |
Cryptosporidium (Crypto) antigen binding, ELISA validated as capture antibody and detection antibody. Pair recommendation with other Cryptosporidium (Crypto) antibodies in Crypto level test of Infectious disease (cryptosporidiosis) and related syndrome evaluation. | ![]() |
Respiratory syncytial virus (RSV)
Cat No. | Pathogen | Target | Disease | Cat No.of Antigen | Bioactivity validation of Antigen | Cat No.of Antibodies | Bioactivity validation of Antibodies | Order |
GMP-IVD-P038-Tg001 | Respiratory syncytial virus (RSV) | major surface glycoproteins (G and F) | cold | GMP-IVD-P038-Tg001-Ag01: Recombinant Respiratory syncytial virus (RSV) major surface glycoproteins (G and F) Protein |
Respiratory syncytial virus (major surface glycoproteins (G and F)) antibodies binding, Immunogen in Sandwich Elisa, lateral-flow tests,and other immunoassays as control material in major surface glycoproteins (G and F) level test of Infectious disease(cold) and related syndrome evaluation. | GMP-IVD-P038-Tg001-Ab01; GMP-IVD-P038-Tg001-Ab02: Anti-Respiratory syncytial virus (RSV) major surface glycoproteins (G and F) mouse monoclonal antibody (mAb) |
Respiratory syncytial virus (major surface glycoproteins (G and F)) antigen binding, ELISA validated as capture antibody and detection antibody. Pair recommendation with other Respiratory syncytial virus (major surface glycoproteins (G and F)) antibodies in major surface glycoproteins (G and F) level test of Infectious disease (cold) and related syndrome evaluation. | ![]() |
Rhinoviruses (RV)
Cat No. | Pathogen | Target | Disease | Cat No.of Antigen | Bioactivity validation of Antigen | Cat No.of Antibodies | Bioactivity validation of Antibodies | Order |
GMP-IVD-P039-Tg001 | Rhinoviruses (RV) | VP1 and VP3 | common cold | GMP-IVD-P039-Tg001-Ag01: Recombinant Rhinoviruses (RV) VP1 and VP3 Protein |
Rhinoviruses (VP1 and VP3) antibodies binding, Immunogen in Sandwich Elisa, lateral-flow tests,and other immunoassays as control material in VP1 and VP3 level test of Infectious disease(common cold) and related syndrome evaluation. | GMP-IVD-P039-Tg001-Ab01; GMP-IVD-P039-Tg001-Ab02: Anti-Rhinoviruses (RV) VP1 and VP3 mouse monoclonal antibody (mAb) |
Rhinoviruses (VP1 and VP3) antigen binding, ELISA validated as capture antibody and detection antibody. Pair recommendation with other Rhinoviruses (VP1 and VP3) antibodies in VP1 and VP3 level test of Infectious disease (common cold) and related syndrome evaluation. | ![]() |
dengue nonstructural 1 (DEN-NS1)
Cat No. | Pathogen | Target | Disease | Cat No.of Antigen | Bioactivity validation of Antigen | Cat No.of Antibodies | Bioactivity validation of Antibodies | Order |
GMP-IVD-P040-Tg001 | dengue nonstructural 1 (DEN-NS1) | nonstructural protein 1 (NS1) | dengue | GMP-IVD-P040-Tg001-Ag01: Recombinant dengue nonstructural 1 (DEN-NS1) nonstructural protein 1 (NS1) Protein |
dengue nonstructural 1 (nonstructural protein 1 (NS1)) antibodies binding, Immunogen in Sandwich Elisa, lateral-flow tests,and other immunoassays as control material in nonstructural protein 1 (NS1) level test of Infectious disease(dengue) and related syndrome evaluation. | GMP-IVD-P040-Tg001-Ab01; GMP-IVD-P040-Tg001-Ab02: Anti-dengue nonstructural 1 (DEN-NS1) nonstructural protein 1 (NS1) mouse monoclonal antibody (mAb) |
dengue nonstructural 1 (nonstructural protein 1 (NS1)) antigen binding, ELISA validated as capture antibody and detection antibody. Pair recommendation with other dengue nonstructural 1 (nonstructural protein 1 (NS1)) antibodies in nonstructural protein 1 (NS1) level test of Infectious disease (dengue) and related syndrome evaluation. | ![]() |
Enterovirus 71 (EV71)
Cat No. | Pathogen | Target | Disease | Cat No.of Antigen | Bioactivity validation of Antigen | Cat No.of Antibodies | Bioactivity validation of Antibodies | Order |
GMP-IVD-P041-Tg001 | Enterovirus 71 (EV71) | VP1 | neurological diseases | GMP-IVD-P041-Tg001-Ag01: Recombinant Enterovirus 71 (EV71) VP1 Protein |
Enterovirus 71 (VP1) antibodies binding, Immunogen in Sandwich Elisa, lateral-flow tests,and other immunoassays as control material in VP1 level test of Infectious disease (neurological diseases) and related syndrome evaluation. | GMP-IVD-P041-Tg001-Ab01; GMP-IVD-P041-Tg001-Ab02: Anti-Enterovirus 71 (EV71) VP1 mouse monoclonal antibody (mAb); GMP-IVD-P041-Tg001-Ab03: Anti-Enterovirus 71 (EV71) VP1 mouse monoclonal antibody (mAb)-Mouse IgM |
Enterovirus 71 (VP1) antigen binding, ELISA validated as capture antibody and detection antibody. Pair recommendation with other Enterovirus 71 (VP1) antibodies in VP1 level test of Infectious disease (neurological diseases ) and related syndrome evaluation. | ![]() |
streptolysin O (SLO)
Cat No. | Pathogen | Target | Disease | Cat No.of Antigen | Bioactivity validation of Antigen | Cat No.of Antibodies | Bioactivity validation of Antibodies | Order |
GMP-IVD-P042-Tg001 | streptolysin O (SLO) | streptolysin O | Streptococcus pyogenes infection | GMP-IVD-P042-Tg001-Ag01: Recombinant streptolysin O (SLO) streptolysin O Protein |
streptolysin O (streptolysin O) antibodies binding, Immunogen in Sandwich Elisa, lateral-flow tests,and other immunoassays as control material in streptolysin O level test of Infectious disease(Streptococcus pyogenes infection) and related syndrome evaluation. | GMP-IVD-P042-Tg001-Ab01; GMP-IVD-P042-Tg001-Ab02: Anti-streptolysin O (SLO) streptolysin O mouse monoclonal antibody (mAb) |
streptolysin O (streptolysin O) antigen binding, ELISA validated as capture antibody and detection antibody. Pair recommendation with other streptolysin O (streptolysin O) antibodies in streptolysin O level test of Infectious disease (Streptococcus pyogenes infection) and related syndrome evaluation. | ![]() |
Mycoplasma pneumoniae
Cat No. | Pathogen | Target | Disease | Cat No.of Antigen | Bioactivity validation of Antigen | Cat No.of Antibodies | Bioactivity validation of Antibodies | Order |
GMP-IVD-P043-Tg001 | Mycoplasma pneumoniae | M-P1-10 | pneumonia | GMP-IVD-P043-Tg001-Ag01: Recombinant Mycoplasma pneumoniae M-P1-10 Protein |
Mycoplasma pneumoniae P1 adhesion protein (M-P1-10) antibodies binding, Immunogen in Sandwich Elisa, lateral-flow tests,and other immunoassays as control material in M-P1-10 level test of Infectious disease(pneumonia) and related syndrome evaluation. | GMP-IVD-P043-Tg001-Ab01; GMP-IVD-P043-Tg001-Ab02: Anti-Mycoplasma pneumoniae M-P1-10 mouse monoclonal antibody (mAb) |
Mycoplasma pneumoniae P1 adhesion protein (M-P1-10) antigen binding, ELISA validated as capture antibody and detection antibody. Pair recommendation with other Mycoplasma pneumoniae P1 adhesion protein (M-P1-10) antibodies in M-P1-10 level test of Infectious disease (pneumonia) and related syndrome evaluation. | ![]() |
Helicobacter pylori (H. pylori)
Cat No. | Pathogen | Target | Disease | Cat No.of Antigen | Bioactivity validation of Antigen | Cat No.of Antibodies | Bioactivity validation of Antibodies | Order |
GMP-IVD-P044-Tg001 | Helicobacter pylori (H. pylori) | CagA | peptic ulcer and gastritis | GMP-IVD-P044-Tg001-Ag01: Recombinant Helicobacter pylori (H. pylori) CagA Protein |
Helicobacter pylori cytotoxin-related protein A (CagA) antibodies binding, Immunogen in Sandwich Elisa, lateral-flow tests,and other immunoassays as control material in CagA level test of Infectious disease(peptic ulcer and gastritis) and related syndrome evaluation. | GMP-IVD-P044-Tg001-Ab01; GMP-IVD-P044-Tg001-Ab02: Anti-Helicobacter pylori (H. pylori) CagA mouse monoclonal antibody (mAb) |
Helicobacter pylori cytotoxin-related protein A (CagA) antigen binding, ELISA validated as capture antibody and detection antibody. Pair recommendation with other Helicobacter pylori cytotoxin-related protein A (CagA) antibodies in CagA level test of Infectious disease (peptic ulcer and gastritis) and related syndrome evaluation. | ![]() |
GMP-IVD-P044-Tg002 | Helicobacter pylori (H. pylori) | Flagellin A (FlaA) | peptic ulcer and gastritis | GMP-IVD-P044-Tg002-Ag01: Recombinant Helicobacter pylori (H. pylori) FlaA Protein |
Helicobacter pylori flagellin A (FlaA) antibodies binding, Immunogen in Sandwich Elisa, lateral-flow tests,and other immunoassays as control material in FlaA level test of Infectious disease(peptic ulcer and gastritis) and related syndrome evaluation. | GMP-IVD-P044-Tg002-Ab01; GMP-IVD-P044-Tg002-Ab02: Anti-Helicobacter pylori (H. pylori) FlaA mouse monoclonal antibody (mAb) |
Helicobacter pylori flagellin A (FlaA) antigen binding, ELISA validated as capture antibody and detection antibody. Pair recommendation with other Helicobacter pylori flagellin A (FlaA) antibodies in FlaA level test of Infectious disease (peptic ulcer and gastritis) and related syndrome evaluation. | ![]() |
GMP-IVD-P044-Tg003 | Helicobacter pylori (H. pylori) | Flagellin B (FlaB) | peptic ulcer and gastritis | GMP-IVD-P044-Tg003-Ag01: Recombinant Helicobacter pylori (H. pylori) FlaB Protein |
Helicobacter pylori flagellin B (FlaB) antibodies binding, Immunogen in Sandwich Elisa, lateral-flow tests,and other immunoassays as control material in FlaB level test of Infectious disease(peptic ulcer and gastritis) and related syndrome evaluation. | GMP-IVD-P044-Tg003-Ab01; GMP-IVD-P044-Tg003-Ab02: Anti-Helicobacter pylori (H. pylori) FlaB mouse monoclonal antibody (mAb) |
Helicobacter pylori flagellin B (FlaB) antigen binding, ELISA validated as capture antibody and detection antibody. Pair recommendation with other Helicobacter pylori flagellin B (FlaB) antibodies in FlaB level test of Infectious disease (peptic ulcer and gastritis) and related syndrome evaluation. | ![]() |
GMP-IVD-P044-Tg004 | Helicobacter pylori (H. pylori) | Vac A | peptic ulcer and gastritis | GMP-IVD-P044-Tg004-Ag01: Recombinant Helicobacter pylori (H. pylori) Vac A Protein |
Helicobacter pylori vacuolar cytotoxin A (Vac A) antibodies binding, Immunogen in Sandwich Elisa, lateral-flow tests,and other immunoassays as control material in Vac A level test of Infectious disease(peptic ulcer and gastritis) and related syndrome evaluation. | GMP-IVD-P044-Tg004-Ab01; GMP-IVD-P044-Tg004-Ab02: Anti-Helicobacter pylori (H. pylori) Vac A mouse monoclonal antibody (mAb) |
Helicobacter pylori vacuolar cytotoxin A (Vac A) antigen binding, ELISA validated as capture antibody and detection antibody. Pair recommendation with other Helicobacter pylori vacuolar cytotoxin A (Vac A) antibodies in Vac A level test of Infectious disease (peptic ulcer and gastritis) and related syndrome evaluation. | ![]() | GMP-IVD-P044-Tg005 | Helicobacter pylori (H. pylori) | Ure B | peptic ulcer and gastritis | GMP-IVD-P044-Tg005-Ag01: Recombinant Helicobacter pylori (H. pylori) Ure B Protein |
Helicobacter pylori urease B (Ure B) antibodies binding, Immunogen in Sandwich Elisa, lateral-flow tests,and other immunoassays as control material in Ure B level test of Infectious disease(peptic ulcer and gastritis) and related syndrome evaluation. | GMP-IVD-P044-Tg005-Ab01; GMP-IVD-P044-Tg005-Ab02: Anti-Helicobacter pylori (H. pylori) Ure B mouse monoclonal antibody (mAb) |
Helicobacter pylori urease B (Ure B) antigen binding, ELISA validated as capture antibody and detection antibody. Pair recommendation with other Helicobacter pylori urease B (Ure B) antibodies in Ure B level test of Infectious disease (peptic ulcer and gastritis) and related syndrome evaluation. | ![]() |
GMP-IVD-P044-Tg006 | Helicobacter pylori (H. pylori) | HSP | peptic ulcer and gastritis | GMP-IVD-P044-Tg006-Ag01: Recombinant Helicobacter pylori (H. pylori) HSP Protein |
Helicobacter pylori heat shock protein (HSP) antibodies binding, Immunogen in Sandwich Elisa, lateral-flow tests,and other immunoassays as control material in HSP level test of Infectious disease(peptic ulcer and gastritis) and related syndrome evaluation. | GMP-IVD-P044-Tg006-Ab01; GMP-IVD-P044-Tg006-Ab02: Anti-Helicobacter pylori (H. pylori) HSP mouse monoclonal antibody (mAb) |
Helicobacter pylori heat shock protein (HSP) antigen binding, ELISA validated as capture antibody and detection antibody. Pair recommendation with other Helicobacter pylori heat shock protein (HSP) antibodies in HSP level test of Infectious disease (peptic ulcer and gastritis) and related syndrome evaluation. | ![]() |
GMP-IVD-P044-Tg007 | Helicobacter pylori (H. pylori) | outer membrane protein 1 (OMP-1) | peptic ulcer and gastritis | GMP-IVD-P044-Tg007-Ag01: Recombinant Helicobacter pylori (H. pylori) OMP-1 Protein |
Helicobacter pylori outer membrane protein 1 (OMP-1) antibodies binding, Immunogen in Sandwich Elisa, lateral-flow tests,and other immunoassays as control material in OMP-1 level test of Infectious disease(peptic ulcer and gastritis) and related syndrome evaluation. | GMP-IVD-P044-Tg007-Ab01; GMP-IVD-P044-Tg007-Ab02: Anti-Helicobacter pylori (H. pylori) OMP-1 mouse monoclonal antibody (mAb) |
Helicobacter pylori outer membrane protein 1 (OMP-1) antigen binding, ELISA validated as capture antibody and detection antibody. Pair recommendation with other Helicobacter pylori outer membrane protein 1 (OMP-1) antibodies in OMP-1 level test of Infectious disease (peptic ulcer and gastritis) and related syndrome evaluation. | ![]() |
GMP-IVD-P044-Tg008 | Helicobacter pylori (H. pylori) | outer membrane protein 2 (OMP-2) | peptic ulcer and gastritis | GMP-IVD-P044-Tg008-Ag01: Recombinant Helicobacter pylori (H. pylori) OMP-2 Protein |
Helicobacter pylori outer membrane protein 3 (OMP-2) antibodies binding, Immunogen in Sandwich Elisa, lateral-flow tests,and other immunoassays as control material in OMP-2 level test of Infectious disease(peptic ulcer and gastritis) and related syndrome evaluation. | GMP-IVD-P044-Tg008-Ab01; GMP-IVD-P044-Tg008-Ab02: Anti-Helicobacter pylori (H. pylori) OMP-2 mouse monoclonal antibody (mAb) |
Helicobacter pylori outer membrane protein 3 (OMP-2) antigen binding, ELISA validated as capture antibody and detection antibody. Pair recommendation with other Helicobacter pylori outer membrane protein 3 (OMP-2) antibodies in OMP-2 level test of Infectious disease (peptic ulcer and gastritis) and related syndrome evaluation. | ![]() |
PrP
Cat No. | Pathogen | Target | Disease | Cat No.of Antigen | Bioactivity validation of Antigen | Cat No.of Antibodies | Bioactivity validation of Antibodies | Order |
GMP-IVD-P045-Tg001 | Prion | PrP | Transmissible spongiform encephalopathies | GMP-IVD-P045-Tg001-Ag01: Recombinant Prion PrP Protein |
Prion (PrP) antibodies binding, Immunogen in Sandwich Elisa, lateral-flow tests,and other immunoassays as control material in PrP level test of Infectious disease(Transmissible spongiform encephalopathies) and related syndrome evaluation. | GMP-IVD-P045-Tg001-Ab01; GMP-IVD-P045-Tg001-Ab02: Anti-Prion PrP mouse monoclonal antibody (mAb) |
Prion (PrP) antigen binding, ELISA validated as capture antibody and detection antibody. Pair recommendation with other Prion (PrP) antibodies in PrP level test of Infectious disease (Transmissible spongiform encephalopathies) and related syndrome evaluation. | ![]() |
STDs
Cat No. | Pathogen | Target | Disease | Cat No.of Antigen | Bioactivity validation of Antigen | Cat No.of Antibodies | Bioactivity validation of Antibodies | Order |
GMP-IVD-P046-Tg001 | NA | STDs | Sexually transmitted diseases | GMP-IVD-P046-Tg001-Ag01: Recombinant STDs Protein |
Sexually transmitted diseases (STDs) antibodies binding, Immunogen in Sandwich Elisa, lateral-flow tests,and other immunoassays as control material in STDs level test of Infectious disease(Sexually transmitted diseases) and related syndrome evaluation. | GMP-IVD-P046-Tg001-Ab01; GMP-IVD-P046-Tg001-Ab02: Anti-STDs mouse monoclonal antibody (mAb) |
Sexually transmitted diseases (STDs) antigen binding, ELISA validated as capture antibody and detection antibody. Pair recommendation with other Sexually transmitted diseases (STDs) antibodies in STDs level test of Infectious disease (Sexually transmitted diseases) and related syndrome evaluation. | ![]() |
ARTI
Cat No. | Pathogen | Target | Disease | Cat No.of Antigen | Bioactivity validation of Antigen | Cat No.of Antibodies | Bioactivity validation of Antibodies | Order |
GMP-IVD-P047-Tg001 | NA | ARTI | acute respiratory infectious diseases | GMP-IVD-P047-Tg001-Ag01: Recombinant ARTI Protein |
acute respiratory infectious diseases (ARTI) antibodies binding, Immunogen in Sandwich Elisa, lateral-flow tests,and other immunoassays as control material in ARTI level test of Infectious disease(acute respiratory infectious diseases) and related syndrome evaluation. | GMP-IVD-P047-Tg001-Ab01; GMP-IVD-P047-Tg001-Ab02: Anti-ARTI mouse monoclonal antibody (mAb) |
acute respiratory infectious diseases (ARTI) antigen binding, ELISA validated as capture antibody and detection antibody. Pair recommendation with other acute respiratory infectious diseases (ARTI) antibodies in ARTI level test of Infectious disease (acute respiratory infectious diseases) and related syndrome evaluation. | ![]() |
Nucleocapsid
Cat No. | Pathogen | Target | Disease | Cat No.of Antigen | Bioactivity validation of Antigen | Cat No.of Antibodies | Bioactivity validation of Antibodies | Order |
GMP-IVD-P049-Tg001 | SARS-CoV2 | Nucleocapsid | Nucleocapsid protein | GMP-IVD-P048-Tg001-Ag01: Recombinant SARS-CoV2 Nucleocapsid Protein |
SARS-CoV2 Nucleocapsid protein (Nucleocapsid) antibodies binding, Immunogen in Sandwich Elisa, lateral-flow tests,and other immunoassays as control material in Nucleocapsid level test of Infectious disease(Nucleocapsid protein) and related syndrome evaluation. | GMP-IVD-P048-Tg001-Ab01; GMP-IVD-P048-Tg001-Ab02: Anti-SARS-CoV2 Nucleocapsid mouse monoclonal antibody (mAb) |
SARS-CoV2 Nucleocapsid protein (Nucleocapsid) antigen binding, ELISA validated as capture antibody and detection antibody. Pair recommendation with other Nucleocapsid protein (Nucleocapsid) antibodies in Nucleocapsid level test of Infectious disease (Nucleocapsid protein) and related syndrome evaluation. | ![]() |
Diagnostic antibodies and antigens for Inflammation/autoimmune/inflammatory diseases testing-IL-6, PCT, CRP, SAA, IFNγ, AQP4, HBP, MOG, S100-A9, TPO, SAA1, TNFα, α defensin 5
Inflammation/autoimmune/inflammatory diseases occur when the immune system attacks the normal tissue within joints, vasculature, and other organ systems, causing inflammation, pain, diminished mobility, fatigue, and other non-specific symptoms. The strong overlap of signs and symptoms among the autoimmune diseases can lead to delays in diagnosis and appropriate treatment. However, immunodiagnostics has been developed to detect the inflammation/autoimmune/inflammatory disease such as ankylosing spondylitis, bacterial infections, bacterial meningitis, cerebrovascular diseases, crohn's disease, fungal infection, graves' disease, inflammatory amyloidosis, inflammatory bowel disease, mog antibody disease, osteomyelitis, rheumatoid arthritis, sepsis, respiratory illnesses and so on at an early stage. Biomarkers have been developed to detect this autoimmune disease at an early stage. Detecting the quantity of marker proteins from different samples may benefit from ELISA, Lateral flow immunoassay (LFIA), colloidal gold immunochromatographic assay, Chemiluminescent immunoassay (CLIA), turbidimetric inhibition immuno assay (TINIA), immunonephelometry and POCT.
Classification:
IL-6
PCT
CRP
SAA
IFNγ
AQP4
HBP
MOG
S100-A9
TPO
SAA1
TNFα
MPA
CCP
alpha defensin 1
alpha defensin 5
Interleukin 6 (IL-6)
Cat No. | Species | Biomarker | Disease | Cat No.of Antigen | Bioactivity validation of Antigen | Cat No.of Antibodies | Bioactivity validation of Antibodies | Order |
GMP-h-IL-6 | Human | Interleukin 6 (IL-6) | systemic juvenile idiopathic arthritis, systemic lupus erythematosus, ankylosing spondylitis, psoriasis and Crohn's disease. | GMP-h-IL-6-Ag01: Recombinant human IL-6 Protein |
Interleukin 6 (IL-6) antibodies binding, Immunogen in Sandwich Elisa, lateral-flow tests,and other immunoassays as control material in IL-6 level test of Inflammation/autoimmune/inflammatory disease(systemic juvenile idiopathic arthritis, systemic lupus erythematosus, ankylosing spondylitis, psoriasis and Crohn's disease.) and related syndrome evaluation. | GMP-h-IL-6-Ab01; GMP-h-IL-6-Ab02: Anti-human IL-6 mouse monoclonal antibody(mAb) |
Human Interleukin 6 (IL-6) antigen binding, ELISA validated as capture antibody and detection antibody. Pair recommendation with other Interleukin 6 (IL-6) antibodies in IL-6 level test of Inflammation/autoimmune/inflammatory disease (systemic juvenile idiopathic arthritis, systemic lupus erythematosus, ankylosing spondylitis, psoriasis and Crohn's disease.) and related syndrome evaluation. | ![]() |
procalcitonin (PCT)
Cat No. | Species | Biomarker | Disease | Cat No.of Antigen | Bioactivity validation of Antigen | Cat No.of Antibodies | Bioactivity validation of Antibodies | Order |
GMP-h-PCT | Human | procalcitonin (PCT) | Sepsis; Respiratory illnesses; bacterial meningitis and etc. | GMP-h-PCT-Ag01: Recombinant human PCT Protein |
procalcitonin (PCT) antibodies binding, Immunogen in Sandwich Elisa, lateral-flow tests,and other immunoassays as control material in PCT level test of Inflammation/autoimmune/inflammatory disease(Sepsis; Respiratory illnesses; bacterial meningitis and etc.) and related syndrome evaluation. | GMP-h-PCT-Ab01; GMP-h-PCT-Ab02: Anti-human PCT mouse monoclonal antibody(mAb) |
Human procalcitonin (PCT) antigen binding, ELISA validated as capture antibody and detection antibody. Pair recommendation with other procalcitonin (PCT) antibodies in PCT level test of Inflammation/autoimmune/inflammatory disease (Sepsis; Respiratory illnesses; bacterial meningitis and etc.) and related syndrome evaluation. | ![]() |
C-Reactive Protein (CRP)
Cat No. | Species | Biomarker | Disease | Cat No.of Antigen | Bioactivity validation of Antigen | Cat No.of Antibodies | Bioactivity validation of Antibodies | Order |
GMP-h-CRP | Human | C-Reactive Protein (CRP) | Bacterial infections, sepsis, fungal infection, Inflammatory bowel disease, autoimmune, cancer and etc disorder, osteomyelitis | GMP-h-CRP-Ag01: Recombinant human CRP Protein |
C-Reactive Protein (CRP) antibodies binding, Immunogen in Sandwich Elisa, lateral-flow tests,and other immunoassays as control material in CRP level test of Inflammation/autoimmune/inflammatory disease(Bacterial infections, sepsis, fungal infection, Inflammatory bowel disease, autoimmune, cancer and etc disorder, osteomyelitis) and related syndrome evaluation. | GMP-h-CRP-Ab01; GMP-h-CRP-Ab02: Anti-human CRP mouse monoclonal antibody(mAb) |
Human C-Reactive Protein (CRP) antigen binding, ELISA validated as capture antibody and detection antibody. Pair recommendation with other C-Reactive Protein (CRP) antibodies in CRP level test of Inflammation/autoimmune/inflammatory disease (Bacterial infections, sepsis, fungal infection, Inflammatory bowel disease, autoimmune, cancer and etc disorder, osteomyelitis) and related syndrome evaluation. | ![]() |
Serum Amyloid A (SAA)
Cat No. | Species | Biomarker | Disease | Cat No.of Antigen | Bioactivity validation of Antigen | Cat No.of Antibodies | Bioactivity validation of Antibodies | Order |
GMP-h-SAA | Human | Serum Amyloid A (SAA) | Rheumatoid arthritis, inflammatory bowel disease (Crohn’s disease, ulcerative colitis), and chronic infections | GMP-h-SAA-Ag01: Recombinant human SAA Protein |
Serum Amyloid A (SAA) antibodies binding, Immunogen in Sandwich Elisa, lateral-flow tests,and other immunoassays as control material in SAA level test of Inflammation/autoimmune/inflammatory disease(Rheumatoid arthritis, inflammatory bowel disease (Crohn’s disease, ulcerative colitis), and chronic infections) and related syndrome evaluation. | GMP-h-SAA-Ab01; GMP-h-SAA-Ab02: Anti-human SAA mouse monoclonal antibody(mAb) |
Human Serum Amyloid A (SAA) antigen binding, ELISA validated as capture antibody and detection antibody. Pair recommendation with other Serum Amyloid A (SAA) antibodies in SAA level test of Inflammation/autoimmune/inflammatory disease (Rheumatoid arthritis, inflammatory bowel disease (Crohn’s disease, ulcerative colitis), and chronic infections) and related syndrome evaluation. | ![]() |
Interferon gamma (IFNγ)
Cat No. | Species | Biomarker | Disease | Cat No.of Antigen | Bioactivity validation of Antigen | Cat No.of Antibodies | Bioactivity validation of Antibodies | Order |
GMP-h-IFNγ | Human | Interferon gamma (IFNγ) | inflamation, autoimmune disease | GMP-h-IFNγ-Ag01: Recombinant human IFNγ Protein |
Interferon gamma (IFNγ) antibodies binding, Immunogen in Sandwich Elisa, lateral-flow tests,and other immunoassays as control material in IFNγ level test of Inflammation/autoimmune/inflammatory disease(inflamation, autoimmune disease) and related syndrome evaluation. | GMP-h-IFNγ-Ab01; GMP-h-IFNγ-Ab02: Anti-human IFNγ mouse monoclonal antibody(mAb) |
Human Interferon gamma (IFNγ) antigen binding, ELISA validated as capture antibody and detection antibody. Pair recommendation with other Interferon gamma (IFNγ) antibodies in IFNγ level test of Inflammation/autoimmune/inflammatory disease (inflamation, autoimmune disease) and related syndrome evaluation. | ![]() |
aquaporin-4 (AQP4)
Cat No. | Species | Biomarker | Disease | Cat No.of Antigen | Bioactivity validation of Antigen | Cat No.of Antibodies | Bioactivity validation of Antibodies | Order |
GMP-h-AQP4 | Human | aquaporin-4 (AQP4) | Cerebrovascular diseases | GMP-h-AQP4-Ag01: Recombinant human AQP4 Protein |
aquaporin-4 (AQP4) antibodies binding, Immunogen in Sandwich Elisa, lateral-flow tests,and other immunoassays as control material in AQP4 level test of Inflammation/autoimmune/inflammatory disease(Cerebrovascular diseases) and related syndrome evaluation. | GMP-h-AQP4-Ab01; GMP-h-AQP4-Ab02: Anti-human AQP4 mouse monoclonal antibody(mAb) |
Human aquaporin-4 (AQP4) antigen binding, ELISA validated as capture antibody and detection antibody. Pair recommendation with other aquaporin-4 (AQP4) antibodies in AQP4 level test of Inflammation/autoimmune/inflammatory disease (Cerebrovascular diseases) and related syndrome evaluation. | ![]() |
Heparin-binding protein (HBP)
Cat No. | Species | Biomarker | Disease | Cat No.of Antigen | Bioactivity validation of Antigen | Cat No.of Antibodies | Bioactivity validation of Antibodies | Order |
GMP-h-HBP | Human | Heparin-binding protein (HBP) | inflammation/autoimmune/ inflammatory disease | GMP-h-HBP-Ag01: Recombinant human HBP Protein |
Heparin-binding protein (HBP) antibodies binding, Immunogen in Sandwich Elisa, lateral-flow tests,and other immunoassays as control material in HBP level test of Inflammation/autoimmune/inflammatory disease(inflammation/autoimmune/ inflammatory disease) and related syndrome evaluation. | GMP-h-HBP-Ab01; GMP-h-HBP-Ab02: Anti-human HBP mouse monoclonal antibody(mAb) |
Human Heparin-binding protein (HBP) antigen binding, ELISA validated as capture antibody and detection antibody. Pair recommendation with other Heparin-binding protein (HBP) antibodies in HBP level test of Inflammation/autoimmune/inflammatory disease (inflammation/autoimmune/ inflammatory disease) and related syndrome evaluation. | ![]() |
myelin oligodendrocyte glycoprotein (MOG)
Cat No. | Species | Biomarker | Disease | Cat No.of Antigen | Bioactivity validation of Antigen | Cat No.of Antibodies | Bioactivity validation of Antibodies | Order |
GMP-h-MOG | Human | myelin oligodendrocyte glycoprotein (MOG) | MOG antibody disease | GMP-h-MOG-Ag01: Recombinant human MOG Protein |
myelin oligodendrocyte glycoprotein (MOG) antibodies binding, Immunogen in Sandwich Elisa, lateral-flow tests,and other immunoassays as control material in MOG level test of Inflammation/autoimmune/inflammatory disease(MOG antibody disease) and related syndrome evaluation. | GMP-h-MOG-Ab01; GMP-h-MOG-Ab02: Anti-human MOG mouse monoclonal antibody(mAb) |
Human myelin oligodendrocyte glycoprotein (MOG) antigen binding, ELISA validated as capture antibody and detection antibody. Pair recommendation with other myelin oligodendrocyte glycoprotein (MOG) antibodies in MOG level test of Inflammation/autoimmune/inflammatory disease (MOG antibody disease) and related syndrome evaluation. | ![]() |
Calprotectin heavy chain (S100-A9)
Cat No. | Species | Biomarker | Disease | Cat No.of Antigen | Bioactivity validation of Antigen | Cat No.of Antibodies | Bioactivity validation of Antibodies | Order |
GMP-h-S100-A9 | Human | Calprotectin heavy chain (S100-A9) | inflammatory bowel disease | GMP-h-S100-A9-Ag01: Recombinant human S100-A9 Protein |
Calprotectin heavy chain (S100-A9) antibodies binding, Immunogen in Sandwich Elisa, lateral-flow tests,and other immunoassays as control material in S100-A9 level test of Inflammation/autoimmune/inflammatory disease(inflammatory bowel disease) and related syndrome evaluation. | GMP-h-S100-A9-Ab01; GMP-h-S100-A9-Ab02: Anti-human S100-A9 mouse monoclonal antibody(mAb) |
Human Calprotectin heavy chain (S100-A9) antigen binding, ELISA validated as capture antibody and detection antibody. Pair recommendation with other Calprotectin heavy chain (S100-A9) antibodies in S100-A9 level test of Inflammation/autoimmune/inflammatory disease (inflammatory bowel disease) and related syndrome evaluation. | ![]() |
Thyroid peroxidase (TPO)
Cat No. | Species | Biomarker | Disease | Cat No.of Antigen | Bioactivity validation of Antigen | Cat No.of Antibodies | Bioactivity validation of Antibodies | Order |
GMP-h-TPO | Human | Thyroid peroxidase (TPO) | Hashimoto's disease or Graves' disease | GMP-h-TPO-Ag01: Recombinant human TPO Protein |
Thyroid peroxidase (TPO) antibodies binding, Immunogen in Sandwich Elisa, lateral-flow tests,and other immunoassays as control material in TPO level test of Inflammation/autoimmune/inflammatory disease(Hashimoto's disease or Graves' disease) and related syndrome evaluation. | GMP-h-TPO-Ab01; GMP-h-TPO-Ab02: Anti-human TPO mouse monoclonal antibody(mAb) |
Human Thyroid peroxidase (TPO) antigen binding, ELISA validated as capture antibody and detection antibody. Pair recommendation with other Thyroid peroxidase (TPO) antibodies in TPO level test of Inflammation/autoimmune/inflammatory disease (Hashimoto's disease or Graves' disease) and related syndrome evaluation. | ![]() |
Serum Amyloid A1 (SAA1)
Cat No. | Species | Biomarker | Disease | Cat No.of Antigen | Bioactivity validation of Antigen | Cat No.of Antibodies | Bioactivity validation of Antibodies | Order |
GMP-h-SAA1 | Human | Serum Amyloid A1 (SAA1) | Inflammatory amyloidosis | GMP-h-SAA1-Ag01: Recombinant human SAA1 Protein |
Serum Amyloid A1 (SAA1) antibodies binding, Immunogen in Sandwich Elisa, lateral-flow tests,and other immunoassays as control material in SAA1 level test of Inflammation/autoimmune/inflammatory disease(Inflammatory amyloidosis) and related syndrome evaluation. | GMP-h-SAA1-Ab01; GMP-h-SAA1-Ab02: Anti-human SAA1 mouse monoclonal antibody(mAb) |
Human Serum Amyloid A1 (SAA1) antigen binding, ELISA validated as capture antibody and detection antibody. Pair recommendation with other Serum Amyloid A1 (SAA1) antibodies in SAA1 level test of Inflammation/autoimmune/inflammatory disease (Inflammatory amyloidosis) and related syndrome evaluation. | ![]() |
tumor necrosis factor alpha (TNFα)
Cat No. | Species | Biomarker | Disease | Cat No.of Antigen | Bioactivity validation of Antigen | Cat No.of Antibodies | Bioactivity validation of Antibodies | Order |
GMP-h-TNFα | Human | tumor necrosis factor alpha (TNFα) | rheumatoid arthritis, ankylosing spondylitis, and Crohn’s disease | GMP-h-TNFα-Ag01: Recombinant human TNFα Protein |
tumor necrosis factor alpha (TNFα) antibodies binding, Immunogen in Sandwich Elisa, lateral-flow tests,and other immunoassays as control material in TNFα level test of Inflammation/autoimmune/inflammatory disease(rheumatoid arthritis, ankylosing spondylitis, and Crohn’s disease) and related syndrome evaluation. | GMP-h-TNFα-Ab01; GMP-h-TNFα-Ab02: Anti-human TNFα mouse monoclonal antibody(mAb) |
Human tumor necrosis factor alpha (TNFα) antigen binding, ELISA validated as capture antibody and detection antibody. Pair recommendation with other tumor necrosis factor alpha (TNFα) antibodies in TNFα level test of Inflammation/autoimmune/inflammatory disease (rheumatoid arthritis, ankylosing spondylitis, and Crohn’s disease) and related syndrome evaluation. | ![]() |
mycophenolic acid (MPA)
Cat No. | Species | Biomarker | Disease | Cat No.of Antigen | Bioactivity validation of Antigen | Cat No.of Antibodies | Bioactivity validation of Antibodies | Order |
GMP-SMT-MPA | Human | mycophenolic acid (MPA) | autoimmune disease | GMP-SMT-MPA-Ag01: BSA-mycophenolic acid (MPA); GMP-SMT-MPA-Ag02: OVA-mycophenolic acid (MPA) |
Competitive immunoassay-validated hapten-carrier conjugates [BSA-&OVA-mycophenolic acid (MPA)], mycophenolic acid (MPA) antibodies binding, Immunogen in Competitive immunoassay validation, Elisa, lateral-flow tests,and other immunoassays as control material in MPA level test of Inflammation/autoimmune/inflammatory disease (autoimmune disease) and related syndrome evaluation. | GMP-SMT-MPA-Ab01: Anti-mycophenolic acid (MPA) mouse monoclonal antibody(mAb) |
Human mycophenolic acid (MPA) binding, in Competitive immunoassay validation, Elisa, lateral-flow tests, and other immunoassays in MPA level test of Inflammation/autoimmune/inflammatory disease (autoimmune disease) and related syndrome evaluation. | ![]() |
cyclic citrullinated peptide (CCP)
Cat No. | Species | Biomarker | Disease | Cat No.of Antigen | Bioactivity validation of Antigen | Cat No.of Antibodies | Bioactivity validation of Antibodies | Order |
GMP-SMT-CCP | Human | cyclic citrullinated peptide (CCP) | rheumatoid arthritis | GMP-SMT-CCP-Ag01: BSA-cyclic citrullinated peptide (CCP); GMP-SMT-CCP-Ag02: OVA-cyclic citrullinated peptide (CCP) |
Competitive immunoassay-validated hapten-carrier conjugates [BSA-&OVA-cyclic citrullinated peptide (CCP)], cyclic citrullinated peptide (CCP) antibodies binding, Immunogen in Competitive immunoassay validation, Elisa, lateral-flow tests,and other immunoassays as control material in CCP level test of Inflammation/autoimmune/inflammatory disease (rheumatoid arthritis) and related syndrome evaluation. | GMP-SMT-CCP-Ab01: Anti-cyclic citrullinated peptide (CCP) mouse monoclonal antibody(mAb) |
Human cyclic citrullinated peptide (CCP) binding, in Competitive immunoassay validation, Elisa, lateral-flow tests, and other immunoassays in CCP level test of Inflammation/autoimmune/inflammatory disease (rheumatoid arthritis) and related syndrome evaluation. | ![]() |
alpha defensin 1 (α-defensin 1)
Cat No. | Species | Biomarker | Disease | Cat No.of Antigen | Bioactivity validation of Antigen | Cat No.of Antibodies | Bioactivity validation of Antibodies | Order |
GMP-h-a-defensin-1 | Human | alpha defensin 1 (α-defensin 1) | Prosthetic joint infection (PJI) | GMP-h-a-defensin-1-Ag01: Recombinant Human α-defensin 1 Protein |
alpha defensin 1 (α-defensin 1) antibodies binding, Immunogen in Sandwich Elisa, lateral-flow tests, and other immunoassays as control material in α-defensin 1 level test of Inflammation/autoimmune/inflammatory disease (Prosthetic joint infection (PJI)) and related syndrome evaluation | GMP-h-a-defensin-1-Ab01: GMP-h-a-defensin-1-Ab02: Anti-Human α-defensin 1 mouse monoclonal antibody (mAb) |
Human alpha defensin 1 (α-defensin 1) antigen binding, ELISA validated as capture antibody and detection antibody. Pair recommendation with other alpha defensin 1 (α-defensin 1) antibodies in α-defensin 1 level test of Inflammation/autoimmune/inflammatory disease (Prosthetic joint infection (PJI)) and related syndrome evaluation. | ![]() |
alpha defensin 5 (α-defensin 5)
Cat No. | Species | Biomarker | Disease | Cat No.of Antigen | Bioactivity validation of Antigen | Cat No.of Antibodies | Bioactivity validation of Antibodies | Order |
GMP-h-a-defensin-5 | Human | alpha defensin 5 (α-defensin 5) | Prosthetic joint infection (PJI) | GMP-h-a-defensin-5-Ag01: Recombinant Human α-defensin 5 Protein |
alpha defensin 5 (α-defensin 5) antibodies binding, Immunogen in Sandwich Elisa, lateral-flow tests, and other immunoassays as control material in α-defensin 5 level test of Inflammation/autoimmune/inflammatory disease (Prosthetic joint infection (PJI)) and related syndrome evaluation | GMP-h-a-defensin-5-Ab01: GMP-h-a-defensin-5-Ab02: Anti-Human α-defensin 5 mouse monoclonal antibody (mAb) |
Human alpha defensin 5 (α-defensin 5) antigen binding, ELISA validated as capture antibody and detection antibody. Pair recommendation with other alpha defensin 5 (α-defensin 5) antibodies in α-defensin 5 level test of Inflammation/autoimmune/inflammatory disease (Prosthetic joint infection (PJI)) and related syndrome evaluation. | ![]() |
Diagnostic antibodies and antigens for cardiovascular diseases biomarkers testing
Cardiovascular diseases are a group of disorders that occur in the heart and blood vessels and are the world’s leading cause of death. In vitro diagnostic (IVD) assays for detecting cardiac markers are essential tools to help treat or prevent CVD. Several protein markers are released into the blood when the heart is damaged or stressed. These protein markers support diagnosis of conditions including coronary heart disease, cerebrovascular disease, and deep vein thrombosis to guide therapeutic intervention. Several cardiovascular diseases such as hypertension, coronary artery stenosis, intrinsic cardiac dysfunction, acute ischemic myocardial injury, acute myocardial infarction, angiogenesis, artery lesions, atherosclerosis, blood pressure, congestive heart failure, Deep vein thrombosis (DVT), heart failure, hypertrophic cardiomyopathy, myocardial infarction, renal artery stenosis, restrictive and dilated cardiomyopathy, vascular inflammation and so on have been identified using specific marker. Detecting the quantity of marker proteins from different samples may benefit from ELISA, Lateral flow immunoassay (LFIA), colloidal gold immunochromatographic assay, Chemiluminescent immunoassay (CLIA), turbidimetric inhibition immuno assay (TINIA), immunonephelometry and POCT.
Classification:
MPO
MMP3
GDF-15
CK-MB
Myo
sST2
CKMB
NT-proBNP
cTnT
cTnI
H-FABP
D-Dimer
Dig
ApoA
ApoE
BNP
proBNP
TIMP-1
CNP
ANP
AI
VEGF
PLGF-1
SAH
HCY
RAA/Aldo
Digoxin
HFABP
Myeloperoxidase (MPO)
Cat No. | Species | Biomarker | Disease | Cat No.of Antigen | Bioactivity validation of Antigen | Cat No.of Antibodies | Bioactivity validation of Antibodies | Order |
GMP-h-MPO | Human | Myeloperoxidase (MPO) | vascular inflammation | GMP-h-MPO-Ag01: Recombinant human MPO Protein |
Myeloperoxidase (MPO) antibodies binding, Immunogen in Sandwich Elisa, lateral-flow tests,and other immunoassays as control material in MPO level test of Cardiovascular disease(vascular inflammation) and related syndrome evaluation. | GMP-h-MPO-Ab01; GMP-h-MPO-Ab02: Anti-human MPO mouse monoclonal antibody(mAb) |
Human Myeloperoxidase (MPO) antigen binding, ELISA validated as capture antibody and detection antibody. Pair recommendation with other Myeloperoxidase (MPO) antibodies in MPO level test of Cardiovascular disease (vascular inflammation) and related syndrome evaluation. | ![]() |
matrix metalloproteinase-3 (MMP3)
Cat No. | Species | Biomarker | Disease | Cat No.of Antigen | Bioactivity validation of Antigen | Cat No.of Antibodies | Bioactivity validation of Antibodies | Order |
GMP-h-MMP3 | Human | matrix metalloproteinase-3 (MMP3) | cancer, asthma and rheumatoid arthritis | GMP-h-MMP3-Ag01: Recombinant human MMP3 Protein |
matrix metalloproteinase-3 (MMP3) antibodies binding, Immunogen in Sandwich Elisa, lateral-flow tests,and other immunoassays as control material in MMP3 level test of Cardiovascular disease(cancer, asthma and rheumatoid arthritis) and related syndrome evaluation. | GMP-h-MMP3-Ab01; GMP-h-MMP3-Ab02: Anti-human MMP3 mouse monoclonal antibody(mAb) |
Human matrix metalloproteinase-3 (MMP3) antigen binding, ELISA validated as capture antibody and detection antibody. Pair recommendation with other matrix metalloproteinase-3 (MMP3) antibodies in MMP3 level test of Cardiovascular disease (cancer, asthma and rheumatoid arthritis) and related syndrome evaluation. | ![]() |
Growth differentiation factor-15 (GDF-15)
Cat No. | Species | Biomarker | Disease | Cat No.of Antigen | Bioactivity validation of Antigen | Cat No.of Antibodies | Bioactivity validation of Antibodies | Order |
GMP-h-GDF-15 | Human | Growth differentiation factor-15 (GDF-15) | pressure overload, myocardial infarction, heart failure, and atherosclerosis | GMP-h-GDF-15-Ag01: Recombinant human GDF-15 Protein |
Growth differentiation factor-15 (GDF-15) antibodies binding, Immunogen in Sandwich Elisa, lateral-flow tests,and other immunoassays as control material in GDF-15 level test of Cardiovascular disease(pressure overload, myocardial infarction, heart failure, and atherosclerosis) and related syndrome evaluation. | GMP-h-GDF-15-Ab01; GMP-h-GDF-15-Ab02: Anti-human GDF-15 mouse monoclonal antibody(mAb) |
Human Growth differentiation factor-15 (GDF-15) antigen binding, ELISA validated as capture antibody and detection antibody. Pair recommendation with other Growth differentiation factor-15 (GDF-15) antibodies in GDF-15 level test of Cardiovascular disease (pressure overload, myocardial infarction, heart failure, and atherosclerosis) and related syndrome evaluation. | ![]() |
Creatine Kinase MB (CK-MB)
Cat No. | Species | Biomarker | Disease | Cat No.of Antigen | Bioactivity validation of Antigen | Cat No.of Antibodies | Bioactivity validation of Antibodies | Order |
GMP-h-CK-MB | Human | Creatine Kinase MB (CK-MB) | Myocardial hypoxia | GMP-h-CK-MB-Ag01: Recombinant human CK-MB Protein |
Creatine Kinase MB (CK-MB) antibodies binding, Immunogen in Sandwich Elisa, lateral-flow tests,and other immunoassays as control material in CK-MB level test of Cardiovascular disease(Myocardial hypoxia) and related syndrome evaluation. | GMP-h-CK-MB-Ab01; GMP-h-CK-MB-Ab02: Anti-human CK-MB mouse monoclonal antibody(mAb) |
Human Creatine Kinase MB (CK-MB) antigen binding, ELISA validated as capture antibody and detection antibody. Pair recommendation with other Creatine Kinase MB (CK-MB) antibodies in CK-MB level test of Cardiovascular disease (Myocardial hypoxia) and related syndrome evaluation. | ![]() |
Myoglobin (Myo)
Cat No. | Species | Biomarker | Disease | Cat No.of Antigen | Bioactivity validation of Antigen | Cat No.of Antibodies | Bioactivity validation of Antibodies | Order |
GMP-h-Myo | Human | Myoglobin (Myo) | acute ischemic myocardial injury | GMP-h-Myo-Ag01: Recombinant human Myo Protein |
Myoglobin (Myo) antibodies binding, Immunogen in Sandwich Elisa, lateral-flow tests,and other immunoassays as control material in Myo level test of Cardiovascular disease(acute ischemic myocardial injury) and related syndrome evaluation. | GMP-h-Myo-Ab01; GMP-h-Myo-Ab02: Anti-human Myo mouse monoclonal antibody(mAb) |
Human Myoglobin (Myo) antigen binding, ELISA validated as capture antibody and detection antibody. Pair recommendation with other Myoglobin (Myo) antibodies in Myo level test of Cardiovascular disease (acute ischemic myocardial injury) and related syndrome evaluation. | ![]() |
soluble ST2 (sST2)
Cat No. | Species | Biomarker | Disease | Cat No.of Antigen | Bioactivity validation of Antigen | Cat No.of Antibodies | Bioactivity validation of Antibodies | Order |
GMP-h-sST2 | Human | soluble ST2 (sST2) | chronic and acute heart failure | GMP-h-sST2-Ag01: Recombinant human sST2 Protein |
soluble ST2 (sST2) antibodies binding, Immunogen in Sandwich Elisa, lateral-flow tests,and other immunoassays as control material in sST2 level test of Cardiovascular disease(chronic and acute heart failure) and related syndrome evaluation. | GMP-h-sST2-Ab01; GMP-h-sST2-Ab02: Anti-human sST2 mouse monoclonal antibody(mAb) |
Human soluble ST2 (sST2) antigen binding, ELISA validated as capture antibody and detection antibody. Pair recommendation with other soluble ST2 (sST2) antibodies in sST2 level test of Cardiovascular disease (chronic and acute heart failure) and related syndrome evaluation. | ![]() |
creatine kinase myocardial band (CKMB)
Cat No. | Species | Biomarker | Disease | Cat No.of Antigen | Bioactivity validation of Antigen | Cat No.of Antibodies | Bioactivity validation of Antibodies | Order |
GMP-h-CKMB | Human | creatine kinase myocardial band (CKMB) | acute myocardial infarction | GMP-h-CKMB-Ag01: Recombinant human CKMB Protein |
creatine kinase myocardial band (CKMB) antibodies binding, Immunogen in Sandwich Elisa, lateral-flow tests,and other immunoassays as control material in CKMB level test of Cardiovascular disease(acute myocardial infarction) and related syndrome evaluation. | GMP-h-CKMB-Ab01; GMP-h-CKMB-Ab02: Anti-human CKMB mouse monoclonal antibody(mAb) |
Human creatine kinase myocardial band (CKMB) antigen binding, ELISA validated as capture antibody and detection antibody. Pair recommendation with other creatine kinase myocardial band (CKMB) antibodies in CKMB level test of Cardiovascular disease (acute myocardial infarction) and related syndrome evaluation. | ![]() |
N-terminal prohormone of brain natriuretic peptide (NT-proBNP)
Cat No. | Species | Biomarker | Disease | Cat No.of Antigen | Bioactivity validation of Antigen | Cat No.of Antibodies | Bioactivity validation of Antibodies | Order |
GMP-h-NT-proBNP | Human | N-terminal prohormone of brain natriuretic peptide (NT-proBNP) | congestive heart failure | GMP-h-NT-proBNP-Ag01: Recombinant human NT-proBNP Protein |
N-terminal prohormone of brain natriuretic peptide (NT-proBNP) antibodies binding, Immunogen in Sandwich Elisa, lateral-flow tests,and other immunoassays as control material in NT-proBNP level test of Cardiovascular disease( congestive heart failure) and related syndrome evaluation. | GMP-h-NT-proBNP-Ab01; GMP-h-NT-proBNP-Ab02: Anti-human NT-proBNP mouse monoclonal antibody(mAb) |
Human N-terminal prohormone of brain natriuretic peptide (NT-proBNP) antigen binding, ELISA validated as capture antibody and detection antibody. Pair recommendation with other N-terminal prohormone of brain natriuretic peptide (NT-proBNP) antibodies in NT-proBNP level test of Cardiovascular disease ( congestive heart failure) and related syndrome evaluation. | ![]() |
cardiac troponin T (cTnT)
Cat No. | Species | Biomarker | Disease | Cat No.of Antigen | Bioactivity validation of Antigen | Cat No.of Antibodies | Bioactivity validation of Antibodies | Order |
GMP-h-cTnT | Human | cardiac troponin T (cTnT) | hypertrophic cardiomyopathy, restrictive and dilated cardiomyopathy. | GMP-h-cTnT-Ag01: Recombinant human cTnT Protein |
cardiac troponin T (cTnT) antibodies binding, Immunogen in Sandwich Elisa, lateral-flow tests,and other immunoassays as control material in cTnT level test of Cardiovascular disease(hypertrophic cardiomyopathy, restrictive and dilated cardiomyopathy. ) and related syndrome evaluation. | GMP-h-cTnT-Ab01; GMP-h-cTnT-Ab02: Anti-human cTnT mouse monoclonal antibody(mAb) |
Human cardiac troponin T (cTnT) antigen binding, ELISA validated as capture antibody and detection antibody. Pair recommendation with other cardiac troponin T (cTnT) antibodies in cTnT level test of Cardiovascular disease (hypertrophic cardiomyopathy, restrictive and dilated cardiomyopathy. ) and related syndrome evaluation. | ![]() |
Cardiac troponin I (cTnI)
Cat No. | Species | Biomarker | Disease | Cat No.of Antigen | Bioactivity validation of Antigen | Cat No.of Antibodies | Bioactivity validation of Antibodies | Order |
GMP-h-cTnI | Human | Cardiac troponin I (cTnI) | myocardial infarction | GMP-h-cTnI-Ag01: Recombinant human cTnI Protein |
Cardiac troponin I (cTnI) antibodies binding, Immunogen in Sandwich Elisa, lateral-flow tests,and other immunoassays as control material in cTnI level test of Cardiovascular disease( myocardial infarction ) and related syndrome evaluation. | GMP-h-cTnI-Ab01; GMP-h-cTnI-Ab02: Anti-human cTnI mouse monoclonal antibody(mAb) |
Human Cardiac troponin I (cTnI) antigen binding, ELISA validated as capture antibody and detection antibody. Pair recommendation with other Cardiac troponin I (cTnI) antibodies in cTnI level test of Cardiovascular disease ( myocardial infarction ) and related syndrome evaluation. | ![]() |
Heart-type Fatty Acid-Binding Protein (H-FABP)
Cat No. | Species | Biomarker | Disease | Cat No.of Antigen | Bioactivity validation of Antigen | Cat No.of Antibodies | Bioactivity validation of Antibodies | Order |
GMP-h-H-FABP | Human | Heart-type Fatty Acid-Binding Protein (H-FABP) | myocardial injury | GMP-h-H-FABP-Ag01: Recombinant human H-FABP Protein |
Heart-type Fatty Acid-Binding Protein (H-FABP) antibodies binding, Immunogen in Sandwich Elisa, lateral-flow tests,and other immunoassays as control material in H-FABP level test of Cardiovascular disease(myocardial injury) and related syndrome evaluation. | GMP-h-H-FABP-Ab01; GMP-h-H-FABP-Ab02: Anti-human H-FABP mouse monoclonal antibody(mAb) |
Human Heart-type Fatty Acid-Binding Protein (H-FABP) antigen binding, ELISA validated as capture antibody and detection antibody. Pair recommendation with other Heart-type Fatty Acid-Binding Protein (H-FABP) antibodies in H-FABP level test of Cardiovascular disease (myocardial injury) and related syndrome evaluation. | ![]() |
D dimer (D-Dimer)
Cat No. | Species | Biomarker | Disease | Cat No.of Antigen | Bioactivity validation of Antigen | Cat No.of Antibodies | Bioactivity validation of Antibodies | Order |
GMP-h-D-Dimer | Human | D dimer (D-Dimer) | Deep vein thrombosis (DVT) | GMP-h-D-Dimer-Ag01: Recombinant human D-Dimer Protein |
D dimer (D-Dimer) antibodies binding, Immunogen in Sandwich Elisa, lateral-flow tests,and other immunoassays as control material in D-Dimer level test of Cardiovascular disease(Deep vein thrombosis (DVT)) and related syndrome evaluation. | GMP-h-D-Dimer-Ab01; GMP-h-D-Dimer-Ab02: Anti-human D-Dimer mouse monoclonal antibody(mAb) |
Human D dimer (D-Dimer) antigen binding, ELISA validated as capture antibody and detection antibody. Pair recommendation with other D dimer (D-Dimer) antibodies in D-Dimer level test of Cardiovascular disease (Deep vein thrombosis (DVT)) and related syndrome evaluation. | ![]() |
Digoxigenin (Dig)
Cat No. | Species | Biomarker | Disease | Cat No.of Antigen | Bioactivity validation of Antigen | Cat No.of Antibodies | Bioactivity validation of Antibodies | Order |
GMP-h-Dig | Human | Digoxigenin (Dig) | NA | GMP-h-Dig-Ag01: Recombinant human Dig Protein |
Digoxigenin (Dig) antibodies binding, Immunogen in Sandwich Elisa, lateral-flow tests,and other immunoassays as control material in Dig level test of Cardiovascular disease() and related syndrome evaluation. | GMP-h-Dig-Ab01; GMP-h-Dig-Ab02: Anti-human Dig mouse monoclonal antibody(mAb) |
Human Digoxigenin (Dig) antigen binding, ELISA validated as capture antibody and detection antibody. Pair recommendation with other Digoxigenin (Dig) antibodies in Dig level test of Cardiovascular disease () and related syndrome evaluation. | ![]() |
Apolipoprotein A (ApoA)
Cat No. | Species | Biomarker | Disease | Cat No.of Antigen | Bioactivity validation of Antigen | Cat No.of Antibodies | Bioactivity validation of Antibodies | Order |
GMP-h-ApoA | Human | Apolipoprotein A (ApoA) | Cardiovascular Disease | GMP-h-ApoA-Ag01: Recombinant human ApoA Protein |
Apolipoprotein A (ApoA) antibodies binding, Immunogen in Sandwich Elisa, lateral-flow tests,and other immunoassays as control material in ApoA level test of Cardiovascular disease(Cardiovascular Disease) and related syndrome evaluation. | GMP-h-ApoA-Ab01; GMP-h-ApoA-Ab02: Anti-human ApoA mouse monoclonal antibody(mAb) |
Human Apolipoprotein A (ApoA) antigen binding, ELISA validated as capture antibody and detection antibody. Pair recommendation with other Apolipoprotein A (ApoA) antibodies in ApoA level test of Cardiovascular disease (Cardiovascular Disease) and related syndrome evaluation. | ![]() |
Apolipoprotein E (ApoE)
Cat No. | Species | Biomarker | Disease | Cat No.of Antigen | Bioactivity validation of Antigen | Cat No.of Antibodies | Bioactivity validation of Antibodies | Order |
GMP-h-ApoE | Human | Apolipoprotein E (ApoE) | Cardiovascular Disease | GMP-h-ApoE-Ag01: Recombinant human ApoE Protein |
Apolipoprotein E (ApoE) antibodies binding, Immunogen in Sandwich Elisa, lateral-flow tests,and other immunoassays as control material in ApoE level test of Cardiovascular disease(Cardiovascular Disease) and related syndrome evaluation. | GMP-h-ApoE-Ab01; GMP-h-ApoE-Ab02: Anti-human ApoE mouse monoclonal antibody(mAb) |
Human Apolipoprotein E (ApoE) antigen binding, ELISA validated as capture antibody and detection antibody. Pair recommendation with other Apolipoprotein E (ApoE) antibodies in ApoE level test of Cardiovascular disease (Cardiovascular Disease) and related syndrome evaluation. | ![]() |
B-type natriuretic peptide (BNP)
Cat No. | Species | Biomarker | Disease | Cat No.of Antigen | Bioactivity validation of Antigen | Cat No.of Antibodies | Bioactivity validation of Antibodies | Order |
GMP-h-BNP | Human | B-type natriuretic peptide (BNP) | Cardiovascular Disease | GMP-h-BNP-Ag01: Recombinant human BNP Protein |
B-type natriuretic peptide (BNP) antibodies binding, Immunogen in Sandwich Elisa, lateral-flow tests,and other immunoassays as control material in BNP level test of Cardiovascular disease(Cardiovascular Disease) and related syndrome evaluation. | GMP-h-BNP-Ab01; GMP-h-BNP-Ab02: Anti-human BNP mouse monoclonal antibody(mAb) |
Human B-type natriuretic peptide (BNP) antigen binding, ELISA validated as capture antibody and detection antibody. Pair recommendation with other B-type natriuretic peptide (BNP) antibodies in BNP level test of Cardiovascular disease (Cardiovascular Disease) and related syndrome evaluation. | ![]() |
pro B-type natriuretic peptide (proBNP)
Cat No. | Species | Biomarker | Disease | Cat No.of Antigen | Bioactivity validation of Antigen | Cat No.of Antibodies | Bioactivity validation of Antibodies | Order |
GMP-h-proBNP | Human | pro B-type natriuretic peptide (proBNP) | intrinsic cardiac dysfunction | GMP-h-proBNP-Ag01: Recombinant human proBNP Protein |
pro B-type natriuretic peptide (proBNP) antibodies binding, Immunogen in Sandwich Elisa, lateral-flow tests,and other immunoassays as control material in proBNP level test of Cardiovascular disease(intrinsic cardiac dysfunction) and related syndrome evaluation. | GMP-h-proBNP-Ab01; GMP-h-proBNP-Ab02: Anti-human proBNP mouse monoclonal antibody(mAb) |
Human pro B-type natriuretic peptide (proBNP) antigen binding, ELISA validated as capture antibody and detection antibody. Pair recommendation with other pro B-type natriuretic peptide (proBNP) antibodies in proBNP level test of Cardiovascular disease (intrinsic cardiac dysfunction) and related syndrome evaluation. | ![]() |
Matrix Metalloproteinase Inhibitor-1 (TIMP-1)
Cat No. | Species | Biomarker | Disease | Cat No.of Antigen | Bioactivity validation of Antigen | Cat No.of Antibodies | Bioactivity validation of Antibodies | Order |
GMP-h-TIMP-1 | Human | Matrix Metalloproteinase Inhibitor-1 (TIMP-1) | coronary artery stenosis, coronary artery lesions | GMP-h-TIMP-1-Ag01: Recombinant human TIMP-1 Protein |
Matrix Metalloproteinase Inhibitor-1 (TIMP-1) antibodies binding, Immunogen in Sandwich Elisa, lateral-flow tests,and other immunoassays as control material in TIMP-1 level test of Cardiovascular disease(coronary artery stenosis, coronary artery lesions) and related syndrome evaluation. | GMP-h-TIMP-1-Ab01; GMP-h-TIMP-1-Ab02: Anti-human TIMP-1 mouse monoclonal antibody(mAb) |
Human Matrix Metalloproteinase Inhibitor-1 (TIMP-1) antigen binding, ELISA validated as capture antibody and detection antibody. Pair recommendation with other Matrix Metalloproteinase Inhibitor-1 (TIMP-1) antibodies in TIMP-1 level test of Cardiovascular disease (coronary artery stenosis, coronary artery lesions) and related syndrome evaluation. | ![]() |
C-type natriuretic peptide (CNP)
Cat No. | Species | Biomarker | Disease | Cat No.of Antigen | Bioactivity validation of Antigen | Cat No.of Antibodies | Bioactivity validation of Antibodies | Order |
GMP-h-CNP | Human | C-type natriuretic peptide (CNP) | cardiovascular disease | GMP-h-CNP-Ag01: Recombinant human CNP Protein |
C-type natriuretic peptide (CNP) antibodies binding, Immunogen in Sandwich Elisa, lateral-flow tests,and other immunoassays as control material in CNP level test of Cardiovascular disease(cardiovascular disease) and related syndrome evaluation. | GMP-h-CNP-Ab01; GMP-h-CNP-Ab02: Anti-human CNP mouse monoclonal antibody(mAb) |
Human C-type natriuretic peptide (CNP) antigen binding, ELISA validated as capture antibody and detection antibody. Pair recommendation with other C-type natriuretic peptide (CNP) antibodies in CNP level test of Cardiovascular disease (cardiovascular disease) and related syndrome evaluation. | ![]() |
human atrial natriuretic peptide (ANP)
Cat No. | Species | Biomarker | Disease | Cat No.of Antigen | Bioactivity validation of Antigen | Cat No.of Antibodies | Bioactivity validation of Antibodies | Order |
GMP-h-ANP | Human | human atrial natriuretic peptide (ANP) | hypertension, cardiac hypertrophy and heart failure | GMP-h-ANP-Ag01: Recombinant human ANP Protein |
human atrial natriuretic peptide (ANP) antibodies binding, Immunogen in Sandwich Elisa, lateral-flow tests,and other immunoassays as control material in ANP level test of Cardiovascular disease(hypertension, cardiac hypertrophy and heart failure) and related syndrome evaluation. | GMP-h-ANP-Ab01; GMP-h-ANP-Ab02: Anti-human ANP mouse monoclonal antibody(mAb) |
Human human atrial natriuretic peptide (ANP) antigen binding, ELISA validated as capture antibody and detection antibody. Pair recommendation with other human atrial natriuretic peptide (ANP) antibodies in ANP level test of Cardiovascular disease (hypertension, cardiac hypertrophy and heart failure) and related syndrome evaluation. | ![]() |
Angiotensin (AI)
Cat No. | Species | Biomarker | Disease | Cat No.of Antigen | Bioactivity validation of Antigen | Cat No.of Antibodies | Bioactivity validation of Antibodies | Order |
GMP-h-AI | Human | Angiotensin (AI) | hypertension, renal disease, and congestive heart failure | GMP-h-AI-Ag01: Recombinant human AI Protein |
Angiotensin (AI) antibodies binding, Immunogen in Sandwich Elisa, lateral-flow tests,and other immunoassays as control material in AI level test of Cardiovascular disease(hypertension, renal disease, and congestive heart failure) and related syndrome evaluation. | GMP-h-AI-Ab01; GMP-h-AI-Ab02: Anti-human AI mouse monoclonal antibody(mAb) |
Human Angiotensin (AI) antigen binding, ELISA validated as capture antibody and detection antibody. Pair recommendation with other Angiotensin (AI) antibodies in AI level test of Cardiovascular disease (hypertension, renal disease, and congestive heart failure) and related syndrome evaluation. | ![]() |
Vascular Endothelial Growth Factor (VEGF)
Cat No. | Species | Biomarker | Disease | Cat No.of Antigen | Bioactivity validation of Antigen | Cat No.of Antibodies | Bioactivity validation of Antibodies | Order |
GMP-h-VEGF | Human | Vascular Endothelial Growth Factor (VEGF) | angiogenesis | GMP-h-VEGF-Ag01: Recombinant human VEGF Protein |
Vascular Endothelial Growth Factor (VEGF) antibodies binding, Immunogen in Sandwich Elisa, lateral-flow tests,and other immunoassays as control material in VEGF level test of Cardiovascular disease(angiogenesis) and related syndrome evaluation. | GMP-h-VEGF-Ab01; GMP-h-VEGF-Ab02: Anti-human VEGF mouse monoclonal antibody(mAb) |
Human Vascular Endothelial Growth Factor (VEGF) antigen binding, ELISA validated as capture antibody and detection antibody. Pair recommendation with other Vascular Endothelial Growth Factor (VEGF) antibodies in VEGF level test of Cardiovascular disease (angiogenesis) and related syndrome evaluation. | ![]() |
recombinant human placental growth factor-1 (PLGF-1)
Cat No. | Species | Biomarker | Disease | Cat No.of Antigen | Bioactivity validation of Antigen | Cat No.of Antibodies | Bioactivity validation of Antibodies | Order |
GMP-h-PLGF-1 | Human | recombinant human placental growth factor-1 (PLGF-1) | angiogenesis | GMP-h-PLGF-1-Ag01: Recombinant human PLGF-1 Protein |
recombinant human placental growth factor-1 (PLGF-1) antibodies binding, Immunogen in Sandwich Elisa, lateral-flow tests,and other immunoassays as control material in PLGF-1 level test of Cardiovascular disease(angiogenesis) and related syndrome evaluation. | GMP-h-PLGF-1-Ab01; GMP-h-PLGF-1-Ab02: Anti-human PLGF-1 mouse monoclonal antibody(mAb) |
Human recombinant human placental growth factor-1 (PLGF-1) antigen binding, ELISA validated as capture antibody and detection antibody. Pair recommendation with other recombinant human placental growth factor-1 (PLGF-1) antibodies in PLGF-1 level test of Cardiovascular disease (angiogenesis) and related syndrome evaluation. | ![]() |
S-Adenosylhomocysteine (SAH)
Cat No. | Species | Biomarker | Disease | Cat No.of Antigen | Bioactivity validation of Antigen | Cat No.of Antibodies | Bioactivity validation of Antibodies | Order |
GMP-SMT-SAH | Human | S-Adenosylhomocysteine (SAH) | cardiovascular disease, cancers, liver disease, and many other diseases | GMP-SMT-SAH-Ag01: BSA-S-Adenosylhomocysteine (SAH); GMP-SMT-SAH-Ag02: OVA-S-Adenosylhomocysteine (SAH) |
Competitive immunoassay-validated hapten-carrier conjugates [BSA-&OVA-S-Adenosylhomocysteine (SAH)], S-Adenosylhomocysteine (SAH) antibodies binding, Immunogen in Competitive immunoassay validation, Elisa, lateral-flow tests,and other immunoassays as control material in SAH level test of Cardiovascular disease (cardiovascular disease, cancers, liver disease, and many other diseases) and related syndrome evaluation. | GMP-SMT-SAH-Ab01: Anti-S-Adenosylhomocysteine (SAH) mouse monoclonal antibody(mAb) |
Human S-Adenosylhomocysteine (SAH) binding, in Competitive immunoassay validation, Elisa, lateral-flow tests, and other immunoassays in SAH level test of Cardiovascular disease (cardiovascular disease, cancers, liver disease, and many other diseases) and related syndrome evaluation. | ![]() |
Homocysteine (HCY)
Cat No. | Species | Biomarker | Disease | Cat No.of Antigen | Bioactivity validation of Antigen | Cat No.of Antibodies | Bioactivity validation of Antibodies | Order |
GMP-SMT-HCY | Human | Homocysteine (HCY) | dementia, heart disease and stroke. | GMP-SMT-HCY-Ag01: BSA-Homocysteine (HCY); GMP-SMT-HCY-Ag02: OVA-Homocysteine (HCY) |
Competitive immunoassay-validated hapten-carrier conjugates [BSA-&OVA-Homocysteine (HCY)], Homocysteine (HCY) antibodies binding, Immunogen in Competitive immunoassay validation, Elisa, lateral-flow tests,and other immunoassays as control material in HCY level test of Cardiovascular disease (dementia, heart disease and stroke.) and related syndrome evaluation. | GMP-SMT-HCY-Ab01: Anti-Homocysteine (HCY) mouse monoclonal antibody(mAb) |
Human Homocysteine (HCY) binding, in Competitive immunoassay validation, Elisa, lateral-flow tests, and other immunoassays in HCY level test of Cardiovascular disease (dementia, heart disease and stroke.) and related syndrome evaluation. | ![]() |
aldosterone (RAA/Aldo)
Cat No. | Species | Biomarker | Disease | Cat No.of Antigen | Bioactivity validation of Antigen | Cat No.of Antibodies | Bioactivity validation of Antibodies | Order |
GMP-SMT-RAA/Aldo | Human | aldosterone (RAA/Aldo) | Hypertension, blood pressure, hyperaldosteronism, renal artery stenosis (narrowing of the renal artery), congestive heart failure, cirrhosis, some kidney diseases (e.g., nephrotic syndrome). | GMP-SMT-RAA/Aldo-Ag01: BSA-aldosterone (RAA/Aldo); GMP-SMT-RAA/Aldo-Ag02: OVA-aldosterone (RAA/Aldo) |
Competitive immunoassay-validated hapten-carrier conjugates [BSA-&OVA-aldosterone (RAA/Aldo)], aldosterone (RAA/Aldo) antibodies binding, Immunogen in Competitive immunoassay validation, Elisa, lateral-flow tests,and other immunoassays as control material in RAA/Aldo level test of Cardiovascular disease ( Hypertension, blood pressure, hyperaldosteronism, renal artery stenosis (narrowing of the renal artery), congestive heart failure, cirrhosis, some kidney diseases (e.g., nephrotic syndrome).) and related syndrome evaluation. | GMP-SMT-RAA/Aldo-Ab01: Anti-aldosterone (RAA/Aldo) mouse monoclonal antibody(mAb) |
Human aldosterone (RAA/Aldo) binding, in Competitive immunoassay validation, Elisa, lateral-flow tests, and other immunoassays in RAA/Aldo level test of Cardiovascular disease ( Hypertension, blood pressure, hyperaldosteronism, renal artery stenosis (narrowing of the renal artery), congestive heart failure, cirrhosis, some kidney diseases (e.g., nephrotic syndrome).) and related syndrome evaluation. | ![]() |
digoxigenin (Digoxin)
Cat No. | Species | Biomarker | Disease | Cat No.of Antigen | Bioactivity validation of Antigen | Cat No.of Antibodies | Bioactivity validation of Antibodies | Order |
GMP-SMT-Digoxin | Human | digoxigenin (Digoxin) | NA | GMP-SMT-Digoxin-Ag01: BSA-digoxigenin (Digoxin); GMP-SMT-Digoxin-Ag02: OVA-digoxigenin (Digoxin) |
Competitive immunoassay-validated hapten-carrier conjugates [BSA-&OVA-digoxigenin (Digoxin)], digoxigenin (Digoxin) antibodies binding, Immunogen in Competitive immunoassay validation, Elisa, lateral-flow tests,and other immunoassays as control material in Digoxin level test of Cardiovascular disease and related syndrome evaluation. | GMP-SMT-Digoxin-Ab01: Anti-digoxigenin (Digoxin) mouse monoclonal antibody(mAb) |
Human digoxigenin (Digoxin) binding, in Competitive immunoassay validation, Elisa, lateral-flow tests, and other immunoassays in Digoxin level test of Cardiovascular disease and related syndrome evaluation. | ![]() |
Human Fatty Acid Binding Protein (HFABP)
Cat No. | Species | Biomarker | Disease | Cat No.of Antigen | Bioactivity validation of Antigen | Cat No.of Antibodies | Bioactivity validation of Antibodies | Order |
GMP-SMT-HFABP | Human | Human Fatty Acid Binding Protein (HFABP) | metabolic syndrome, atherosclerosis, insulin resistance and low-grade inflammation | GMP-SMT-HFABP-Ag01: BSA-Human Fatty Acid Binding Protein (HFABP); GMP-SMT-HFABP-Ag02: OVA-Human Fatty Acid Binding Protein (HFABP) |
Competitive immunoassay-validated hapten-carrier conjugates [BSA-&OVA-Human Fatty Acid Binding Protein (HFABP)], Human Fatty Acid Binding Protein (HFABP) antibodies binding, Immunogen in Competitive immunoassay validation, Elisa, lateral-flow tests,and other immunoassays as control material in HFABP level test of Cardiovascular disease (metabolic syndrome, atherosclerosis, insulin resistance and low-grade inflammation) and related syndrome evaluation. | GMP-SMT-HFABP-Ab01: Anti-Human Fatty Acid Binding Protein (HFABP) mouse monoclonal antibody(mAb) |
Human Human Fatty Acid Binding Protein (HFABP) binding, in Competitive immunoassay validation, Elisa, lateral-flow tests, and other immunoassays in HFABP level test of Cardiovascular disease (metabolic syndrome, atherosclerosis, insulin resistance and low-grade inflammation) and related syndrome evaluation. | ![]() |
Diagnostic antibodies and antigens for Liver Diseases testing: Hyaluronic acid (HA), laminins (LN), collagen type IV (cIV), Procollagen III N-terminal peptide (PIIINP), Lithocholic Acid (LCA), deoxycholic acid (cholanoic acid), hyaluronic acid (HA), Cholyglycine (CG), Prealbumin (PA)
Liver is an important organ and it is responsible for the metabolism, energy storage, and waste filtering. Liver disease is a generally designates to any condition that affects the liver. These conditions may be because of different reasons, but all these reasons damage the liver and affect its function. Many people with liver disease do not cause any symptoms in the early stages. At a certain point in the development of liver disease damage can become irreversible and lead to liver failure, liver cancer, or death. Early diagnosis of liver disease may prevent liver damage. GENEMEDI produces core diagnostic ingredients such as collagen type IV, Procollagen III N-terminal peptide, Lithocholic Acid, deoxycholic acid, hyaluronic acid, Cholyglycine, Prealbumin and so on for test of Liver Diseases and related syndrome using ELISA, Lateral flow immunoassay (LFIA), colloidal gold immunochromatographic assay, Chemiluminescent immunoassay (CLIA), turbidimetric inhibition immuno assay (TINIA), immunonephelometry and POCT Kit.
Classification:
HABP
LN
cIV
PIIINP
LCA
cholanoic acid
HA
CG
PA
Hyaluronic acid binding protein (HABP)
Cat No. | Species | Biomarker | Disease | Cat No.of Antigen | Bioactivity validation of Antigen | Cat No.of Antibodies | Bioactivity validation of Antibodies | Order |
GMP-h-HABP | Human | Hyaluronic acid binding protein (HABP) | rheumatoid arthritis (RA) andosteoarthritis | GMP-h-HABP-Ag01: Hyaluronic acid binding protein (HABP) |
Hyaluronic acid (HA) Antibody Binding, Immunogen in Sandwich ELISA test, Lateral flow immunoassay (LFIA),colloidal gold immunochromatographic assay, Chemiluminescent immunoassay (CLIA),turbidimetric inhibition immuno assay (TINIA), immunonephelometry and POCT. | GMP-h-HABP-Ab01; GMP-h-HABP-Ab02: Anti-Hyaluronic acid binding protein (HABP) mouse monoclonal antibody(mAb) |
Human Hyaluronic acid (HA) protein binding, ELISA validated as capture antibody and detection antibody. Pair in HAlevel test and Liver Diseases/Fibrosis evaluation. | ![]() |
laminins (LN)
Cat No. | Species | Biomarker | Disease | Cat No.of Antigen | Bioactivity validation of Antigen | Cat No.of Antibodies | Bioactivity validation of Antibodies | Order |
GMP-h-LN | Human | laminins (LN) | muscular dystrophy, lethal skin blistering disease (junctional epidermolysis bullosa) and nephrotic syndrome | GMP-h-LN-Ag01: Recombinant human LN Protein |
laminins (LN) antibodies binding, Immunogen in Sandwich Elisa, lateral-flow tests,and other immunoassays as control material in LN level test of Liver diseases(muscular dystrophy, lethal skin blistering disease (junctional epidermolysis bullosa) and nephrotic syndrome) and related syndrome evaluation. | GMP-h-LN-Ab01; GMP-h-LN-Ab02: Anti-human LN mouse monoclonal antibody(mAb) |
Human laminins (LN) antigen binding, ELISA validated as capture antibody and detection antibody. Pair recommendation with other laminins (LN) antibodies in LN level test of Liver diseases (muscular dystrophy, lethal skin blistering disease (junctional epidermolysis bullosa) and nephrotic syndrome) and related syndrome evaluation. | ![]() |
collagen type IV (cIV)
Cat No. | Species | Biomarker | Disease | Cat No.of Antigen | Bioactivity validation of Antigen | Cat No.of Antibodies | Bioactivity validation of Antibodies | Order |
GMP-h-cIV | Human | collagen type IV (cIV) | Goodpasture syndrome, Alport syndrome, glomerular basement membrane, Liver fibrosis and cirrhosis, alcoholic liver disease, hepatitis C and fall following successful therapy. autosomal dominant hereditary angiopathy, nephropathy, aneurysms, and muscle cramps. porencephaly, schizencephaly, congenital cataract, coronary artery disease, diabetic nephropathy and renal injury. | GMP-h-cIV-Ag01: Recombinant human cIV Protein |
collagen type IV (cIV) antibodies binding, Immunogen in Sandwich Elisa, lateral-flow tests,and other immunoassays as control material in cIV level test of Liver diseases(Goodpasture syndrome, Alport syndrome, glomerular basement membrane, Liver fibrosis and cirrhosis, alcoholic liver disease, hepatitis C and fall following successful therapy. autosomal dominant hereditary angiopathy, nephropathy, aneurysms, and muscle cramps. porencephaly, schizencephaly, congenital cataract, coronary artery disease, diabetic nephropathy and renal injury.) and related syndrome evaluation. | GMP-h-cIV-Ab01; GMP-h-cIV-Ab02: Anti-human cIV mouse monoclonal antibody(mAb) |
Human collagen type IV (cIV) antigen binding, ELISA validated as capture antibody and detection antibody. Pair recommendation with other collagen type IV (cIV) antibodies in cIV level test of Liver diseases (Goodpasture syndrome, Alport syndrome, glomerular basement membrane, Liver fibrosis and cirrhosis, alcoholic liver disease, hepatitis C and fall following successful therapy. autosomal dominant hereditary angiopathy, nephropathy, aneurysms, and muscle cramps. porencephaly, schizencephaly, congenital cataract, coronary artery disease, diabetic nephropathy and renal injury.) and related syndrome evaluation. | ![]() |
Procollagen III N-terminal peptide (PIIINP)
Cat No. | Species | Biomarker | Disease | Cat No.of Antigen | Bioactivity validation of Antigen | Cat No.of Antibodies | Bioactivity validation of Antibodies | Order |
GMP-h-PIIINP | Human | Procollagen III N-terminal peptide (PIIINP) | liver fibrosis and cirrhosis | GMP-h-PIIINP-Ag01: Recombinant human PIIINP Protein |
Procollagen III N-terminal peptide (PIIINP) antibodies binding, Immunogen in Sandwich Elisa, lateral-flow tests,and other immunoassays as control material in PIIINP level test of Liver diseases(liver fibrosis and cirrhosis) and related syndrome evaluation. | GMP-h-PIIINP-Ab01; GMP-h-PIIINP-Ab02: Anti-human PIIINP mouse monoclonal antibody(mAb) |
Human Procollagen III N-terminal peptide (PIIINP) antigen binding, ELISA validated as capture antibody and detection antibody. Pair recommendation with other Procollagen III N-terminal peptide (PIIINP) antibodies in PIIINP level test of Liver diseases (liver fibrosis and cirrhosis) and related syndrome evaluation. | ![]() |
Lithocholic Acid (LCA)
Cat No. | Species | Biomarker | Disease | Cat No.of Antigen | Bioactivity validation of Antigen | Cat No.of Antibodies | Bioactivity validation of Antibodies | Order |
GMP-SMT-LCA | Human | Lithocholic Acid (LCA) | liver damage | GMP-SMT-LCA-Ag01: BSA-Lithocholic Acid (LCA); GMP-SMT-LCA-Ag02: OVA-Lithocholic Acid (LCA) |
Competitive immunoassay-validated hapten-carrier conjugates [BSA-&OVA-Lithocholic Acid (LCA)], Lithocholic Acid (LCA) antibodies binding, Immunogen in Competitive immunoassay validation, Elisa, lateral-flow tests,and other immunoassays as control material in LCA level test of Liver diseases (liver damage) and related syndrome evaluation. | GMP-SMT-LCA-Ab01: Anti-Lithocholic Acid (LCA) mouse monoclonal antibody(mAb) |
Human Lithocholic Acid (LCA) binding, in Competitive immunoassay validation, Elisa, lateral-flow tests, and other immunoassays in LCA level test of Liver diseases (liver damage) and related syndrome evaluation. | ![]() |
deoxycholic acid (cholanoic acid)
Cat No. | Species | Biomarker | Disease | Cat No.of Antigen | Bioactivity validation of Antigen | Cat No.of Antibodies | Bioactivity validation of Antibodies | Order |
GMP-SMT-cholanoic-acid | Human | deoxycholic acid (cholanoic acid) | liver cirrhosis, chronic kidney disease, vascular calcification, vasculature toxicity | GMP-SMT-cholanoic-acid-Ag01: BSA-deoxycholic acid (cholanoic acid); GMP-SMT-cholanoic-acid-Ag02: OVA-deoxycholic acid (cholanoic acid) |
Competitive immunoassay-validated hapten-carrier conjugates [BSA-&OVA-deoxycholic acid (cholanoic acid)], deoxycholic acid (cholanoic acid) antibodies binding, Immunogen in Competitive immunoassay validation, Elisa, lateral-flow tests,and other immunoassays as control material in cholanoic acid level test of Liver diseases (liver cirrhosis, chronic kidney disease, vascular calcification, vasculature toxicity) and related syndrome evaluation. | GMP-SMT-cholanoic-acid-Ab01: Anti-deoxycholic acid (cholanoic acid) mouse monoclonal antibody(mAb) |
Human deoxycholic acid (cholanoic acid) binding, in Competitive immunoassay validation, Elisa, lateral-flow tests, and other immunoassays in cholanoic acid level test of Liver diseases (liver cirrhosis, chronic kidney disease, vascular calcification, vasculature toxicity) and related syndrome evaluation. | ![]() |
hyaluronic acid (HA)
Cat No. | Species | Biomarker | Disease | Cat No.of Antigen | Bioactivity validation of Antigen | Cat No.of Antibodies | Bioactivity validation of Antibodies | Order |
GMP-SMT-HA | Human | hyaluronic acid (HA) | GMP-SMT-HA-Ag01: BSA-hyaluronic acid (HA); GMP-SMT-HA-Ag02: OVA-hyaluronic acid (HA) |
Competitive immunoassay-validated hapten-carrier conjugates [BSA-&OVA-hyaluronic acid (HA)], hyaluronic acid (HA) antibodies binding, Immunogen in Competitive immunoassay validation, Elisa, lateral-flow tests,and other immunoassays as control material in HA level test of Liver diseases and related syndrome evaluation. | GMP-SMT-HA-Ab01: Anti-hyaluronic acid (HA) mouse monoclonal antibody(mAb) |
Human hyaluronic acid (HA) binding, in Competitive immunoassay validation, Elisa, lateral-flow tests, and other immunoassays in HA level test of Liver diseases and related syndrome evaluation. | ![]() |
Cholyglycine (CG)
Cat No. | Species | Biomarker | Disease | Cat No.of Antigen | Bioactivity validation of Antigen | Cat No.of Antibodies | Bioactivity validation of Antibodies | Order |
GMP-SMT-CG | Human | Cholyglycine (CG) | liver cirrhosis or obstructive liver disease | GMP-SMT-CG-Ag01: BSA-Cholyglycine (CG) GMP-SMT-CG-Ag02: OVA-Cholyglycine (CG) |
Competitive immunoassay-validated hapten-carrier conjugates [BSA-&OVA-Cholyglycine (CG)], Cholyglycine (CG) antibodies binding, Immunogen in Competitive immunoassay validation, Elisa, lateral-flow tests,and other immunoassays as control material in CG level test of Liver diseases (liver cirrhosis or obstructive liver disease) and related syndrome evaluation. | GMP-SMT-CG-Ab01: Anti-Cholyglycine (CG) mouse monoclonal antibody(mAb) |
Human Cholyglycine (CG) binding, in Competitive immunoassay validation, Elisa, lateral-flow tests, and other immunoassays in CG level test of Liver diseases (liver cirrhosis or obstructive liver disease) and related syndrome evaluation. | ![]() |
Prealbumin (PA)
Cat No. | Species | Biomarker | Disease | Cat No.of Antigen | Bioactivity validation of Antigen | Cat No.of Antibodies | Bioactivity validation of Antibodies | Order |
GMP-h-PA | Human | Prealbumin (PA) | liver disease, inflammation, or tissue death | GMP-h-PA-Ag01: Recombinant human PA Protein |
Prealbumin (PA) antibodies binding, Immunogen in Sandwich Elisa, lateral-flow tests,and other immunoassays as control material in PA level test of Liver diseases(liver disease, inflammation, or tissue death) and related syndrome evaluation. | GMP-h-PA-Ab01; GMP-h-PA-Ab02: Anti-human PA mouse monoclonal antibody(mAb) |
Human Prealbumin (PA) antigen binding, ELISA validated as capture antibody and detection antibody. Pair recommendation with other Prealbumin (PA) antibodies in PA level test of Liver diseases (liver disease, inflammation, or tissue death) and related syndrome evaluation. | ![]() |
Diagnostic antibodies and antigens for lung diseases testing: ACE2/hFc, ACE2/his
Lung disease such as asthma, COPD, infections like influenza, pneumonia and tuberculosis and lung cancer can affect respiratory function, or the ability to breathe, and pulmonary function. some of the lung diseases are caused by bacterial, viral, or fungal infections and some other lung diseases are associated with environmental factors, including asthma, mesothelioma, and lung cancer. The early diagnosis of the lung disease is an important step to prevent the respiratory failure. Biomarker such as human angiotensin converting enzyme 2 and so on are suitable for monitoring lung disease at early stages. Detecting the quantity of these marker proteins from different samples may benefit from ELISA, Lateral flow immunoassay (LFIA), colloidal gold immunochromatographic assay, Chemiluminescent immunoassay (CLIA), turbidimetric inhibition immuno assay (TINIA), immunonephelometry and POCT.
Classification:
ACE2/hFc
ACE2/his
Human Angiotensin Converting Enzyme 2 (ACE2/hFc
Cat No. | Species | Biomarker | Disease | Cat No.of Antigen | Bioactivity validation of Antigen | Cat No.of Antibodies | Bioactivity validation of Antibodies | Order |
GMP-h-ACE2/hFc | Human | Human Angiotensin Converting Enzyme 2 (ACE2/hFc | acute respiratory distress syndrome | GMP-h-ACE2/hFc-Ag01: Recombinant human ACE2/hFc Protein |
Human Angiotensin Converting Enzyme 2 (ACE2/hFc) antibodies binding, Immunogen in Sandwich Elisa, lateral-flow tests,and other immunoassays as control material in ACE2/hFc level test of Lung injury(acute respiratory distress syndrome) and related syndrome evaluation. | GMP-h-ACE2/hFc-Ab01; GMP-h-ACE2/hFc-Ab02: Anti-human ACE2/hFc mouse monoclonal antibody(mAb) |
Human Human Angiotensin Converting Enzyme 2 (ACE2/hFc) antigen binding, ELISA validated as capture antibody and detection antibody. Pair recommendation with other Human Angiotensin Converting Enzyme 2 (ACE2/hFc) antibodies in ACE2/hFc level test of Lung injury (acute respiratory distress syndrome) and related syndrome evaluation. | ![]() |
Human Angiotensin Converting Enzyme 2 (His)
Cat No. | Species | Biomarker | Disease | Cat No.of Antigen | Bioactivity validation of Antigen | Cat No.of Antibodies | Bioactivity validation of Antibodies | Order |
GMP-h-ACE2/his | Human | Human Angiotensin Converting Enzyme 2 (His) | acute respiratory distress syndrome | GMP-h-ACE2/his-Ag01: Recombinant human ACE2/his Protein |
Human Angiotensin Converting Enzyme 2 (His) (ACE2/his) antibodies binding, Immunogen in Sandwich Elisa, lateral-flow tests,and other immunoassays as control material in ACE2/his level test of Lung injury(acute respiratory distress syndrome) and related syndrome evaluation. | GMP-h-ACE2/his-Ab01; GMP-h-ACE2/his-Ab02: Anti-human ACE2/his mouse monoclonal antibody(mAb) |
Human Human Angiotensin Converting Enzyme 2 (His) (ACE2/his) antigen binding, ELISA validated as capture antibody and detection antibody. Pair recommendation with other Human Angiotensin Converting Enzyme 2 (His) (ACE2/his) antibodies in ACE2/his level test of Lung injury (acute respiratory distress syndrome) and related syndrome evaluation. | ![]() |
Diagnostic antibodies and antigens for kidney function (renal damages) testing: Beta-2 microglobulin (B2M), Cystatin C (CYSC), Neutrophil gelatinase-associated lipocalin (NGAL), Alpha-1-microglobulin (A1M), creatinine (cr)
The kidneys are important to filter wastes and excess fluids from the blood and excreted in urine. Chronic kidney disease steadily loss the kidney function and fail to filter the waste in the body. The chronic kidney disease (CKD) includes advanced stage of renal parenchyma damage and the loss of functional nephrons. The loss of functional nephrons induces several molecular and cellular events, which leads to the development of renal lesions. The chronic kidney disease disperses the podocytes from basal membrane and excrete in the urine, therefore the diagnosis usually made with the serum proteins (creatinine) and blood urea (sCr). The early diagnosis of this disease is an important step to prevent the CKD. Biomarker such as Cystatin C (CYSC) Neutrophil gelatinase-associated lipocalin (NGAL),Beta-2 microglobulin (B2M),Alpha-1-microglobulin (A1M) and so on are suitable for monitoring CKD at early stages. Detecting the quantity of these marker proteins from different samples may benefit from ELISA, Lateral flow immunoassay (LFIA), colloidal gold immunochromatographic assay, Chemiluminescent immunoassay (CLIA), turbidimetric inhibition immuno assay (TINIA), immunonephelometry and POCT.
Classification: B2M CYSC NGAL A1M cr
Beta-2 microglobulin (B2M)
Cat No. | Species | Biomarker | Disease | Cat No.of Antigen | Bioactivity validation of Antigen | Cat No.of Antibodies | Bioactivity validation of Antibodies | Order |
GMP-h-B2M | Human | Beta-2 microglobulin (B2M) | renal disease | GMP-h-B2M-Ag01: Recombinant human B2M Protein |
Beta-2 microglobulin (B2M) antibodies binding, Immunogen in Sandwich Elisa, lateral-flow tests,and other immunoassays as control material in B2M level test of Kidney function (renal damages)(renal disease) and related syndrome evaluation. | GMP-h-B2M-Ab01; GMP-h-B2M-Ab02: Anti-human B2M mouse monoclonal antibody(mAb) |
Human Beta-2 microglobulin (B2M) antigen binding, ELISA validated as capture antibody and detection antibody. Pair recommendation with other Beta-2 microglobulin (B2M) antibodies in B2M level test of Kidney function (renal damages) (renal disease) and related syndrome evaluation. | ![]() |
Cystatin C (CYSC)
Cat No. | Species | Biomarker | Disease | Cat No.of Antigen | Bioactivity validation of Antigen | Cat No.of Antibodies | Bioactivity validation of Antibodies | Order |
GMP-h-CYSC | Human | Cystatin C (CYSC) | kidney function (renal damages) | GMP-h-CYSC-Ag01: Recombinant human CYSC Protein |
Cystatin C (CYSC) antibodies binding, Immunogen in Sandwich Elisa, lateral-flow tests,and other immunoassays as control material in CYSC level test of Kidney function (renal damages)(kidney function (renal damages)) and related syndrome evaluation. | GMP-h-CYSC-Ab01; GMP-h-CYSC-Ab02: Anti-human CYSC mouse monoclonal antibody(mAb) |
Human Cystatin C (CYSC) antigen binding, ELISA validated as capture antibody and detection antibody. Pair recommendation with other Cystatin C (CYSC) antibodies in CYSC level test of Kidney function (renal damages) (kidney function (renal damages)) and related syndrome evaluation. | ![]() |
Neutrophil gelatinase-associated lipocalin (NGAL)
Cat No. | Species | Biomarker | Disease | Cat No.of Antigen | Bioactivity validation of Antigen | Cat No.of Antibodies | Bioactivity validation of Antibodies | Order |
GMP-h-NGAL | Human | Neutrophil gelatinase-associated lipocalin (NGAL) | kidney injury | GMP-h-NGAL-Ag01: Recombinant human NGAL Protein |
Neutrophil gelatinase-associated lipocalin (NGAL) antibodies binding, Immunogen in Sandwich Elisa, lateral-flow tests,and other immunoassays as control material in NGAL level test of Kidney function (renal damages)(kidney injury) and related syndrome evaluation. | GMP-h-NGAL-Ab01; GMP-h-NGAL-Ab02: Anti-human NGAL mouse monoclonal antibody(mAb) |
Human Neutrophil gelatinase-associated lipocalin (NGAL) antigen binding, ELISA validated as capture antibody and detection antibody. Pair recommendation with other Neutrophil gelatinase-associated lipocalin (NGAL) antibodies in NGAL level test of Kidney function (renal damages) (kidney injury) and related syndrome evaluation. | ![]() |
Alpha-1-microglobulin (A1M)
Cat No. | Species | Biomarker | Disease | Cat No.of Antigen | Bioactivity validation of Antigen | Cat No.of Antibodies | Bioactivity validation of Antibodies | Order |
GMP-h-A1M | Human | Alpha-1-microglobulin (A1M) | Proteinuria, preeclampsia, | GMP-h-A1M-Ag01: Recombinant human A1M Protein |
Alpha-1-microglobulin (A1M) antibodies binding, Immunogen in Sandwich Elisa, lateral-flow tests,and other immunoassays as control material in A1M level test of Kidney function (renal damages)(Proteinuria, preeclampsia,) and related syndrome evaluation. | GMP-h-A1M-Ab01; GMP-h-A1M-Ab02: Anti-human A1M mouse monoclonal antibody(mAb) |
Human Alpha-1-microglobulin (A1M) antigen binding, ELISA validated as capture antibody and detection antibody. Pair recommendation with other Alpha-1-microglobulin (A1M) antibodies in A1M level test of Kidney function (renal damages) (Proteinuria, preeclampsia,) and related syndrome evaluation. | ![]() |
creatinine (cr)
Cat No. | Species | Biomarker | Disease | Cat No.of Antigen | Bioactivity validation of Antigen | Cat No.of Antibodies | Bioactivity validation of Antibodies | Order |
GMP-SMT-cr | Human | creatinine (cr) | Autoimmune diseases, Bacterial infection of the kidneys, Blocked urinary tract | GMP-SMT-cr-Ag01: BSA-creatinine (cr) GMP-SMT-cr-Ag02: OVA-creatinine (cr) |
Competitive immunoassay-validated hapten-carrier conjugates [BSA-creatinine (cr)], creatinine (cr) antibodies binding, Immunogen in Competitive immunoassay validation, Elisa, lateral-flow tests, and other immunoassays as control material in TFF2 level test of Kidney function (renal damages) (Autoimmune diseases, Bacterial infection of the kidneys, Blocked urinary tract) and related syndrome evaluation. | GMP-SMT-cr-Ab01: Anti-creatinine (cr) mouse monoclonal antibody(mAb) |
Human creatinine (cr) binding, in Competitive immunoassay validation, Elisa, lateral-flow tests, and other immunoassays in TFF2 level test of Kidney function (renal damages) (Autoimmune diseases, Bacterial infection of the kidneys, Blocked urinary tract) and related syndrome evaluation. | ![]() |
Diagnostic antibodies and antigens for gastric disease testing: pepsinogen I (PG I), Pepsinogen II (PG II), Gastrin 17 (G17), trefoil factor 1 (TFF1), Gastrin (G100)
Gastric disorders are the most common disease leads to the death. Most death of gastric disease is mostly due the diagnosis at late-stage. The diagnosis of Gastric disease at early-stage is delayed due to the lack symptoms and effective diagnostic technique. The traditional technology, including endoscopic examination and gastroscopic biopsy are invasive to screen large population. Hence, biomarkers such as pepsinogen I, Pepsinogen II, Gastrin 17, trefoil factor 1, Gastrin and so on have been developed to detect the gastric diseases at an early stage for large population to significantly reduce the death caused by gastric cancer. However, the detection of these marker proteins from different samples may benefit from ELISA, Lateral flow immunoassay (LFIA), colloidal gold immunochromatographic assay, Chemiluminescent immunoassay (CLIA), turbidimetric inhibition immuno assay (TINIA), immunonephelometry and POCT.
Classification:
PG I
PG II
G17
TFF1
G100
pepsinogen I (PG I)
Cat No. | Species | Biomarker | Disease | Cat No.of Antigen | Bioactivity validation of Antigen | Cat No.of Antibodies | Bioactivity validation of Antibodies | Order |
GMP-h-PG-I | Human | pepsinogen I (PG I) | atrophic gastritis, pernicious anemia, intestinal metaplasia, dysplasia, gastric polyps, and gastric cancer | GMP-h-PG-I-Ag01: Recombinant human PG I Protein |
pepsinogen I (PG I) antibodies binding, Immunogen in Sandwich Elisa, lateral-flow tests,and other immunoassays as control material in PG I level test of Gastric disease(atrophic gastritis, pernicious anemia, intestinal metaplasia, dysplasia, gastric polyps, and gastric cancer) and related syndrome evaluation. | GMP-h-PG-I-Ab01; GMP-h-PG-I-Ab02: Anti-human PG I mouse monoclonal antibody(mAb) |
Human pepsinogen I (PG I) antigen binding, ELISA validated as capture antibody and detection antibody. Pair recommendation with other pepsinogen I (PG I) antibodies in PG I level test of Gastric disease (atrophic gastritis, pernicious anemia, intestinal metaplasia, dysplasia, gastric polyps, and gastric cancer) and related syndrome evaluation. | ![]() |
Pepsinogen II (PG II)
Cat No. | Species | Biomarker | Disease | Cat No.of Antigen | Bioactivity validation of Antigen | Cat No.of Antibodies | Bioactivity validation of Antibodies | Order |
GMP-h-PG-II | Human | Pepsinogen II (PG II) | pernicious anemia | GMP-h-PG-II-Ag01: Recombinant human PG II Protein |
Pepsinogen II (PG II) antibodies binding, Immunogen in Sandwich Elisa, lateral-flow tests,and other immunoassays as control material in PG II level test of Gastric disease(pernicious anemia) and related syndrome evaluation. | GMP-h-PG-II-Ab01; GMP-h-PG-II-Ab02: Anti-human PG II mouse monoclonal antibody(mAb) |
Human Pepsinogen II (PG II) antigen binding, ELISA validated as capture antibody and detection antibody. Pair recommendation with other Pepsinogen II (PG II) antibodies in PG II level test of Gastric disease (pernicious anemia) and related syndrome evaluation. | ![]() |
Gastrin 17 (G17)
Cat No. | Species | Biomarker | Disease | Cat No.of Antigen | Bioactivity validation of Antigen | Cat No.of Antibodies | Bioactivity validation of Antibodies | Order |
GMP-SMT-G17 | Human | Gastrin 17 (G17) | Chronic atrophic gastritis (CAG) | GMP-SMT-G17-Ag01: BSA-Gastrin 17 (G17) GMP-SMT-G17-Ag02: OVA-Gastrin 17 (G17) |
Competitive immunoassay-validated hapten-carrier conjugates [BSA-&OVA-Gastrin 17 (G17)], Gastrin 17 (G17) antibodies binding, Immunogen in Competitive immunoassay validation, Elisa, lateral-flow tests,and other immunoassays as control material in G17 level test of Gastric disease (Chronic atrophic gastritis (CAG)) and related syndrome evaluation. | GMP-SMT-G17-Ab01: Anti-Gastrin 17 (G17) mouse monoclonal antibody(mAb) |
Human Gastrin 17 (G17) binding, in Competitive immunoassay validation, Elisa, lateral-flow tests, and other immunoassays in G17 level test of Gastric disease (Chronic atrophic gastritis (CAG)) and related syndrome evaluation. | ![]() |
trefoil factor 1 (TFF1)
Cat No. | Species | Biomarker | Disease | Cat No.of Antigen | Bioactivity validation of Antigen | Cat No.of Antibodies | Bioactivity validation of Antibodies | Order |
GMP-SMT-TFF1 | Human | trefoil factor 1 (TFF1) | Bile Reflux and Gastric Ulcer | GMP-SMT-TFF1-Ag01: BSA-trefoil factor 1 (TFF1) GMP-SMT-TFF1-Ag02: OVA-trefoil factor 1 (TFF1) |
Competitive immunoassay-validated hapten-carrier conjugates [BSA-&OVA-trefoil factor 1 (TFF1)], trefoil factor 1 (TFF1) antibodies binding, Immunogen in Competitive immunoassay validation, Elisa, lateral-flow tests,and other immunoassays as control material in TFF1 level test of Gastric disease (Bile Reflux and Gastric Ulcer) and related syndrome evaluation. | GMP-SMT-TFF1-Ab01: Anti-trefoil factor 1 (TFF1) mouse monoclonal antibody(mAb) |
Human trefoil factor 1 (TFF1) binding, in Competitive immunoassay validation, Elisa, lateral-flow tests, and other immunoassays in TFF1 level test of Gastric disease (Bile Reflux and Gastric Ulcer) and related syndrome evaluation. | ![]() |
Gastrin (G100)
Cat No. | Species | Biomarker | Disease | Cat No.of Antigen | Bioactivity validation of Antigen | Cat No.of Antibodies | Bioactivity validation of Antibodies | Order |
GMP-h-G100 | Human | Gastrin (G100) | gastrinoma | GMP-h-G100-Ag01: Recombinant human G100 Protein |
Gastrin (G100) antibodies binding, Immunogen in Sandwich Elisa, lateral-flow tests,and other immunoassays as control material in G100 level test of Gastric disease(gastrinoma) and related syndrome evaluation. | GMP-h-G100-Ab01; GMP-h-G100-Ab02: Anti-human G100 mouse monoclonal antibody(mAb) |
Human Gastrin (G100) antigen binding, ELISA validated as capture antibody and detection antibody. Pair recommendation with other Gastrin (G100) antibodies in G100 level test of Gastric disease (gastrinoma) and related syndrome evaluation. | ![]() |
Diagnostic antibodies and antigens for thyroid disease testing: Reverse triiodothyronine (rT3), Thyroid Stimulating Hormone (TSH)
Thyroid gland produces the hormones that keep body functioning normally. When concentration of these hormone increases or decrease, it’s called a thyroid disease. There are several types of thyroid disease, which includes hyperthyroidism, hypothyroidism, thyroiditis and Hashimoto’s thyroiditis. The most commonly measured thyroid hormones are thyroid stimulating hormone (TSH), total thyroxine (T4), free T4, total triiodothyronine (T3), and free T3. The thyroid gland produces T4, as well as some T3. After its release from the thyroid gland, T4 is converted to T3, which is an active thyroid hormone, or to Reverse triiodothyronine (rT3), which is considered an inactive form. The rate and ratio of T4 conversion to either T3 or rT3 is depends upon the body's metabolic requirement. Hence, the measurement of reverse triiodothyronine, thyroid-stimulating hormone and so on is useful to diagnose the thyroid disorder. GeneMedi offers diagnostic antigen and antibody to detect the thyroid disorder.
Classification:
rT3
TSH
Reverse triiodothyronine (rT3)
Cat No. | Species | Biomarker | Disease | Cat No.of Antigen | Bioactivity validation of Antigen | Cat No.of Antibodies | Bioactivity validation of Antibodies | Order |
GMP-SMT-rT3 | Human | Reverse triiodothyronine (rT3) | stress | GMP-SMT-rT3-Ag01: BSA-Reverse triiodothyronine (rT3) GMP-SMT-rT3-Ag02: OVA-Reverse triiodothyronine (rT3) |
Competitive immunoassay-validated hapten-carrier conjugates [BSA-&OVA-Reverse triiodothyronine (rT3)], Reverse triiodothyronine (rT3) antibodies binding, Immunogen in Competitive immunoassay validation, Elisa, lateral-flow tests,and other immunoassays as control material in rT3 level test of Thyroid diseases (stress ) and related syndrome evaluation. | GMP-SMT-rT3-Ab01: Anti-Reverse triiodothyronine (rT3) mouse monoclonal antibody(mAb) |
Human Reverse triiodothyronine (rT3) binding, in Competitive immunoassay validation, Elisa, lateral-flow tests, and other immunoassays in rT3 level test of Thyroid diseases (stress ) and related syndrome evaluation. | ![]() |
Thyroid Stimulating Hormone (TSH)
Cat No. | Species | Biomarker | Disease | Cat No.of Antigen | Bioactivity validation of Antigen | Cat No.of Antibodies | Bioactivity validation of Antibodies | Order |
GMP-h-TSH | Human | Thyroid Stimulating Hormone (TSH) | Hypothyroidism, hyperthyroidism | GMP-h-TSH-Ag01: Recombinant human TSH Protein |
Thyroid Stimulating Hormone (TSH) antibodies binding, Immunogen in Sandwich Elisa, lateral-flow tests,and other immunoassays as control material in TSH level test of Thyroid diseases(Hypothyroidism, hyperthyroidism) and related syndrome evaluation. | GMP-h-TSH-Ab01; GMP-h-TSH-Ab02: Anti-human TSH mouse monoclonal antibody(mAb) |
Human Thyroid Stimulating Hormone (TSH) antigen binding, ELISA validated as capture antibody and detection antibody. Pair recommendation with other Thyroid Stimulating Hormone (TSH) antibodies in TSH level test of Thyroid diseases (Hypothyroidism, hyperthyroidism) and related syndrome evaluation. | ![]() |
Diagnostic antibodies and antigens for inflammatory bowel disease testing: Calprotectin (S100-A8)
Inflammatory bowel disease (IBD) is a group of idiopathic inflammatory disorders of the gastrointestinal (GI) tract characterized by the symptoms of abdominal pain and diarrhea. IBD is diagnosed by the comprehensive analysis of clinical findings, radiological imaging, invasive endoscopy and histopathological examination. Due to a lack of a gold standard, certain patients do not receive a definitive diagnosis using current diagnostic criteria. Recently, the search for a noninvasive marker that could augment or replace part of this diagnostic process has become a focus of IBD research. antibody markers, including microbial antibodies, autoantibodies and peptide antibodies, will minimize the use of endoscopic and radiologic examinations and improve the long-term prognosis of patients with IBD. Several intestinal inflammations and so on have been identified using specific marker. Detecting the quantity of marker proteins from different samples may benefit from ELISA, Lateral flow immunoassay (LFIA), colloidal gold immunochromatographic assay, Chemiluminescent immunoassay (CLIA), turbidimetric inhibition immuno assay (TINIA), immunonephelometry and POCT.
Classification:
S100-A8
Calprotectin (S100-A8)
Cat No. | Species | Biomarker | Disease | Cat No.of Antigen | Bioactivity validation of Antigen | Cat No.of Antibodies | Bioactivity validation of Antibodies | Order |
GMP-h-S100-A8 | Human | Calprotectin (S100-A8) | intestinal inflammation | GMP-h-S100-A8-Ag01: Recombinant human S100-A8 Protein |
Calprotectin (S100-A8) antibodies binding, Immunogen in Sandwich Elisa, lateral-flow tests,and other immunoassays as control material in S100-A8 level test of Bowel disease (intestinal inflammation) and related syndrome evaluation. | GMP-h-S100-A8-Ab01; GMP-h-S100-A8-Ab02: Anti-human S100-A8 mouse monoclonal antibody(mAb) |
Human Calprotectin (S100-A8) antigen binding, ELISA validated as capture antibody and detection antibody. Pair recommendation with other Calprotectin (S100-A8) antibodies in S100-A8 level test of Bowel disease (intestinal inflammation) and related syndrome evaluation. | ![]() |
Diagnostic antibodies and antigens for fertility testing: Anti-Mullerian hormone (AMH), Fetal fibronectin (fFN), acrosome protein (ACRV1)
The pregnancy contains multiple steps that must effectively happen at a precise time and in the precise place. For fertilization, oocytes and sperm cells must experience a series of differentiation and development process. Abnormalities on the placement of embryo in the woman’s uterus, decidualization, placentation and intrauterine embryonic development consequence the onset of pre-eclampsia, miscarriage and/or preterm birth. On the other hand, sperm cells of the man should undergo capacitation and acrosome exocytosis to fertilize oocytes appropriately. A little imbalance in this process may disturb the capability of sperm cells to fertilize the egg. Thus, the detection of biomarkers to monitor the pregnancy process, and complication in both female and male gametes is an opportunity for successful pregnancy. Recently, several biomarkers have been developed to improve diagnostic accuracy. Indeed, GENEMEDI offer the biomarkers such as Anti-Mullerian hormone (AMH), Fetal fibronectin (fFN), acrosome protein and so on to make a successful pregnancy. Detecting the quantity of these marker proteins from different samples may benefit from ELISA, Lateral flow immunoassay (LFIA), colloidal gold immunochromatographic assay, Chemiluminescent immunoassay (CLIA), turbidimetric inhibition immuno assay (TINIA), immunonephelometry and POCT.
Classification:
AMH
fFN
ACRV1
Anti-Mu¨llerian hormone (AMH)
Cat No. | Species | Biomarker | Disease | Cat No.of Antigen | Bioactivity validation of Antigen | Cat No.of Antibodies | Bioactivity validation of Antibodies | Order |
GMP-h-AMH | Human | Anti-Mu¨llerian hormone (AMH) | polycystic ovary syndrome (PCOS) | GMP-h-AMH-Ag01: Recombinant human AMH Protein |
Anti-Mu¨llerian hormone (AMH) antibodies binding, Immunogen in Sandwich Elisa, lateral-flow tests,and other immunoassays as control material in AMH level test of Fertility(polycystic ovary syndrome (PCOS)) and related syndrome evaluation. | GMP-h-AMH-Ab01; GMP-h-AMH-Ab02: Anti-human AMH mouse monoclonal antibody(mAb) |
Human Anti-Mu¨llerian hormone (AMH) antigen binding, ELISA validated as capture antibody and detection antibody. Pair recommendation with other Anti-Mu¨llerian hormone (AMH) antibodies in AMH level test of Fertility (polycystic ovary syndrome (PCOS)) and related syndrome evaluation. | ![]() |
Fetal fibronectin (fFN)
Cat No. | Species | Biomarker | Disease | Cat No.of Antigen | Bioactivity validation of Antigen | Cat No.of Antibodies | Bioactivity validation of Antibodies | Order |
GMP-h-fFN | Human | Fetal fibronectin (fFN) | premature delivery | GMP-h-fFN-Ag01: Recombinant human fFN Protein |
Fetal fibronectin (fFN) antibodies binding, Immunogen in Sandwich Elisa, lateral-flow tests,and other immunoassays as control material in fFN level test of Fertility(premature delivery) and related syndrome evaluation. | GMP-h-fFN-Ab01; GMP-h-fFN-Ab02; GMP-h-fFN-Ab03; GMP-h-fFN-Ab04; GMP-h-fFN-Ab05: Anti-human fFN mouse monoclonal antibody(mAb) |
Human Fetal fibronectin (fFN) antigen binding, ELISA validated as capture antibody and detection antibody. Pair recommendation with other Fetal fibronectin (fFN) antibodies in fFN level test of Fertility (premature delivery) and related syndrome evaluation. | ![]() |
acrosome protein (ACRV1)
Cat No. | Species | Biomarker | Disease | Cat No.of Antigen | Bioactivity validation of Antigen | Cat No.of Antibodies | Bioactivity validation of Antibodies | Order |
GMP-h-ACRV1 | Human | acrosome protein (ACRV1) | Fertilization | GMP-h-ACRV1-Ag01: Recombinant human ACRV1 Protein |
acrosome protein (ACRV1) antibodies binding, Immunogen in Sandwich Elisa, lateral-flow tests,and other immunoassays as control material in ACRV1 level test of Fertility(Fertilization) and related syndrome evaluation. | GMP-h-ACRV1-Ab01; GMP-h-ACRV1-Ab02: Anti-human ACRV1 mouse monoclonal antibody(mAb) |
Human acrosome protein (ACRV1) antigen binding, ELISA validated as capture antibody and detection antibody. Pair recommendation with other acrosome protein (ACRV1) antibodies in ACRV1 level test of Fertility (Fertilization) and related syndrome evaluation. | ![]() |
Diagnostic antibodies and antigens for diabetes testing: C-peptide, Copeptin, Human Insulin (Ins), Human Proinsulin (Proinsulin), Adiponectin (ADPN)
Diabetes mellitus is the most known chronic disorder characterized by hyperglycemia. Diabetes mellitus is classified based on the deficiency of insulin production due to β-cell destruction (type 1) and by increased insulin resistance (type 2). The increasing rate of obesity increased the difficulties to determine the type of diabetes mellitus. The classification of diabetes mellitus is important for treatment. Beside the conventional method, the detection of biomarkers such as c-peptide, copeptin, insulin, proinsulin, adiponectin and so on are used to differentiate the diabetes mellitus type. However, the detection of these marker proteins from different samples may benefit from ELISA, Lateral flow immunoassay (LFIA), colloidal gold immunochromatographic assay, Chemiluminescent immunoassay (CLIA), turbidimetric inhibition immuno assay (TINIA), immunonephelometry and POCT.
Classification:
C-Peptide
Copeptin
Ins
Proinsulin
ADPN
C-peptide
Cat No. | Species | Biomarker | Disease | Cat No.of Antigen | Bioactivity validation of Antigen | Cat No.of Antibodies | Bioactivity validation of Antibodies | Order |
GMP-h-C-Peptide | Human | C-peptide | type 1 diabetes mellitus | GMP-h-C-Peptide-Ag01: Recombinant human C-Peptide Protein |
C-peptide (C-Peptide) antibodies binding, Immunogen in Sandwich Elisa, lateral-flow tests,and other immunoassays as control material in C-Peptide level test of Diabetes diseases(type 1 diabetes mellitus) and related syndrome evaluation. | GMP-h-C-Peptide-Ab01; GMP-h-C-Peptide-Ab02: Anti-human C-Peptide mouse monoclonal antibody(mAb) |
Human C-peptide (C-Peptide) antigen binding, ELISA validated as capture antibody and detection antibody. Pair recommendation with other C-peptide (C-Peptide) antibodies in C-Peptide level test of Diabetes diseases (type 1 diabetes mellitus) and related syndrome evaluation. | ![]() |
Copeptin
Cat No. | Species | Biomarker | Disease | Cat No.of Antigen | Bioactivity validation of Antigen | Cat No.of Antibodies | Bioactivity validation of Antibodies | Order |
GMP-h-Copeptin | Human | Copeptin | diabetes insipidus, syndrome of inappropriate antidiuresis (SIAD) | GMP-h-Copeptin-Ag01: Recombinant human Copeptin Protein |
Copeptin antibodies binding, Immunogen in Sandwich Elisa, lateral-flow tests,and other immunoassays as control material in Copeptin level test of Diabetes diseases(diabetes insipidus, syndrome of inappropriate antidiuresis (SIAD)) and related syndrome evaluation. | GMP-h-Copeptin-Ab01; GMP-h-Copeptin-Ab02: Anti-human Copeptin mouse monoclonal antibody(mAb) |
Human Copeptin antigen binding, ELISA validated as capture antibody and detection antibody. Pair recommendation with other Copeptin antibodies in Copeptin level test of Diabetes diseases (diabetes insipidus, syndrome of inappropriate antidiuresis (SIAD)) and related syndrome evaluation. | ![]() |
Human Insulin (Ins)
Cat No. | Species | Biomarker | Disease | Cat No.of Antigen | Bioactivity validation of Antigen | Cat No.of Antibodies | Bioactivity validation of Antibodies | Order |
GMP-h-Ins | Human | Human Insulin (Ins) | Diabetes mellitus | GMP-h-Ins-Ag01: Recombinant human Ins Protein |
Human Insulin (Ins) antibodies binding, Immunogen in Sandwich Elisa, lateral-flow tests,and other immunoassays as control material in Ins level test of Diabetes diseases(Diabetes mellitus) and related syndrome evaluation. | GMP-h-Ins-Ab01; GMP-h-Ins-Ab02: Anti-human Ins mouse monoclonal antibody(mAb) |
Human Human Insulin (Ins) antigen binding, ELISA validated as capture antibody and detection antibody. Pair recommendation with other Human Insulin (Ins) antibodies in Ins level test of Diabetes diseases (Diabetes mellitus) and related syndrome evaluation. | ![]() |
Human Proinsulin (Proinsulin)
Cat No. | Species | Biomarker | Disease | Cat No.of Antigen | Bioactivity validation of Antigen | Cat No.of Antibodies | Bioactivity validation of Antibodies | Order |
GMP-h-Proinsulin | Human | Human Proinsulin (Proinsulin) | type 2 diabetes | GMP-h-Proinsulin-Ag01: Recombinant human Proinsulin Protein |
Human Proinsulin (Proinsulin) antibodies binding, Immunogen in Sandwich Elisa, lateral-flow tests,and other immunoassays as control material in Proinsulin level test of Diabetes diseases(type 2 diabetes) and related syndrome evaluation. | GMP-h-Proinsulin-Ab01; GMP-h-Proinsulin-Ab02: Anti-human Proinsulin mouse monoclonal antibody(mAb) |
Human Human Proinsulin (Proinsulin) antigen binding, ELISA validated as capture antibody and detection antibody. Pair recommendation with other Human Proinsulin (Proinsulin) antibodies in Proinsulin level test of Diabetes diseases (type 2 diabetes) and related syndrome evaluation. | ![]() |
Adiponectin (ADPN)
Cat No. | Species | Biomarker | Disease | Cat No.of Antigen | Bioactivity validation of Antigen | Cat No.of Antibodies | Bioactivity validation of Antibodies | Order |
GMP-h-ADPN | Human | Adiponectin (ADPN) | diabetes, obesity and atherosclerosis | GMP-h-ADPN-Ag01: Recombinant human ADPN Protein |
Adiponectin (ADPN) antibodies binding, Immunogen in Sandwich Elisa, lateral-flow tests,and other immunoassays as control material in ADPN level test of Diabetes diseases(diabetes, obesity and atherosclerosis) and related syndrome evaluation. | GMP-h-ADPN-Ab01; GMP-h-ADPN-Ab02: Anti-human ADPN mouse monoclonal antibody(mAb) |
Human Adiponectin (ADPN) antigen binding, ELISA validated as capture antibody and detection antibody. Pair recommendation with other Adiponectin (ADPN) antibodies in ADPN level test of Diabetes diseases (diabetes, obesity and atherosclerosis) and related syndrome evaluation. | ![]() |
Diagnostic antibodies and antigens for metabolic diseases testing: 25-OH-(VD3+VD2), PINP, N-MID OC, β-CTx, 25-OH-VD, 25-OH-VD-3, SAHH, CBL, CBS, LP-PLA2, RBP4
Metabolism is the process of making energy from the food. metabolic disease, any of the diseases or disorders that disrupt normal metabolism, the process of converting food to energy on a cellular level. Thousands of enzymes participating in numerous interdependent metabolic pathways carry out this process. Metabolic diseases affect the ability of the cell to perform critical biochemical reactions that involve the processing or transport of proteins (amino acids), carbohydrates (sugars and starches), or lipids (fatty acids). The consequences of metabolic disorder may be severe; intellectual disability, seizures, decreased muscle tone, organ failure, blindness, and deafness may occur, depending on which enzyme is dysfunctional. Biomarker such as -25 hydroxyvitamin D, procollagen type I N-terminal propeptide (PINP), β-isomerized C-terminal telopeptides, 25-hydroxy (OH) Vitamin, S-adenosylhomocysteine (AdoHcy) hydrolase, cystathionine-β-synthase enzyme, Phospholipase A2, Retinol binding protein 4 and so on are suitable for monitoring metabolic disease. Detecting the quantity of these marker proteins from different samples may benefit from ELISA, Lateral flow immunoassay (LFIA), colloidal gold immunochromatographic assay, Chemiluminescent immunoassay (CLIA), turbidimetric inhibition immuno assay (TINIA), immunonephelometry and POCT.
Classification:
25-OH-(VD3+VD2)
PINP
N-MID OC
β-CTx
25-OH-VD
25-OH-VD-3
SAHH
CBL
CBS
LP-PLA2
RBP4
25 hydroxyvitamin D (25-OH-(VD3+VD2))
Cat No. | Species | Biomarker | Disease | Cat No.of Antigen | Bioactivity validation of Antigen | Cat No.of Antibodies | Bioactivity validation of Antibodies | Order |
GMP-SMT-25-OH-VD3/2 | Human | 25 hydroxyvitamin D (25-OH-(VD3+VD2)) | bone fracture, coronary heart disease, cancer, and all-cause mortality | GMP-SMT-25-OH-VD3/2-Ag01: BSA-25 hydroxyvitamin D (25-OH-(VD3+VD2)) GMP-SMT-25-OH-VD3/2-Ag02: OVA-25 hydroxyvitamin D (25-OH-(VD3+VD2)) |
Competitive immunoassay-validated hapten-carrier conjugates [BSA-&OVA-25 hydroxyvitamin D (25-OH-(VD3+VD2))], 25 hydroxyvitamin D (25-OH-(VD3+VD2)) antibodies binding, Immunogen in Competitive immunoassay validation, Elisa, lateral-flow tests,and other immunoassays as control material in 25-OH-(VD3+VD2) level test of Metabolic diseases (bone fracture, coronary heart disease, cancer, and all-cause mortality) and related syndrome evaluation. | GMP-SMT-25-OH-VD3/2-Ab01: Anti-25 hydroxyvitamin D (25-OH-(VD3+VD2)) mouse monoclonal antibody(mAb) |
Human 25 hydroxyvitamin D (25-OH-(VD3+VD2)) binding, in Competitive immunoassay validation, Elisa, lateral-flow tests, and other immunoassays in 25-OH-(VD3+VD2) level test of Metabolic diseases (bone fracture, coronary heart disease, cancer, and all-cause mortality) and related syndrome evaluation. | ![]() |
procollagen type I N-terminal propeptide (PINP)
Cat No. | Species | Biomarker | Disease | Cat No.of Antigen | Bioactivity validation of Antigen | Cat No.of Antibodies | Bioactivity validation of Antibodies | Order |
GMP-h-PINP | Human | procollagen type I N-terminal propeptide (PINP) | osteoporosis therapy | GMP-h-PINP-Ag01: Recombinant human PINP Protein |
procollagen type I N-terminal propeptide (PINP) antibodies binding, Immunogen in Sandwich Elisa, lateral-flow tests,and other immunoassays as control material in PINP level test of Metabolic diseases(osteoporosis therapy) and related syndrome evaluation. | GMP-h-PINP-Ab01; GMP-h-PINP-Ab02: Anti-human PINP mouse monoclonal antibody(mAb) |
Human procollagen type I N-terminal propeptide (PINP) antigen binding, ELISA validated as capture antibody and detection antibody. Pair recommendation with other procollagen type I N-terminal propeptide (PINP) antibodies in PINP level test of Metabolic diseases (osteoporosis therapy) and related syndrome evaluation. | ![]() |
N-terminal midfragment of Osteocalcin (N-MID OC)
Cat No. | Species | Biomarker | Disease | Cat No.of Antigen | Bioactivity validation of Antigen | Cat No.of Antibodies | Bioactivity validation of Antibodies | Order |
GMP-h-N-MID-OC | Human | N-terminal midfragment of Osteocalcin (N-MID OC) | osteoporosis | GMP-h-N-MID-OC-Ag01: Recombinant Human N-MID OC Protein |
N-terminal midfragment of Osteocalcin (N-MID OC) antibodies binding, Immunogen in Sandwich Elisa, lateral-flow tests, and other immunoassays as control material in N-MID OC level test of Metabolic diseases (osteoporosis) and related syndrome evaluation | GMP-h-N-MID-OC-Ab01; GMP-h-N-MID-OC-Ab02: Anti-Human N-MID OC mouse monoclonal antibody (mAb) |
Human N-terminal midfragment of Osteocalcin (N-MID OC) antigen binding, ELISA validated as capture antibody and detection antibody. Pair recommendation with other N-terminal midfragment of Osteocalcin (N-MID OC) antibodies in N-MID OC level test of Metabolic diseases (osteoporosis) and related syndrome evaluation. | ![]() |
β-isomerized C-terminal telopeptides (β-CTx)
Cat No. | Species | Biomarker | Disease | Cat No.of Antigen | Bioactivity validation of Antigen | Cat No.of Antibodies | Bioactivity validation of Antibodies | Order |
GMP-h-β-CTx | Human | β-isomerized C-terminal telopeptides (β-CTx) | osteoporosis | GMP-h-β-CTx-Ag01: Recombinant human β-CTx Protein |
β-isomerized C-terminal telopeptides (β-CTx) antibodies binding, Immunogen in Sandwich Elisa, lateral-flow tests,and other immunoassays as control material in β-CTx level test of Metabolic diseases(osteoporosis) and related syndrome evaluation. | GMP-h-β-CTx-Ab01; GMP-h-β-CTx-Ab02: Anti-human β-CTx mouse monoclonal antibody(mAb) |
Human β-isomerized C-terminal telopeptides (β-CTx) antigen binding, ELISA validated as capture antibody and detection antibody. Pair recommendation with other β-isomerized C-terminal telopeptides (β-CTx) antibodies in β-CTx level test of Metabolic diseases (osteoporosis) and related syndrome evaluation. | ![]() |
25-hydroxy (OH) Vitamin (25-OH-VD)
Cat No. | Species | Biomarker | Disease | Cat No.of Antigen | Bioactivity validation of Antigen | Cat No.of Antibodies | Bioactivity validation of Antibodies | Order |
GMP-SMT-25-OH-VD | Human | 25-hydroxy (OH) Vitamin (25-OH-VD) | osteoporosis and rickets | GMP-SMT-25-OH-VD-Ag01: BSA-25-hydroxy (OH) Vitamin (25-OH-VD) GMP-SMT-25-OH-VD-Ag02: OVA-25-hydroxy (OH) Vitamin (25-OH-VD) |
Competitive immunoassay-validated hapten-carrier conjugates [BSA-&OVA-25-hydroxy (OH) Vitamin (25-OH-VD)], 25-hydroxy (OH) Vitamin (25-OH-VD) antibodies binding, Immunogen in Competitive immunoassay validation, Elisa, lateral-flow tests,and other immunoassays as control material in 25-OH-VD level test of Metabolic diseases (osteoporosis and rickets) and related syndrome evaluation. | GMP-SMT-25-OH-VD-Ab01: Anti-25-hydroxy (OH) Vitamin (25-OH-VD) mouse monoclonal antibody(mAb) |
Human 25-hydroxy (OH) Vitamin (25-OH-VD) binding, in Competitive immunoassay validation, Elisa, lateral-flow tests, and other immunoassays in 25-OH-VD level test of Metabolic diseases (osteoporosis and rickets) and related syndrome evaluation. | ![]() |
25-hydroxy (OH) Vitamin (25-OH-VD)
Cat No. | Species | Biomarker | Disease | Cat No.of Antigen | Bioactivity validation of Antigen | Cat No.of Antibodies | Bioactivity validation of Antibodies | Order |
GMP-SMT-25-OH-VD-3 | Human | 25-hydroxy (OH) Vitamin D3 (25-OH-VD-3) | osteoporosis and rickets | GMP-SMT-25-OH-VD-3-Ag01: BSA-25-hydroxy (OH) Vitamin D3 (25-OH-VD) GMP-SMT-25-OH-VD-3-Ag02: OVA-25-hydroxy (OH) Vitamin D3 (25-OH-VD-3) |
Competitive immunoassay-validated hapten-carrier conjugates [BSA-&OVA-25-hydroxy (OH) Vitamin D3 (25-OH-VD-3)], 25-hydroxy (OH) Vitamin D3 (25-OH-VD-3) antibodies binding, Immunogen in Competitive immunoassay validation, Elisa, lateral-flow tests,and other immunoassays as control material in 25-OH-VD-3 level test of Metabolic diseases (osteoporosis and rickets) and related syndrome evaluation. | GMP-SMT-25-OH-VD-3-Ab01; GMP-SMT-25-OH-VD-3-Ab02: Anti-25-hydroxy (OH) Vitamin D3 (25-OH-VD-3) mouse monoclonal antibody(mAb) |
Human 25-hydroxy (OH) Vitamin D3 (25-OH-VD-3) binding, in Competitive immunoassay validation, Elisa, lateral-flow tests, and other immunoassays in 25-OH-VD-3 level test of Metabolic diseases (osteoporosis and rickets) and related syndrome evaluation. | ![]() |
S-adenosylhomocysteine (AdoHcy) hydrolase (SAHH)
Cat No. | Species | Biomarker | Disease | Cat No.of Antigen | Bioactivity validation of Antigen | Cat No.of Antibodies | Bioactivity validation of Antibodies | Order |
GMP-h-SAHH | Human | S-adenosylhomocysteine (AdoHcy) hydrolase (SAHH) | S-adenosylhomocysteine (AdoHcy) hydrolase deficiency | GMP-h-SAHH-Ag01: Recombinant human SAHH Protein |
S-adenosylhomocysteine (AdoHcy) hydrolase (SAHH) antibodies binding, Immunogen in Sandwich Elisa, lateral-flow tests,and other immunoassays as control material in SAHH level test of Metabolic diseases(S-adenosylhomocysteine (AdoHcy) hydrolase deficiency) and related syndrome evaluation. | GMP-h-SAHH-Ab01; GMP-h-SAHH-Ab02: Anti-human SAHH mouse monoclonal antibody(mAb) |
Human S-adenosylhomocysteine (AdoHcy) hydrolase (SAHH) antigen binding, ELISA validated as capture antibody and detection antibody. Pair recommendation with other S-adenosylhomocysteine (AdoHcy) hydrolase (SAHH) antibodies in SAHH level test of Metabolic diseases (S-adenosylhomocysteine (AdoHcy) hydrolase deficiency) and related syndrome evaluation. | ![]() |
cystathionine-β-synthase enzyme (CBL)
Cat No. | Species | Biomarker | Disease | Cat No.of Antigen | Bioactivity validation of Antigen | Cat No.of Antibodies | Bioactivity validation of Antibodies | Order |
GMP-h-CBL | Human | cystathionine-β-synthase enzyme (CBL) | ectopia lentis, learning difficulties and skeletal abnormalities | GMP-h-CBL-Ag01: Recombinant human CBL Protein |
cystathionine-β-synthase enzyme (CBL) antibodies binding, Immunogen in Sandwich Elisa, lateral-flow tests,and other immunoassays as control material in CBL level test of Metabolic diseases(ectopia lentis, learning difficulties and skeletal abnormalities) and related syndrome evaluation. | GMP-h-CBL-Ab01; GMP-h-CBL-Ab02: Anti-human CBL mouse monoclonal antibody(mAb) |
Human cystathionine-β-synthase enzyme (CBL) antigen binding, ELISA validated as capture antibody and detection antibody. Pair recommendation with other cystathionine-β-synthase enzyme (CBL) antibodies in CBL level test of Metabolic diseases (ectopia lentis, learning difficulties and skeletal abnormalities) and related syndrome evaluation. | ![]() |
cystathionine-β-synthase enzyme (CBS)
Cat No. | Species | Biomarker | Disease | Cat No.of Antigen | Bioactivity validation of Antigen | Cat No.of Antibodies | Bioactivity validation of Antibodies | Order |
GMP-h-CBS | Human | cystathionine-β-synthase enzyme (CBS) | ectopia lentis, learning difficulties and skeletal abnormalities | GMP-h-CBS-Ag01: Recombinant human CBS Protein |
cystathionine-β-synthase enzyme (CBS) antibodies binding, Immunogen in Sandwich Elisa, lateral-flow tests,and other immunoassays as control material in CBS level test of Metabolic diseases(ectopia lentis, learning difficulties and skeletal abnormalities) and related syndrome evaluation. | GMP-h-CBS-Ab01; GMP-h-CBS-Ab02: Anti-human CBS mouse monoclonal antibody(mAb) |
Human cystathionine-β-synthase enzyme (CBS) antigen binding, ELISA validated as capture antibody and detection antibody. Pair recommendation with other cystathionine-β-synthase enzyme (CBS) antibodies in CBS level test of Metabolic diseases (ectopia lentis, learning difficulties and skeletal abnormalities) and related syndrome evaluation. | ![]() |
Phospholipase A2 (LP-PLA2)
Cat No. | Species | Biomarker | Disease | Cat No.of Antigen | Bioactivity validation of Antigen | Cat No.of Antibodies | Bioactivity validation of Antibodies | Order |
GMP-SMT-LP-PLA2 | Human | Phospholipase A2 (LP-PLA2) | atherosclerosis, hyperlipidemia, obesity, and diabetes | GMP-SMT-LP-PLA2-Ag01: BSA-Phospholipase A2 (LP-PLA2) |
Competitive immunoassay-validated hapten-carrier conjugates [BSA-Phospholipase A2 (LP-PLA2)], Phospholipase A2 (LP-PLA2) antibodies binding, Immunogen in Competitive immunoassay validation, Elisa, lateral-flow tests,and other immunoassays as control material in LP-PLA2 level test of Metabolic diseases (atherosclerosis, hyperlipidemia, obesity, and diabetes) and related syndrome evaluation. | GMP-SMT-LP-PLA2-Ab01; GMP-SMT-LP-PLA2-Ab02: Anti-Phospholipase A2 (LP-PLA2) mouse monoclonal antibody(mAb) |
Human Phospholipase A2 (LP-PLA2) binding, in Competitive immunoassay validation, Elisa, lateral-flow tests, and other immunoassays in LP-PLA2 level test of Metabolic diseases (atherosclerosis, hyperlipidemia, obesity, and diabetes) and related syndrome evaluation. | ![]() |
Retinol binding protein 4 (RBP4)
Cat No. | Species | Biomarker | Disease | Cat No.of Antigen | Bioactivity validation of Antigen | Cat No.of Antibodies | Bioactivity validation of Antibodies | Order |
GMP-SMT-RBP4 | Human | Retinol binding protein 4 (RBP4) | obesity, type 2 diabetes, metabolic syndrome, and cardiovascular diseases | GMP-SMT-RBP4-Ag01: BSA-Retinol binding protein 4 (RBP4) |
Competitive immunoassay-validated hapten-carrier conjugates [BSA-Retinol binding protein 4 (RBP4)], Retinol binding protein 4 (RBP4) antibodies binding, Immunogen in Competitive immunoassay validation, Elisa, lateral-flow tests,and other immunoassays as control material in RBP4 level test of Metabolic diseases (obesity, type 2 diabetes, metabolic syndrome, and cardiovascular diseases) and related syndrome evaluation. | GMP-SMT-RBP4-Ab01; GMP-SMT-RBP4-Ab02: Anti-Retinol binding protein 4 (RBP4) mouse monoclonal antibody(mAb) |
Human Retinol binding protein 4 (RBP4) binding, in Competitive immunoassay validation, Elisa, lateral-flow tests, and other immunoassays in RBP4 level test of Metabolic diseases (obesity, type 2 diabetes, metabolic syndrome, and cardiovascular diseases) and related syndrome evaluation. | ![]() |
Diagnostic antibodies and antigens for hormonal disorders testing: DHEA, DEX, Calcitonin, Cortisol, Testosterone, PG, EPO, Progesterone, LH, Prolactin, Estrone, Estradiol, HCG, DES/HES, Bisphenol A, Thyroxin T4, Forchlorfenuron, Norethisterone, Flugestone Acetate, Thyroxin T3, IGFBP-1, ACTH, PTH, TBG, FSH
Hormones are proteins, which help organs and tissues to perform specific functions. hormones play an integral role in your overall health. It controls growth, fertility, sexual function, emotions, and absorption of nutrients. Hormone disorders are the result of a hormonal imbalance i.e production of too much or too little of one or more hormones. Several hormonal disorders such as Anemia, hypothyroidism, irregular bleeding, pituitary or adrenal malfunction, acromegaly, acute inflammation, breast cancer, Cushing's syndrome, erythrocytosis, gigantism, hypergonadotrophic-hypogonadism, Hyperparathyroidism, hypertension, hypopituitarism, infertility, mood swings, polycythemia, pregnancy, Testosterone Deficiency Syndrome, thyroid cancer and so on have been identified using specific marker. Detecting the quantity of marker proteins from different samples may benefit from ELISA, Lateral flow immunoassay (LFIA), colloidal gold immunochromatographic assay, Chemiluminescent immunoassay (CLIA), turbidimetric inhibition immuno assay (TINIA), immunonephelometry and POCT.
Classification:
DHEA
DEX
Calcitonin
Cortisol
Testosterone
PG
EPO
Progesterone
LH
Prolactin
E1
E2/E3
hGH
HCG
DES/HES
Bisphenol A
Thyroxin T4
Forchlorfenuron
Norethisterone
Flugestone Acetate
Thyroxin T3
IGFBP-1
ACTH
PTH
TBG
FSH
dehydroepiandrosterone (DHEA)
Cat No. | Species | Biomarker | Disease | Cat No.of Antigen | Bioactivity validation of Antigen | Cat No.of Antibodies | Bioactivity validation of Antibodies | Order |
GMP-SMT-DHEA | Human | dehydroepiandrosterone (DHEA) | Hormone disorders | GMP-SMT-DHEA-Ag01: BSA-dehydroepiandrosterone (DHEA); GMP-SMT-DHEA-Ag02: OVA-dehydroepiandrosterone (DHEA) |
Competitive immunoassay-validated hapten-carrier conjugates [BSA-dehydroepiandrosterone (DHEA)], dehydroepiandrosterone (DHEA) antibodies binding, Immunogen in Competitive immunoassay validation, Elisa, lateral-flow tests,and other immunoassays as control material in DHEA level test of Hormone disorders (Hormone disorders) and related syndrome evaluation. | GMP-SMT-DHEA-Ab01: Anti-dehydroepiandrosterone (DHEA) mouse monoclonal antibody(mAb) |
Human dehydroepiandrosterone (DHEA) binding, in Competitive immunoassay validation, Elisa, lateral-flow tests, and other immunoassays in DHEA level test of Hormone disorders (Hormone disorders) and related syndrome evaluation. | ![]() |
Dexamethasone (DEX)
Cat No. | Species | Biomarker | Disease | Cat No.of Antigen | Bioactivity validation of Antigen | Cat No.of Antibodies | Bioactivity validation of Antibodies | Order |
GMP-SMT-DEX | Human | Dexamethasone (DEX) | Cushing's syndrome | GMP-SMT-DEX-Ag01: BSA-Dexamethasone (DEX); GMP-SMT-DEX-Ag02: OVA-Dexamethasone (DEX) |
Competitive immunoassay-validated hapten-carrier conjugates [BSA-Dexamethasone (DEX)], Dexamethasone (DEX) antibodies binding, Immunogen in Competitive immunoassay validation, Elisa, lateral-flow tests,and other immunoassays as control material in DEX level test of Hormone disorders (Cushing's syndrome) and related syndrome evaluation. | GMP-SMT-DEX-Ab01: Anti-Dexamethasone (DEX) mouse monoclonal antibody(mAb) |
Human Dexamethasone (DEX) binding, in Competitive immunoassay validation, Elisa, lateral-flow tests, and other immunoassays in DEX level test of Hormone disorders (Cushing's syndrome) and related syndrome evaluation. | ![]() |
Calcitonin
Cat No. | Species | Biomarker | Disease | Cat No.of Antigen | Bioactivity validation of Antigen | Cat No.of Antibodies | Bioactivity validation of Antibodies | Order |
GMP-SMT-Calcitonin | Human | Calcitonin | thyroid cancer | GMP-SMT-Calcitonin-Ag01: BSA-Calcitonin; GMP-SMT-Calcitonin-Ag02: OVA-Calcitonin |
Competitive immunoassay-validated hapten-carrier conjugates [BSA-Calcitonin], Calcitonin antibodies binding, Immunogen in Competitive immunoassay validation, Elisa, lateral-flow tests, and other immunoassays as control material in Calcitonin level test of Hormone disorders (thyroid cancer) and related syndrome evaluation. | GMP-SMT-Calcitonin-Ab01: Anti-Calcitonin mouse monoclonal antibody(mAb) |
Human Calcitonin binding, in Competitive immunoassay validation, Elisa, lateral-flow tests, and other immunoassays in Calcitonin level test of Hormone disorders (thyroid cancer) and related syndrome evaluation. | ![]() |
Cortisol
Cat No. | Species | Biomarker | Disease | Cat No.of Antigen | Bioactivity validation of Antigen | Cat No.of Antibodies | Bioactivity validation of Antibodies | Order |
GMP-SMT-Cortisol | Human | Cortisol | adrenal gland disorder | GMP-SMT-Cortisol-Ag01: BSA-Cortisol; GMP-SMT-Cortisol-Ag02: OVA-Cortisol |
Competitive immunoassay-validated hapten-carrier conjugates [BSA-Cortisol], Cortisol antibodies binding, Immunogen in Competitive immunoassay validation, Elisa, lateral-flow tests, and other immunoassays as control material in Cortisol level test of Hormone disorders (adrenal gland disorder) and related syndrome evaluation. | GMP-SMT-Cortisol-Ab01: Anti-Cortisol mouse monoclonal antibody(mAb) |
Human Cortisol binding, in Competitive immunoassay validation, Elisa, lateral-flow tests, and other immunoassays in Cortisol level test of Hormone disorders (adrenal gland disorder) and related syndrome evaluation. | ![]() |
Testosterone
Cat No. | Species | Biomarker | Disease | Cat No.of Antigen | Bioactivity validation of Antigen | Cat No.of Antibodies | Bioactivity validation of Antibodies | Order |
GMP-SMT-Testosterone | Human | Testosterone | Testosterone Deficiency Syndrome | GMP-SMT-Testosterone-Ag01: BSA-Testosterone; GMP-SMT-Testosterone-Ag02: OVA-Testosterone |
Competitive immunoassay-validated hapten-carrier conjugates [BSA-Testosterone], Testosterone antibodies binding, Immunogen in Competitive immunoassay validation, Elisa, lateral-flow tests, and other immunoassays as control material in Testosterone level test of Hormone disorders (Testosterone Deficiency Syndrome) and related syndrome evaluation. | GMP-SMT-Testosterone-Ab01: Anti-Testosterone mouse monoclonal antibody(mAb) |
Human Testosterone binding, in Competitive immunoassay validation, Elisa, lateral-flow tests, and other immunoassays in Testosterone level test of Hormone disorders (Testosterone Deficiency Syndrome) and related syndrome evaluation. | ![]() |
Prostaglandin (PG)
Cat No. | Species | Biomarker | Disease | Cat No.of Antigen | Bioactivity validation of Antigen | Cat No.of Antibodies | Bioactivity validation of Antibodies | Order |
GMP-SMT-PG | Human | Prostaglandin (PG) | acute inflammation | GMP-SMT-PG-Ag01: BSA-Prostaglandin (PG); GMP-SMT-PG-Ag02: OVA-Prostaglandin (PG) |
Competitive immunoassay-validated hapten-carrier conjugates [BSA-Prostaglandin (PG)], Prostaglandin (PG) antibodies binding, Immunogen in Competitive immunoassay validation, Elisa, lateral-flow tests,and other immunoassays as control material in PG level test of Hormone disorders (acute inflammation) and related syndrome evaluation. | GMP-SMT-PG-Ab01: Anti-Prostaglandin (PG) mouse monoclonal antibody(mAb) |
Human Prostaglandin (PG) binding, in Competitive immunoassay validation, Elisa, lateral-flow tests, and other immunoassays in PG level test of Hormone disorders (acute inflammation) and related syndrome evaluation. | ![]() |
Erythropoetin (EPO)
Cat No. | Species | Biomarker | Disease | Cat No.of Antigen | Bioactivity validation of Antigen | Cat No.of Antibodies | Bioactivity validation of Antibodies | Order |
GMP-SMT-EPO | Human | Erythropoetin (EPO) | Anemia, polycythemia or erythrocytosis, hypertension | GMP-SMT-EPO-Ag01: BSA-Erythropoetin (EPO); GMP-SMT-EPO-Ag02: OVA-Erythropoetin (EPO) |
Competitive immunoassay-validated hapten-carrier conjugates [BSA-Erythropoetin (EPO)], Erythropoetin (EPO) antibodies binding, Immunogen in Competitive immunoassay validation, Elisa, lateral-flow tests,and other immunoassays as control material in EPO level test of Hormone disorders (Anemia, polycythemia or erythrocytosis, hypertension) and related syndrome evaluation. | GMP-SMT-EPO-Ab01: Anti-Erythropoetin (EPO) mouse monoclonal antibody(mAb) |
Human Erythropoetin (EPO) binding, in Competitive immunoassay validation, Elisa, lateral-flow tests, and other immunoassays in EPO level test of Hormone disorders (Anemia, polycythemia or erythrocytosis, hypertension) and related syndrome evaluation. | ![]() |
Progesterone
Cat No. | Species | Biomarker | Disease | Cat No.of Antigen | Bioactivity validation of Antigen | Cat No.of Antibodies | Bioactivity validation of Antibodies | Order |
GMP-SMT-Progesterone | Human | Progesterone | fertility | GMP-SMT-Progesterone-Ag01: BSA-Progesterone; GMP-SMT-Progesterone-Ag02: OVA-Progesterone |
Competitive immunoassay-validated hapten-carrier conjugates [BSA-Progesterone], Progesterone antibodies binding, Immunogen in Competitive immunoassay validation, Elisa, lateral-flow tests, and other immunoassays as control material in Progesterone level test of Hormone disorders (fertility) and related syndrome evaluation. | GMP-SMT-Progesterone-Ab01: Anti-Progesterone mouse monoclonal antibody(mAb) |
Human Progesterone binding, in Competitive immunoassay validation, Elisa, lateral-flow tests, and other immunoassays in Progesterone level test of Hormone disorders (fertility) and related syndrome evaluation. | ![]() |
Luteinizing hormone (LH)
Cat No. | Species | Biomarker | Disease | Cat No.of Antigen | Bioactivity validation of Antigen | Cat No.of Antibodies | Bioactivity validation of Antibodies | Order |
GMP-SMT-LH | Human | Luteinizing hormone (LH) | fertility | GMP-SMT-LH-Ag01: BSA-Luteinizing hormone (LH); GMP-SMT-LH-Ag02: OVA-Luteinizing hormone (LH) |
Competitive immunoassay-validated hapten-carrier conjugates [BSA-Luteinizing hormone (LH)], Luteinizing hormone (LH) antibodies binding, Immunogen in Competitive immunoassay validation, Elisa, lateral-flow tests,and other immunoassays as control material in LH level test of Hormone disorders (fertility) and related syndrome evaluation. | GMP-SMT-LH-Ab01: Anti-Luteinizing hormone (LH) mouse monoclonal antibody(mAb) |
Human Luteinizing hormone (LH) binding, in Competitive immunoassay validation, Elisa, lateral-flow tests, and other immunoassays in LH level test of Hormone disorders (fertility) and related syndrome evaluation. | ![]() |
Prolactin
Cat No. | Species | Biomarker | Disease | Cat No.of Antigen | Bioactivity validation of Antigen | Cat No.of Antibodies | Bioactivity validation of Antibodies | Order |
GMP-SMT-Prolactin | Human | Prolactin | fertility | GMP-SMT-Prolactin-Ag01: BSA-Prolactin; GMP-SMT-Prolactin-Ag02: OVA-Prolactin |
Competitive immunoassay-validated hapten-carrier conjugates [BSA-Prolactin], Prolactin antibodies binding, Immunogen in Competitive immunoassay validation, Elisa, lateral-flow tests, and other immunoassays as control material in Prolactin level test of Hormone disorders (fertility) and related syndrome evaluation. | GMP-SMT-Prolactin-Ab01: Anti-Prolactin mouse monoclonal antibody(mAb) |
Human Prolactin binding, in Competitive immunoassay validation, Elisa, lateral-flow tests, and other immunoassays in Prolactin level test of Hormone disorders (fertility) and related syndrome evaluation. | ![]() |
Estrone (E1)
Cat No. | Species | Biomarker | Disease | Cat No.of Antigen | Bioactivity validation of Antigen | Cat No.of Antibodies | Bioactivity validation of Antibodies | Order |
GMP-SMT-E1 | Human | Estrone (E1) | irregular bleeding, fatigue or mood swings | GMP-SMT-E1-Ag01: BSA-Estrone (E1); GMP-SMT-E1-Ag02: OVA-Estrone (E1) |
Competitive immunoassay-validated hapten-carrier conjugates [BSA-Estrone (E1)], Estrone (E1) antibodies binding, Immunogen in Competitive immunoassay validation, Elisa, lateral-flow tests,and other immunoassays as control material in E1 level test of Hormone disorders (irregular bleeding, fatigue or mood swings) and related syndrome evaluation. | GMP-SMT-E1-Ab01: Anti-Estrone (E1) mouse monoclonal antibody(mAb) |
Human Estrone (E1) binding, in Competitive immunoassay validation, Elisa, lateral-flow tests, and other immunoassays in E1 level test of Hormone disorders (irregular bleeding, fatigue or mood swings) and related syndrome evaluation. | ![]() |
Estradiol (E2/E3)
Cat No. | Species | Biomarker | Disease | Cat No.of Antigen | Bioactivity validation of Antigen | Cat No.of Antibodies | Bioactivity validation of Antibodies | Order |
GMP-SMT-E2/E3 | Human | Estradiol (E2/E3) | Fertility | GMP-SMT-E2/E3-Ag01: BSA-Estradiol (E2/E3); GMP-SMT-E2/E3-Ag02: OVA-Estradiol (E2/E3) |
Competitive immunoassay-validated hapten-carrier conjugates [BSA-Estradiol (E2/E3)], Estradiol (E2/E3) antibodies binding, Immunogen in Competitive immunoassay validation, Elisa, lateral-flow tests,and other immunoassays as control material in E2/E3 level test of Hormone disorders (Fertility) and related syndrome evaluation. | GMP-SMT-E2/E3-Ab01: Anti-Estradiol (E2/E3) mouse monoclonal antibody(mAb) |
Human Estradiol (E2/E3) binding, in Competitive immunoassay validation, Elisa, lateral-flow tests, and other immunoassays in E2/E3 level test of Hormone disorders (Fertility) and related syndrome evaluation. | ![]() |
Growth hormone (hGH)
Cat No. | Species | Biomarker | Disease | Cat No.of Antigen | Bioactivity validation of Antigen | Cat No.of Antibodies | Bioactivity validation of Antibodies | Order |
GMP-h-hGH | Human | Growth hormone (hGH) | Acromegaly, gigantism | GMP-h-hGH-Ag01: Recombinant human hGH Protein |
Growth hormone (hGH) antibodies binding, Immunogen in Sandwich Elisa, lateral-flow tests,and other immunoassays as control material in hGH level test of Hormone disorders(Acromegaly, gigantism) and related syndrome evaluation. | GMP-h-hGH-Ab01; GMP-h-hGH-Ab02: Anti-human hGH mouse monoclonal antibody (mAb) |
Human Growth hormone (hGH) antigen binding, ELISA validated as capture antibody and detection antibody. Pair recommendation with other Growth hormone (hGH) antibodies in hGH level test of Hormone disorders (Acromegaly, gigantism) and related syndrome evaluation. | ![]() |
Human chorionic gonadotropin (HCG)
Cat No. | Species | Biomarker | Disease | Cat No.of Antigen | Bioactivity validation of Antigen | Cat No.of Antibodies | Bioactivity validation of Antibodies | Order |
GMP-h-HCG | Human | Human chorionic gonadotropin (HCG) | pregnancy | GMP-h-HCG-Ag01: Recombinant human HCG Protein |
Human chorionic gonadotropin (HCG) antibodies binding, Immunogen in Sandwich Elisa, lateral-flow tests,and other immunoassays as control material in HCG level test of Hormone disorders(Acromegaly, gigantism) and related syndrome evaluation. | GMP-h-HCG-Ab01; GMP-h-HCG-Ab02: Anti-human HCG mouse monoclonal antibody (mAb) |
Human chorionic gonadotropin (HCG) antigen binding, ELISA validated as capture antibody and detection antibody. Pair recommendation with other Human chorionic gonadotropin (HCG) antibodies in HCG level test of Hormone disorders (Acromegaly, gigantism) and related syndrome evaluation. | ![]() |
Diethylstilbestrol/Hexestrol (DES/HES)
Cat No. | Species | Biomarker | Disease | Cat No.of Antigen | Bioactivity validation of Antigen | Cat No.of Antibodies | Bioactivity validation of Antibodies | Order |
GMP-SMT-DES/HES | Human | Diethylstilbestrol/Hexestrol (DES/HES) | Food safety | GMP-SMT-DES/HES-Ag01: BSA-Diethylstilbestrol/Hexestrol (DES/HES); GMP-SMT-DES/HES-Ag02: OVA-Diethylstilbestrol/Hexestrol (DES/HES) |
Competitive immunoassay-validated hapten-carrier conjugates [BSA-Diethylstilbestrol/Hexestrol (DES/HES)], Diethylstilbestrol/Hexestrol (DES/HES) antibodies binding, Immunogen in Competitive immunoassay validation, Elisa, lateral-flow tests,and other immunoassays as control material in DES/HES level test of Hormone disorders (Food safety) and related syndrome evaluation. | GMP-SMT-DES/HES-Ab01: Anti-Diethylstilbestrol/Hexestrol (DES/HES) mouse monoclonal antibody(mAb) |
Human Diethylstilbestrol/Hexestrol (DES/HES) binding, in Competitive immunoassay validation, Elisa, lateral-flow tests, and other immunoassays in DES/HES level test of Hormone disorders (Food safety) and related syndrome evaluation. | ![]() |
Bisphenol A
Cat No. | Species | Biomarker | Disease | Cat No.of Antigen | Bioactivity validation of Antigen | Cat No.of Antibodies | Bioactivity validation of Antibodies | Order |
GMP-SMT-Bisphenol A | Human | Bisphenol A | Toxicity, mutagen and carcinogen | GMP-SMT-Bisphenol A-Ag01: BSA-Bisphenol A; GMP-SMT-Bisphenol A-Ag02: OVA-Bisphenol A |
Competitive immunoassay-validated hapten-carrier conjugates [BSA-Bisphenol A], Bisphenol A antibodies binding, Immunogen in Competitive immunoassay validation, Elisa, lateral-flow tests, and other immunoassays as control material in Bisphenol A level test of Hormone disorders (Toxicity, mutagen and carcinogen) and related syndrome evaluation. | GMP-SMT-Bisphenol A-Ab01: Anti-Bisphenol A mouse monoclonal antibody(mAb) |
Human Bisphenol A binding, in Competitive immunoassay validation, Elisa, lateral-flow tests, and other immunoassays in Bisphenol A level test of Hormone disorders (Toxicity, mutagen and carcinogen) and related syndrome evaluation. | ![]() |
Thyroxin T4
Cat No. | Species | Biomarker | Disease | Cat No.of Antigen | Bioactivity validation of Antigen | Cat No.of Antibodies | Bioactivity validation of Antibodies | Order |
GMP-SMT-Thyroxin T4 | Human | Thyroxin T4 | hyperthyroidism | GMP-SMT-Thyroxin T4-Ag01: BSA-Thyroxin T4; GMP-SMT-Thyroxin T4-Ag02: OVA-Thyroxin T4 |
Competitive immunoassay-validated hapten-carrier conjugates [BSA-Thyroxin T4], Thyroxin T4 antibodies binding, Immunogen in Competitive immunoassay validation, Elisa, lateral-flow tests, and other immunoassays as control material in Thyroxin T4 level test of Hormone disorders (hyperthyroidism) and related syndrome evaluation. | GMP-SMT-Thyroxin T4-Ab01: Anti-Thyroxin T4 mouse monoclonal antibody(mAb) |
Human Thyroxin T4 binding, in Competitive immunoassay validation, Elisa, lateral-flow tests, and other immunoassays in Thyroxin T4 level test of Hormone disorders (hyperthyroidism) and related syndrome evaluation. | ![]() |
Forchlorfenuron
Cat No. | Species | Biomarker | Disease | Cat No.of Antigen | Bioactivity validation of Antigen | Cat No.of Antibodies | Bioactivity validation of Antibodies | Order |
GMP-SMT-Forchlorfenuron | Human | Forchlorfenuron | food safety | GMP-SMT-Forchlorfenuron-Ag01: BSA-Forchlorfenuron; GMP-SMT-Forchlorfenuron-Ag02: OVA-Forchlorfenuron |
Competitive immunoassay-validated hapten-carrier conjugates [BSA-Forchlorfenuron], Forchlorfenuron antibodies binding, Immunogen in Competitive immunoassay validation, Elisa, lateral-flow tests, and other immunoassays as control material in Forchlorfenuron level test of Hormone disorders (food safety) and related syndrome evaluation. | GMP-SMT-Forchlorfenuron-Ab01: Anti-Forchlorfenuron mouse monoclonal antibody(mAb) |
Human Forchlorfenuron binding, in Competitive immunoassay validation, Elisa, lateral-flow tests, and other immunoassays in Forchlorfenuron level test of Hormone disorders (food safety) and related syndrome evaluation. | ![]() |
Norethisterone
Cat No. | Species | Biomarker | Disease | Cat No.of Antigen | Bioactivity validation of Antigen | Cat No.of Antibodies | Bioactivity validation of Antibodies | Order |
GMP-SMT-Norethisterone | Human | Norethisterone | breast cancer | GMP-SMT-Norethisterone-Ag01: BSA-Norethisterone; GMP-SMT-Norethisterone-Ag02: OVA-Norethisterone |
Competitive immunoassay-validated hapten-carrier conjugates [BSA-Norethisterone], Norethisterone antibodies binding, Immunogen in Competitive immunoassay validation, Elisa, lateral-flow tests, and other immunoassays as control material in Norethisterone level test of Hormone disorders (breast cancer) and related syndrome evaluation. | GMP-SMT-Norethisterone-Ab01: Anti-Norethisterone mouse monoclonal antibody(mAb) |
Human Norethisterone binding, in Competitive immunoassay validation, Elisa, lateral-flow tests, and other immunoassays in Norethisterone level test of Hormone disorders (breast cancer) and related syndrome evaluation. | ![]() |
Flugestone Acetate
Cat No. | Species | Biomarker | Disease | Cat No.of Antigen | Bioactivity validation of Antigen | Cat No.of Antibodies | Bioactivity validation of Antibodies | Order |
GMP-SMT-Flugestone Acetate | Human | Flugestone Acetate | GMP-SMT-Flugestone Acetate-Ag01: BSA-Flugestone Acetate; GMP-SMT-Flugestone Acetate-Ag02: OVA-Flugestone Acetate |
Competitive immunoassay-validated hapten-carrier conjugates [BSA-Flugestone Acetate], Flugestone Acetate antibodies binding, Immunogen in Competitive immunoassay validation, Elisa, lateral-flow tests, and other immunoassays as control material in Flugestone Acetate level test of Hormone disorders and related syndrome evaluation. | GMP-SMT-Flugestone Acetate-Ab01: Anti-Flugestone Acetate mouse monoclonal antibody(mAb) |
Human Flugestone Acetate binding, in Competitive immunoassay validation, Elisa, lateral-flow tests, and other immunoassays in Flugestone Acetate level test of Hormone disorders and related syndrome evaluation. | ![]() |
Thyroxin T3
Cat No. | Species | Biomarker | Disease | Cat No.of Antigen | Bioactivity validation of Antigen | Cat No.of Antibodies | Bioactivity validation of Antibodies | Order |
GMP-SMT-Thyroxin T3 | Human | Thyroxin T3 | hyperthyroidism and hypopituitarism | GMP-SMT-Thyroxin T3-Ag01: BSA-Thyroxin T3; GMP-SMT-Thyroxin T3-Ag02: OVA-Thyroxin T3 |
Competitive immunoassay-validated hapten-carrier conjugates [BSA-Thyroxin T3], Thyroxin T3 antibodies binding, Immunogen in Competitive immunoassay validation, Elisa, lateral-flow tests, and other immunoassays as control material in Thyroxin T3 level test of Hormone disorders (hyperthyroidism and hypopituitarism) and related syndrome evaluation. | GMP-SMT-Thyroxin T3-Ab01: Anti-Thyroxin T3 mouse monoclonal antibody(mAb) |
Human Thyroxin T3 binding, in Competitive immunoassay validation, Elisa, lateral-flow tests, and other immunoassays in Thyroxin T3 level test of Hormone disorders (hyperthyroidism and hypopituitarism) and related syndrome evaluation. | ![]() |
Insulin-like growth factor binding protein 1 (IGFBP-1)
Cat No. | Species | Biomarker | Disease | Cat No.of Antigen | Bioactivity validation of Antigen | Cat No.of Antibodies | Bioactivity validation of Antibodies | Order |
GMP-SMT-IGFBP-1 | Human | Insulin-like growth factor binding protein 1 (IGFBP-1) | Pregnancy | GMP-SMT-IGFBP-1-Ag01: BSA-Insulin-like growth factor binding protein 1 (IGFBP-1); GMP-SMT-IGFBP-1-Ag02: OVA-Insulin-like growth factor binding protein 1 (IGFBP-1) |
Competitive immunoassay-validated hapten-carrier conjugates [BSA-Insulin-like growth factor binding protein 1 (IGFBP-1)], Insulin-like growth factor binding protein 1 (IGFBP-1) antibodies binding, Immunogen in Competitive immunoassay validation, Elisa, lateral-flow tests,and other immunoassays as control material in IGFBP-1 level test of Hormone disorders (Pregnancy) and related syndrome evaluation. | GMP-SMT-IGFBP-1-Ab01: Anti-Insulin-like growth factor binding protein 1 (IGFBP-1) mouse monoclonal antibody(mAb) |
Human Insulin-like growth factor binding protein 1 (IGFBP-1) binding, in Competitive immunoassay validation, Elisa, lateral-flow tests, and other immunoassays in IGFBP-1 level test of Hormone disorders (Pregnancy) and related syndrome evaluation. | ![]() |
adrenocorticotropic hormone (ACTH)
Cat No. | Species | Biomarker | Disease | Cat No.of Antigen | Bioactivity validation of Antigen | Cat No.of Antibodies | Bioactivity validation of Antibodies | Order |
GMP-h-ACTH | Human | adrenocorticotropic hormone (ACTH) | pituitary or adrenal malfunction, pituitary tumor, adrenal tumor, lung tumor | GMP-h-ACTH-Ag01: Recombinant human ACTH Protein |
adrenocorticotropic hormone (ACTH) antibodies binding, Immunogen in Sandwich Elisa, lateral-flow tests,and other immunoassays as control material in ACTH level test of Hormone disorders(pituitary or adrenal malfunction, pituitary tumor, adrenal tumor, lung tumor) and related syndrome evaluation. | GMP-h-ACTH-Ab01; GMP-h-ACTH-Ab02: Anti-human ACTH mouse monoclonal antibody(mAb) |
Human adrenocorticotropic hormone (ACTH) antigen binding, ELISA validated as capture antibody and detection antibody. Pair recommendation with other adrenocorticotropic hormone (ACTH) antibodies in ACTH level test of Hormone disorders (pituitary or adrenal malfunction, pituitary tumor, adrenal tumor, lung tumor) and related syndrome evaluation. | ![]() |
parathyroid hormone (PTH)
Cat No. | Species | Biomarker | Disease | Cat No.of Antigen | Bioactivity validation of Antigen | Cat No.of Antibodies | Bioactivity validation of Antibodies | Order |
GMP-h-PTH | Human | parathyroid hormone (PTH) | Hyperparathyroidism | GMP-h-PTH-Ag01: Recombinant human PTH Protein |
parathyroid hormone (PTH) antibodies binding, Immunogen in Sandwich Elisa, lateral-flow tests,and other immunoassays as control material in PTH level test of Hormone disorders(Hyperparathyroidism) and related syndrome evaluation. | GMP-h-PTH-Ab01; GMP-h-PTH-Ab02: Anti-human PTH mouse monoclonal antibody(mAb) |
Human parathyroid hormone (PTH) antigen binding, ELISA validated as capture antibody and detection antibody. Pair recommendation with other parathyroid hormone (PTH) antibodies in PTH level test of Hormone disorders (Hyperparathyroidism) and related syndrome evaluation. | ![]() |
Thyroid Binding Globulin (TBG)
Cat No. | Species | Biomarker | Disease | Cat No.of Antigen | Bioactivity validation of Antigen | Cat No.of Antibodies | Bioactivity validation of Antibodies | Order |
GMP-SMT-TBG | Human | Thyroid Binding Globulin (TBG) | hypothyroidism, liver disease, and pregnancy | GMP-SMT-TBG-Ag01: BSA-Thyroid Binding Globulin (TBG); GMP-SMT-TBG-Ag02: OVA-Thyroid Binding Globulin (TBG) |
Competitive immunoassay-validated hapten-carrier conjugates [BSA-Thyroid Binding Globulin (TBG)], Thyroid Binding Globulin (TBG) antibodies binding, Immunogen in Competitive immunoassay validation, Elisa, lateral-flow tests,and other immunoassays as control material in TBG level test of Hormone disorders (hypothyroidism, liver disease, and pregnancy) and related syndrome evaluation. | GMP-SMT-TBG-Ab01: Anti-Thyroid Binding Globulin (TBG) mouse monoclonal antibody(mAb) |
Human Thyroid Binding Globulin (TBG) binding, in Competitive immunoassay validation, Elisa, lateral-flow tests, and other immunoassays in TBG level test of Hormone disorders (hypothyroidism, liver disease, and pregnancy) and related syndrome evaluation. | ![]() |
follicle stimulating hormone (FSH)
Cat No. | Species | Biomarker | Disease | Cat No.of Antigen | Bioactivity validation of Antigen | Cat No.of Antibodies | Bioactivity validation of Antibodies | Order |
GMP-h-FSH | Human | follicle stimulating hormone (FSH) | hypergonadotrophic-hypogonadism and infertility | GMP-h-FSH-Ag01: Recombinant huamn FSH Protein |
follicle stimulating hormone (FSH) antibodies binding, Immunogen in Sandwich Elisa, lateral-flow tests, and other immunoassays as control material in FSH level test of Hormone disorders (hypergonadotrophic-hypogonadism and infertility) and related syndrome evaluation | GMP-h-FSH-Ab01, GMP-h-FSH-Ab02: Anti-human FSH mouse monoclonal antibody (mAb) |
follicle stimulating hormone (FSH) antigen binding, ELISA validated as capture antibody and detection antibody. Pair recommendation with other follicle stimulating hormone (FSH) antibodies in FSH level test of Hormone disorders (hypergonadotrophic-hypogonadism and infertility) and related syndrome evaluation. | ![]() |
Diagnostic antibodies and antigens for Vitamin deficiency testing: folic acid (FA), vitamin D binding protein (VDBP)
Vitamin deficiency is the condition of a long-term lack of a vitamin. Vitamin deficiency caused by insufficient intake of vitamin is classified as a primary deficiency, whereas vitamin deficiency due to an underlying disorder such as malabsorption is called as a secondary deficiency. Vitamin deficiencies can be detected in several ways. GENEMEDI produces core diagnostic ingredients such as folic acid, vitamin D binding protein and so on to test vitamin deficiency using ELISA, Lateral flow immunoassay (LFIA), colloidal gold immunochromatographic assay, Chemiluminescent immunoassay (CLIA), turbidimetric inhibition immuno assay (TINIA), immunonephelometry and POCT Kit.
Classification:
FA
VDBP
folic acid (FA)
Cat No. | Species | Biomarker | Disease | Cat No.of Antigen | Bioactivity validation of Antigen | Cat No.of Antibodies | Bioactivity validation of Antibodies | Order |
GMP-SMT-FA | Human | folic acid (FA) | vitamin deficiency | GMP-SMT-FA-Ag01: BSA-folic acid (FA) GMP-SMT-FA-Ag02: OVA-folic acid (FA) |
Competitive immunoassay-validated hapten-carrier conjugates [BSA-&OVA-folic acid (FA)], folic acid (FA) antibodies binding, Immunogen in Competitive immunoassay validation, Elisa, lateral-flow tests,and other immunoassays as control material in FA level test of Vitamin deficiency (vitamin deficiency) and related syndrome evaluation. | GMP-SMT-FA-Ab01: Anti-folic acid (FA) mouse monoclonal antibody(mAb) |
Human folic acid (FA) binding, in Competitive immunoassay validation, Elisa, lateral-flow tests, and other immunoassays in FA level test of Vitamin deficiency (vitamin deficiency) and related syndrome evaluation. | ![]() |
vitamin D binding protein (VDBP)
Cat No. | Species | Biomarker | Disease | Cat No.of Antigen | Bioactivity validation of Antigen | Cat No.of Antibodies | Bioactivity validation of Antibodies | Order |
GMP-h-VDBP | Human | vitamin D binding protein (VDBP) | liver failure, type I diabetes, cystic fibrosis | GMP-h-VDBP-Ag01: Recombinant human VDBP Protein |
vitamin D binding protein (VDBP) antibodies binding, Immunogen in Sandwich Elisa, lateral-flow tests,and other immunoassays as control material in VDBP level test of Vitamin deficiency(liver failure, type I diabetes, cystic fibrosis) and related syndrome evaluation. | GMP-h-VDBP-Ab01; GMP-h-VDBP-Ab02: Anti-human VDBP mouse monoclonal antibody(mAb) |
Human vitamin D binding protein (VDBP) antigen binding, ELISA validated as capture antibody and detection antibody. Pair recommendation with other vitamin D binding protein (VDBP) antibodies in VDBP level test of Vitamin deficiency (liver failure, type I diabetes, cystic fibrosis) and related syndrome evaluation. | ![]() |
Diagnostic antibodies and antigens for Fibrinogen disorders testing: Fibrinogen (FIB)
Fibrinogen disorders are a set of hereditary or acquired abnormalities in the quantity and/or quality of circulating fibrinogens. The disorders may lead to pathological bleeding and/or blood clotting or the deposition of fibrinogen in the liver, kidneys, or other organs and tissues. These disorders include Congenital afibrinogenemia, Congenital hypofibrinogenemia, Fibrinogen storage disease, Congenital dysfibrinogenemia, Hereditary fibrinogen Aα-Chain amyloidosis, Acquired dysfibrinogenemia, Congenital hypo dysfibrinogenemia and Cryofibrinogenemia. The detection of fibrinogen and so on are used to diagnose the fibrinogen disorders. However, the detection of these marker proteins from different samples may benefit from ELISA, Lateral flow immunoassay (LFIA), colloidal gold immunochromatographic assay, Chemiluminescent immunoassay (CLIA), turbidimetric inhibition immuno assay (TINIA), immunonephelometry and POCT.
Classification:
Fibrinogen (FIB)
Fibrinogen (FIB)
Cat No. | Species | Biomarker | Disease | Cat No.of Antigen | Bioactivity validation of Antigen | Cat No.of Antibodies | Bioactivity validation of Antibodies | Order |
GMP-h-FIB | Human | Fibrinogen (FIB) | congenital afibrinogenemia, congenital hypofibrinogenemia, fibrinogen storage disease, congenital dysfibrinogenemia, hereditary fibrinogen Aα-Chain amyloidosis, acquired dysfibrinogenemia, congenital hypodysfibrinogenemia, and cryofibrinogenemia | GMP-h-FIB-Ag01: Recombinant human FIB Protein |
Fibrinogen (FIB) antibodies binding, Immunogen in Sandwich Elisa, lateral-flow tests,and other immunoassays as control material in FIB level test of Fibrinogen disorders(congenital afibrinogenemia, congenital hypofibrinogenemia, fibrinogen storage disease, congenital dysfibrinogenemia, hereditary fibrinogen Aα-Chain amyloidosis, acquired dysfibrinogenemia, congenital hypodysfibrinogenemia, and cryofibrinogenemia) and related syndrome evaluation. | GMP-h-FIB-Ab01; GMP-h-FIB-Ab02: Anti-human FIB mouse monoclonal antibody(mAb) |
Human Fibrinogen (FIB) antigen binding, ELISA validated as capture antibody and detection antibody. Pair recommendation with other Fibrinogen (FIB) antibodies in FIB level test of Fibrinogen disorders (congenital afibrinogenemia, congenital hypofibrinogenemia, fibrinogen storage disease, congenital dysfibrinogenemia, hereditary fibrinogen Aα-Chain amyloidosis, acquired dysfibrinogenemia, congenital hypodysfibrinogenemia, and cryofibrinogenemia) and related syndrome evaluation. | ![]() |
Diagnostic antibodies and antigens for Neurodegenerative diseases (Alzheimer Disease (AD)) testing: p-tau181, p-tau217, p-tau231, Tau, NFL, GFAP, Aβ42, Aβ40, albumin, Aβ38, HFABP, MCP-1, neurogranin, NSE, sTREM2, VLP-1, YKL-40, α-synuclein, AD7c-NTP
Neurodegenerative diseases refer to the injury or dysfunction of one or more nerves, which results in numbness, tingling, muscle weakness and discomfort in the nerves affected part. Alzheimer's disease (AD) is a progressive neurodegenerative disease most often characterized by initial memory impairment and cognitive decline that can ultimately affect behavior, speech, visuospatial orientation and the motor system, and it is the most common form of dementia. Peripheral neuropathy refers the injury or dysfunction of the peripheral nerves. Peripheral neuropathy might be acute or chronic, and sometimes it is reversible. Biochemical markers are increasingly used for the early diagnosis of the neuropathy. In addition, such markers may provide additional information for understanding the pathology of disease. Several markers such as a Phospho-tau181 (p-tau181), Phospho-tau217 (p-tau217), Phospho-tau231 (p-tau231), tau proteins (Tau), neurofilament light chain (NFL), Glial fibrillary acid protein (GFAP), beta-amyloid 42 (Aβ42), beta-amyloid 40 (Aβ40), AD-associated neuaronal thread protein (AD7c-NTP) and so on have been identified to be associated with the neurodegenerative diseases. Evidence has shown plasma biomarkers (p-tau181, p-tau217, p-tau231, GFAP, NfL and Aβ42/40) were significantly changed in preclinical Alzheimer Disease (AD). Detecting the quantity of these marker proteins from different samples may benefit from ELISA, Lateral flow immunoassay (LFIA), colloidal gold immunochromatographic assay, Chemiluminescent immunoassay (CLIA), turbidimetric inhibition immuno assay (TINIA), immunonephelometry and POCT.
Classification:
p-tau181
p-tau217
p-tau231
Tau
NFL
GFAP
Aβ42
Aβ40
albumin
Aβ38
HFABP
MCP-1
neurogranin
NSE
sTREM2
VLP-1
YKL-40
α-synuclein
AD7c-NTP
Phospho-tau181 (p-tau181)
Cat No. | Species | Biomarker | Disease | Cat No.of Antigen | Bioactivity validation of Antigen | Cat No.of Antibodies | Bioactivity validation of Antibodies | Order |
GMP-h-p-tau181 | Human | Phospho-tau181 (p-tau181) | Alzheimer Disease(AD) | GMP-h-p-tau181-Ag01: Phospho-tau181 (p-tau181) antigen |
Phospho-tau181 (p-tau181) antibodies binding, Immunogen in Sandwich Elisa, lateral-flow tests,and other immunoassays as control material in p-tau181 level test of Neurodegenerative diseases(Alzheimer Disease (AD)) and related syndrome evaluation. | GMP-h-p-tau181-Ab01; GMP-h-p-tau181-Ab02: Anti-Phospho-tau181 (p-tau181) mouse monoclonal antibody(mAb) |
Human Phospho-tau181 (p-tau181) antigen binding, ELISA validated as capture antibody and detection antibody. Pair recommendation with other Phospho-tau181 (p-tau181) antibodies in p-tau181 level test of Neurodegenerative diseases (Alzheimer Disease (AD)) and related syndrome evaluation. | ![]() |
Phospho-tau217 (p-tau217)
Cat No. | Species | Biomarker | Disease | Cat No.of Antigen | Bioactivity validation of Antigen | Cat No.of Antibodies | Bioactivity validation of Antibodies | Order |
GMP-h-p-tau217 | Human | Phospho-tau217 (p-tau217) | Alzheimer Disease(AD) | GMP-h-p-tau217-Ag01: Phospho-tau217 (p-tau217) antigen |
Phospho-tau217 (p-tau217) antibodies binding, Immunogen in Sandwich Elisa, lateral-flow tests,and other immunoassays as control material in p-tau217 level test of Neurodegenerative diseases(Alzheimer Disease(AD)) and related syndrome evaluation. | GMP-h-p-tau217-Ab01; GMP-h-p-tau217-Ab02: Anti-Phospho-tau217 (p-tau217) mouse monoclonal antibody (mAb) |
Human Phospho-tau217 (p-tau217) antigen binding, ELISA validated as capture antibody and detection antibody. Pair recommendation with other Phospho-tau217 (p-tau217) antibodies in p-tau217 level test of Neurodegenerative diseases (Alzheimer Disease (AD)) and related syndrome evaluation. | ![]() |
Phospho-tau231 (p-tau231)
Cat No. | Species | Biomarker | Disease | Cat No.of Antigen | Bioactivity validation of Antigen | Cat No.of Antibodies | Bioactivity validation of Antibodies | Order |
GMP-h-p-tau231 | Human | Phospho-tau231 (p-tau231) | Alzheimer Disease(AD) | GMP-h-p-tau231-Ag01: Phospho-tau231 (p-tau231) antigen |
Phospho-tau231 (p-tau231) antibodies binding, Immunogen in Sandwich Elisa, lateral-flow tests,and other immunoassays as control material in p-tau231 level test of Neurodegenerative diseases(Alzheimer Disease(AD)) and related syndrome evaluation. | GMP-h-p-tau231-Ab01; GMP-h-p-tau231-Ab02: Anti-Phospho-tau231 (p-tau231) mouse monoclonal antibody (mAb) |
Human Phospho-tau231 (p-tau231) antigen binding, ELISA validated as capture antibody and detection antibody. Pair recommendation with other Phospho-tau231 (p-tau231) antibodies in p-tau231 level test of Neurodegenerative diseases (Alzheimer Disease(AD)) and related syndrome evaluation. | ![]() |
tau proteins (Tau)
Cat No. | Species | Biomarker | Disease | Cat No.of Antigen | Bioactivity validation of Antigen | Cat No.of Antibodies | Bioactivity validation of Antibodies | Order |
GMP-h-Tau | Human | tau proteins (Tau) | Alzheimer Disease(AD) | GMP-h-Tau-Ag01: Recombinant human Tau Protein |
tau proteins (Tau) antibodies binding, Immunogen in Sandwich Elisa, lateral-flow tests,and other immunoassays as control material in Tau level test of Neurodegenerative diseases(Alzheimer Disease(AD)) and related syndrome evaluation. | GMP-h-Tau-Ab01; GMP-h-Tau-Ab02; GMP-h-Tau-Ab03: Anti-human Tau mouse monoclonal antibody(mAb) |
Human tau proteins (Tau) antigen binding, ELISA validated as capture antibody and detection antibody. Pair recommendation with other tau proteins (Tau) antibodies in Tau level test of Neurodegenerative diseases (Alzheimer Disease(AD)) and related syndrome evaluation. | ![]() |
neurofilament light chain (NFL)
Cat No. | Species | Biomarker | Disease | Cat No.of Antigen | Bioactivity validation of Antigen | Cat No.of Antibodies | Bioactivity validation of Antibodies | Order |
GMP-h-NFL | Human | neurofilament light chain (NFL) | Alzheimer Disease(AD) | GMP-h-NFL-Ag01: Recombinant human NFL Protein |
neurofilament light chain (NFL) antibodies binding, Immunogen in Sandwich Elisa, lateral-flow tests,and other immunoassays as control material in NFL level test of Neurodegenerative diseases(Alzheimer Disease(AD)) and related syndrome evaluation. | GMP-h-NFL-Ab01; GMP-h-NFL-Ab02: Anti-human NFL mouse monoclonal antibody(mAb) |
Human neurofilament light chain (NFL) antigen binding, ELISA validated as capture antibody and detection antibody. Pair recommendation with other neurofilament light chain (NFL) antibodies in NFL level test of Neurodegenerative diseases (Alzheimer Disease(AD)) and related syndrome evaluation. | ![]() |
Glial fibrillary acid protein (GFAP)
Cat No. | Species | Biomarker | Disease | Cat No.of Antigen | Bioactivity validation of Antigen | Cat No.of Antibodies | Bioactivity validation of Antibodies | Order |
GMP-h-GFAP | Human | Glial fibrillary acid protein (GFAP) | Alzheimer Disease(AD) | GMP-h-GFAP-Ag01: Recombinant human GFAP Protein |
Glial fibrillary acid protein (GFAP) antibodies binding, Immunogen in Sandwich Elisa, lateral-flow tests,and other immunoassays as control material in GFAP level test of Neurodegenerative diseases(Alzheimer Disease(AD)) and related syndrome evaluation. | GMP-h-GFAP-Ab01; GMP-h-GFAP-Ab02: Anti-human GFAP mouse monoclonal antibody(mAb) |
Human Glial fibrillary acid protein (GFAP) antigen binding, ELISA validated as capture antibody and detection antibody. Pair recommendation with other Glial fibrillary acid protein (GFAP) antibodies in GFAP level test of Neurodegenerative diseases (Alzheimer Disease(AD)) and related syndrome evaluation. | ![]() |
beta-amyloid 42 (Aβ42)
Cat No. | Species | Biomarker | Disease | Cat No.of Antigen | Bioactivity validation of Antigen | Cat No.of Antibodies | Bioactivity validation of Antibodies | Order |
GMP-h-Aβ42 | Human | beta-amyloid 42 (Aβ42) | Alzheimer Disease(AD) | GMP-h-Aβ42-Ag01: Recombinant human Aβ42 Protein |
beta-amyloid 42 (Aβ42) antibodies binding, Immunogen in Sandwich Elisa, lateral-flow tests,and other immunoassays as control material in Aβ42 level test of Neurodegenerative diseases(Alzheimer Disease(AD)) and related syndrome evaluation. | GMP-h-Aβ42-Ab01; GMP-h-Aβ42-Ab02: Anti-human Aβ42 mouse monoclonal antibody(mAb) |
Human beta-amyloid 42 (Aβ42) antigen binding, ELISA validated as capture antibody and detection antibody. Pair recommendation with other beta-amyloid 42 (Aβ42) antibodies in Aβ42 level test of Neurodegenerative diseases (Alzheimer Disease(AD)) and related syndrome evaluation. | ![]() |
beta-amyloid 40 (Aβ40)
Cat No. | Species | Biomarker | Disease | Cat No.of Antigen | Bioactivity validation of Antigen | Cat No.of Antibodies | Bioactivity validation of Antibodies | Order |
GMP-h-Aβ40 | Human | beta-amyloid 40 (Aβ40) | Alzheimer Disease(AD) | GMP-h-Aβ40-Ag01: Recombinant human Aβ40 Protein |
beta-amyloid 40 (Aβ40) antibodies binding, Immunogen in Sandwich Elisa, lateral-flow tests,and other immunoassays as control material in Aβ40 level test of Neurodegenerative diseases(Alzheimer Disease(AD)) and related syndrome evaluation. | GMP-h-Aβ40-Ab01; GMP-h-Aβ40-Ab02: Anti-human Aβ40 mouse monoclonal antibody(mAb) |
Human beta-amyloid 40 (Aβ40) antigen binding, ELISA validated as capture antibody and detection antibody. Pair recommendation with other beta-amyloid 40 (Aβ40) antibodies in Aβ40 level test of Neurodegenerative diseases (Alzheimer Disease(AD)) and related syndrome evaluation. | ![]() |
albumin protein (albumin)
Cat No. | Species | Biomarker | Disease | Cat No.of Antigen | Bioactivity validation of Antigen | Cat No.of Antibodies | Bioactivity validation of Antibodies | Order |
GMP-h-albumin | Human | albumin protein (albumin) | Alzheimer Disease(AD) | GMP-h-albumin-Ag01: Recombinant Human albumin Protein |
albumin protein (albumin) antibodies binding, Immunogen in Sandwich Elisa, lateral-flow tests, and other immunoassays as control material in albumin level test of Neurodegenerative diseases (Alzheimer Disease(AD)) and related syndrome evaluation | GMP-h-albumin-Ab01; GMP-h-albumin-Ab02: Anti-Human albumin mouse monoclonal antibody (mAb) |
Human albumin protein (albumin) antigen binding, ELISA validated as capture antibody and detection antibody. Pair recommendation with other albumin protein (albumin) antibodies in albumin level test of Neurodegenerative diseases (Alzheimer Disease(AD)) and related syndrome evaluation. | ![]() |
beta-amyloid 38 (Aβ38)
Cat No. | Species | Biomarker | Disease | Cat No.of Antigen | Bioactivity validation of Antigen | Cat No.of Antibodies | Bioactivity validation of Antibodies | Order |
GMP-h-Aβ38 | Human | beta-amyloid 38 (Aβ38) | Alzheimer Disease(AD) | GMP-h-Aβ38-Ag01: Recombinant Human Aβ38 Protein |
beta-amyloid 38 (Aβ38) antibodies binding, Immunogen in Sandwich Elisa, lateral-flow tests, and other immunoassays as control material in Aβ38 level test of Neurodegenerative diseases (Alzheimer Disease(AD)) and related syndrome evaluation | GMP-h-Aβ38-Ab01; GMP-h-Aβ38-Ab02: Anti-Human Aβ38 mouse monoclonal antibody (mAb) |
Human beta-amyloid 38 (Aβ38) antigen binding, ELISA validated as capture antibody and detection antibody. Pair recommendation with other beta-amyloid 38 (Aβ38) antibodies in Aβ38 level test of Neurodegenerative diseases (Alzheimer Disease(AD)) and related syndrome evaluation. | ![]() |
Heart fatty acid-binding protein (HFABP)
Cat No. | Species | Biomarker | Disease | Cat No.of Antigen | Bioactivity validation of Antigen | Cat No.of Antibodies | Bioactivity validation of Antibodies | Order |
GMP-h-HFABP | Human | Heart fatty acid-binding protein (HFABP) | Alzheimer Disease(AD) | GMP-h-HFABP-Ag01: Recombinant Human HFABP Protein |
Heart fatty acid-binding protein (HFABP) antibodies binding, Immunogen in Sandwich Elisa, lateral-flow tests, and other immunoassays as control material in HFABP level test of Neurodegenerative diseases (Alzheimer Disease(AD)) and related syndrome evaluation | GMP-h-HFABP-Ab01; GMP-h-HFABP-Ab02: Anti-Human HFABP mouse monoclonal antibody (mAb) |
Human Heart fatty acid-binding protein (HFABP) antigen binding, ELISA validated as capture antibody and detection antibody. Pair recommendation with other Heart fatty acid-binding protein (HFABP) antibodies in HFABP level test of Neurodegenerative diseases (Alzheimer Disease(AD)) and related syndrome evaluation. | ![]() |
Monocyte chemoattractant protein-1 (MCP-1/CCL2)
Cat No. | Species | Biomarker | Disease | Cat No.of Antigen | Bioactivity validation of Antigen | Cat No.of Antibodies | Bioactivity validation of Antibodies | Order |
GMP-h-MCP-1 | Human | Monocyte chemoattractant protein-1 (MCP-1/CCL2) | Alzheimer Disease(AD) | GMP-h-MCP-1-Ag01: Recombinant Human MCP-1 Protein |
Monocyte chemoattractant protein-1 (MCP-1) antibodies binding, Immunogen in Sandwich Elisa, lateral-flow tests, and other immunoassays as control material in MCP-1 level test of Neurodegenerative diseases (Alzheimer Disease(AD)) and related syndrome evaluation | GMP-h-MCP-1-Ab01; GMP-h-MCP-1-Ab02: Anti-Human MCP-1 mouse monoclonal antibody (mAb) |
Human Monocyte chemoattractant protein-1 (MCP-1) antigen binding, ELISA validated as capture antibody and detection antibody. Pair recommendation with other Monocyte chemoattractant protein-1 (MCP-1) antibodies in MCP-1 level test of Neurodegenerative diseases (Alzheimer Disease(AD)) and related syndrome evaluation. | ![]() |
neurogranin protein (neurogranin)
Cat No. | Species | Biomarker | Disease | Cat No.of Antigen | Bioactivity validation of Antigen | Cat No.of Antibodies | Bioactivity validation of Antibodies | Order |
GMP-h-neurogranin | Human | neurogranin protein (neurogranin) | Alzheimer Disease(AD) | GMP-h-neurogranin-Ag01: Recombinant Human neurogranin Protein |
neurogranin protein (neurogranin) antibodies binding, Immunogen in Sandwich Elisa, lateral-flow tests, and other immunoassays as control material in neurogranin level test of Neurodegenerative diseases (Alzheimer Disease(AD)) and related syndrome evaluation | GMP-h-neurogranin-Ab01; GMP-h-neurogranin-Ab02: Anti-Human neurogranin mouse monoclonal antibody (mAb) |
Human neurogranin protein (neurogranin) antigen binding, ELISA validated as capture antibody and detection antibody. Pair recommendation with other neurogranin protein (neurogranin) antibodies in neurogranin level test of Neurodegenerative diseases (Alzheimer Disease(AD)) and related syndrome evaluation. | ![]() |
neuron-specific enolase (NSE)
Cat No. | Species | Biomarker | Disease | Cat No.of Antigen | Bioactivity validation of Antigen | Cat No.of Antibodies | Bioactivity validation of Antibodies | Order |
GMP-h-NSE | Human | neuron-specific enolase (NSE) | Alzheimer Disease(AD) | GMP-h-NSE-Ag01: Recombinant Human NSE Protein |
neuron-specific enolase (NSE) antibodies binding, Immunogen in Sandwich Elisa, lateral-flow tests, and other immunoassays as control material in NSE level test of Neurodegenerative diseases (Alzheimer Disease(AD)) and related syndrome evaluation | GMP-h-NSE-Ab01; GMP-h-NSE-Ab02: Anti-Human NSE mouse monoclonal antibody (mAb) |
Human neuron-specific enolase (NSE) antigen binding, ELISA validated as capture antibody and detection antibody. Pair recommendation with other neuron-specific enolase (NSE) antibodies in NSE level test of Neurodegenerative diseases (Alzheimer Disease(AD)) and related syndrome evaluation. | ![]() |
soluble fragment of triggering receptor expressed on myeloid cells 2 (sTREM2)
Cat No. | Species | Biomarker | Disease | Cat No.of Antigen | Bioactivity validation of Antigen | Cat No.of Antibodies | Bioactivity validation of Antibodies | Order |
GMP-h-sTREM2 | Human | soluble fragment of triggering receptor expressed on myeloid cells 2 (sTREM2) | Alzheimer Disease(AD) | GMP-h-sTREM2-Ag01: Recombinant Human sTREM2 Protein |
soluble fragment of triggering receptor expressed on myeloid cells 2 (sTREM2) antibodies binding, Immunogen in Sandwich Elisa, lateral-flow tests, and other immunoassays as control material in sTREM2 level test of Neurodegenerative diseases (Alzheimer Disease(AD)) and related syndrome evaluation | GMP-h-sTREM2-Ab01; GMP-h-sTREM2-Ab02: Anti-Human sTREM2 mouse monoclonal antibody (mAb) |
Human soluble fragment of triggering receptor expressed on myeloid cells 2 (sTREM2) antigen binding, ELISA validated as capture antibody and detection antibody. Pair recommendation with other soluble fragment of triggering receptor expressed on myeloid cells 2 (sTREM2) antibodies in sTREM2 level test of Neurodegenerative diseases (Alzheimer Disease(AD)) and related syndrome evaluation. | ![]() |
Visinin-like protein 1 (VLP-1)
Cat No. | Species | Biomarker | Disease | Cat No.of Antigen | Bioactivity validation of Antigen | Cat No.of Antibodies | Bioactivity validation of Antibodies | Order |
GMP-h-VLP-1 | Human | Visinin-like protein 1 (VLP-1) | Alzheimer Disease(AD) | GMP-h-VLP-1-Ag01: Recombinant Human VLP-1 Protein |
Visinin-like protein 1 (VLP-1) antibodies binding, Immunogen in Sandwich Elisa, lateral-flow tests, and other immunoassays as control material in VLP-1 level test of Neurodegenerative diseases (Alzheimer Disease(AD)) and related syndrome evaluation | GMP-h-VLP-1-Ab01; GMP-h-VLP-1-Ab02: Anti-Human VLP-1 mouse monoclonal antibody (mAb) |
Human Visinin-like protein 1 (VLP-1) antigen binding, ELISA validated as capture antibody and detection antibody. Pair recommendation with other Visinin-like protein 1 (VLP-1) antibodies in VLP-1 level test of Neurodegenerative diseases (Alzheimer Disease(AD)) and related syndrome evaluation. | ![]() |
Chitinase-3-like protein 1 (CHI3L1/YKL-40)
Cat No. | Species | Biomarker | Disease | Cat No.of Antigen | Bioactivity validation of Antigen | Cat No.of Antibodies | Bioactivity validation of Antibodies | Order |
GMP-h-YKL-40 | Human | Chitinase-3-like protein 1 (CHI3L1/YKL-40) | Alzheimer Disease(AD) | GMP-h-YKL-40-Ag01: Recombinant Human YKL-40 Protein |
Chitinase-3-like protein 1 (YKL-40) antibodies binding, Immunogen in Sandwich Elisa, lateral-flow tests, and other immunoassays as control material in YKL-40 level test of Neurodegenerative diseases (Alzheimer Disease(AD)) and related syndrome evaluation | GMP-h-YKL-40-Ab01; GMP-h-YKL-40-Ab02: Anti-Human YKL-40 mouse monoclonal antibody (mAb) |
Human Chitinase-3-like protein 1 (YKL-40) antigen binding, ELISA validated as capture antibody and detection antibody. Pair recommendation with other Chitinase-3-like protein 1 (YKL-40) antibodies in YKL-40 level test of Neurodegenerative diseases (Alzheimer Disease(AD)) and related syndrome evaluation. | ![]() |
Alpha-synuclein (α-synuclein)
Cat No. | Species | Biomarker | Disease | Cat No.of Antigen | Bioactivity validation of Antigen | Cat No.of Antibodies | Bioactivity validation of Antibodies | Order |
GMP-h-α-synuclein | Human | Alpha-synuclein (α-synuclein) | Alzheimer Disease(AD) | GMP-h-α-synuclein-Ag01: Recombinant Human α-synuclein Protein |
Alpha-synuclein (α-synuclein) antibodies binding, Immunogen in Sandwich Elisa, lateral-flow tests, and other immunoassays as control material in α-synuclein level test of Neurodegenerative diseases (Alzheimer Disease(AD)) and related syndrome evaluation | GMP-h-α-synuclein-Ab01; GMP-h-α-synuclein-Ab02: Anti-Human α-synuclein mouse monoclonal antibody (mAb) |
Human Alpha-synuclein (α-synuclein) antigen binding, ELISA validated as capture antibody and detection antibody. Pair recommendation with other Alpha-synuclein (α-synuclein) antibodies in α-synuclein level test of Neurodegenerative diseases (Alzheimer Disease(AD)) and related syndrome evaluation. | ![]() |
AD-associated neuaronal thread protein (AD7c-NTP)
Cat No. | Species | Biomarker | Disease | Cat No.of Antigen | Bioactivity validation of Antigen | Cat No.of Antibodies | Bioactivity validation of Antibodies | Order |
GMP-h-AD7c-NTP | Human | AD-associated neuaronal thread protein (AD7c-NTP) | Alzheimer Disease(AD) | GMP-h-AD7c-NTP-Ag01: Recombinant human AD7c-NTP Protein |
AD-associated neuaronal thread protein (AD7c-NTP) antibodies binding, Immunogen in Sandwich Elisa, lateral-flow tests,and other immunoassays as control material in AD7c-NTP level test of Neurodegenerative diseases(Alzheimer Disease(AD)) and related syndrome evaluation. | GMP-h-AD7c-NTP-Ab01; GMP-h-AD7c-NTP-Ab02: Anti-human AD7c-NTP mouse monoclonal antibody(mAb) |
Human AD-associated neuaronal thread protein (AD7c-NTP) antigen binding, ELISA validated as capture antibody and detection antibody. Pair recommendation with other AD-associated neuaronal thread protein (AD7c-NTP) antibodies in AD7c-NTP level test of Neurodegenerative diseases (Alzheimer Disease(AD)) and related syndrome evaluation. | ![]() |
Diagnostic antibodies and antigens for Epilepsy-related valproate (VPA) toxicity testing: Sodium valproate (VPA)
Valproate is a commonly used antiepileptic drug for the treatment of epilepsy and seizures. It is safe for use in both adults and children more than three years of age. Valproate toxicity can occur both accidentally and intentionally. Acute valproate overdose usually presents with CNS depression/encephalopathy, electrolyte abnormalities such as hypernatremia, elevated transaminase levels, hyperammonemia, and hepatoxicity. In patients with a severe overdose of valproate, patients can present with hypotension, tachycardia, respiratory depression, metabolic acidosis, cerebral edema, and valproate-related hyperammonemic encephalopathy which may progress to coma and death. GENEMEDI developed the Gastrin-17 (G-17) antigens and antibodies for the diagnosis of valproate toxicity based on ELISA, Lateral flow immunoassay (LFIA), colloidal gold immunochromatographic assay, Chemiluminescent immunoassay (CLIA), turbidimetric inhibition immuno assay (TINIA), immunonephelometry and POCT.
Classification:
VPA
Sodium valproate (VPA)
Cat No. | Species | Biomarker | Disease | Cat No.of Antigen | Bioactivity validation of Antigen | Cat No.of Antibodies | Bioactivity validation of Antibodies | Order |
GMP-SMT-VPA | Human | Sodium valproate (VPA) | toxicity | GMP-SMT-VPA-Ag01: BSA-Sodium valproate (VPA); GMP-SMT-VPA-Ag02: OVA-Sodium valproate (VPA): |
Competitive immunoassay-validated hapten-carrier conjugates [BSA-&OVA-Sodium valproate (VPA)], Sodium valproate (VPA) antibodies binding, Immunogen in Competitive immunoassay validation, Elisa, lateral-flow tests,and other immunoassays as control material in VPA level test of Epilepsy (toxicity) and related syndrome evaluation. | GMP-SMT-VPA-Ab01: Anti-Sodium valproate (VPA) mouse monoclonal antibody(mAb) |
Human Sodium valproate (VPA) binding, in Competitive immunoassay validation, Elisa, lateral-flow tests, and other immunoassays in VPA level test of Epilepsy (toxicity) and related syndrome evaluation. | ![]() |
Diagnostic antibodies and antigens for pain-related acetaminophen (Paracetamol) toxicity testing
Acetaminophen is known as paracetamol in many countries outside the US. It is one of the most frequently used oral analgesics and antipyretics. It has an outstanding safety profile when administered in an appropriate dose, but hepatotoxicity can occur after overdose or when misused in at-risk populations. GENEMEDI developed the antigens and antibodies for the diagnosis of potential acetaminophen toxicity based on ELISA, Lateral flow immunoassay (LFIA), colloidal gold immunochromatographic assay, Chemiluminescent immunoassay (CLIA), turbidimetric inhibition immuno assay (TINIA), immunonephelometry and POCT.
Classification:
Paracetamol
acetaminophen (Paracetamol)
Cat No. | Species | Biomarker | Disease | Cat No.of Antigen | Bioactivity validation of Antigen | Cat No.of Antibodies | Bioactivity validation of Antibodies | Order |
GMP-SMT-Paracetamol | Human | acetaminophen (Paracetamol) | hepatotoxicity | GMP-SMT-Paracetamol-Ag01: BSA-acetaminophen (Paracetamol); GMP-SMT-Paracetamol-Ag02: OVA-acetaminophen (Paracetamol) |
Competitive immunoassay-validated hapten-carrier conjugates [BSA-&OVA-acetaminophen (Paracetamol)], acetaminophen (Paracetamol) antibodies binding, Immunogen in Competitive immunoassay validation, Elisa, lateral-flow tests,and other immunoassays as control material in Paracetamol level test of Pain (hepatotoxicity) and related syndrome evaluation. | GMP-SMT-Paracetamol-Ab01: Anti-acetaminophen (Paracetamol) mouse monoclonal antibody(mAb) |
Human acetaminophen (Paracetamol) binding, in Competitive immunoassay validation, Elisa, lateral-flow tests, and other immunoassays in Paracetamol level test of Pain (hepatotoxicity) and related syndrome evaluation. | ![]() |
Diagnostic antibodies and antigens for multiple disease testing: thioredoxin reductase (TrxR)
Thioredoxin (Trx) and thioredoxin reductase (TrxR) plus NADPH, comprising the thioredoxin system, has a large number of functions in DNA synthesis, defense against oxidative stress and apoptosis or redox signaling with reference to many diseases such as cancer, viral disease, ischaemia– reperfusion injury, cardiac conditions, aging, premature birth and newborn physiology. GENEMEDI produces core diagnostic ingredients such as thioredoxin reductase and so on to test multiple disorders using ELISA, Lateral flow immunoassay (LFIA), colloidal gold immunochromatographic assay, Chemiluminescent immunoassay (CLIA), turbidimetric inhibition immuno assay (TINIA), immunonephelometry and POCT Kit.
Classification:
TrxR
thioredoxin reductase (TrxR)
Cat No. | Species | Biomarker | Disease | Cat No.of Antigen | Bioactivity validation of Antigen | Cat No.of Antibodies | Bioactivity validation of Antibodies | Order |
GMP-h-TrxR | Human | thioredoxin reductase (TrxR) | cancer, viral disease, ischaemia– reperfusion injury, cardiac conditions, aging, premature birth | GMP-h-TrxR-Ag01: Recombinant human TrxR Protein |
thioredoxin reductase (TrxR) antibodies binding, Immunogen in Sandwich Elisa, lateral-flow tests,and other immunoassays as control material in TrxR level test of Multiple disease(cancer, viral disease, ischaemia– reperfusion injury, cardiac conditions, aging, premature birth) and related syndrome evaluation. | GMP-h-TrxR-Ab01 GMP-h-TrxR-Ab02: Anti-human TrxR mouse monoclonal antibody(mAb) |
Human thioredoxin reductase (TrxR) antigen binding, ELISA validated as capture antibody and detection antibody. Pair recommendation with other thioredoxin reductase (TrxR) antibodies in TrxR level test of Multiple disease (cancer, viral disease, ischaemia– reperfusion injury, cardiac conditions, aging, premature birth) and related syndrome evaluation. | ![]() |
Diagnostic antibodies and antigens for biologics testing: Streptavidin (SA), Staphylococcus protein A (SPA)
The biological agent such as streptavidin and staphylococcus protein A have an important role in biochemical research because of its ability to bind biotin and immunoglobulins respectively. GENEMEDI produces core diagnostic ingredients such as streptavidin, staphylococcus protein A and so on for the biochemical research.
Classification:
SA
SPA
Streptavidin (SA)
Cat No. | Species | Biomarker | Disease | Cat No.of Antigen | Bioactivity validation of Antigen | Cat No.of Antibodies | Bioactivity validation of Antibodies | Order |
GMP-SMT-SA | Human | Streptavidin (SA) | NA | GMP-SMT-SA-Ag01: BSA-Streptavidin (SA); GMP-SMT-SA-Ag02: OVA-Streptavidin (SA) |
Competitive immunoassay-validated hapten-carrier conjugates [BSA-Streptavidin (SA)], Streptavidin (SA) antibodies binding, Immunogen in Competitive immunoassay validation, Elisa, lateral-flow tests,and other immunoassays as control material in SA level test of Biology and related syndrome evaluation. | GMP-SMT-SA-Ab01: Anti-Streptavidin (SA) mouse monoclonal antibody(mAb) |
Human Streptavidin (SA) binding, in Competitive immunoassay validation, Elisa, lateral-flow tests, and other immunoassays in SA level test of Biology and related syndrome evaluation. | ![]() |
Staphylococcus protein A (SPA)
Cat No. | Species | Biomarker | Disease | Cat No.of Antigen | Bioactivity validation of Antigen | Cat No.of Antibodies | Bioactivity validation of Antibodies | Order |
GMP-h-SPA | Human | Staphylococcus protein A (SPA) | N/A | GMP-h-SPA-Ag01: Recombinant human SPA Protein |
Staphylococcus protein A (SPA) antibodies binding, Immunogen in Sandwich Elisa, lateral-flow tests,and other immunoassays as control material in SPA level test of Biology(N/A) and related syndrome evaluation. | GMP-h-SPA-Ab01; GMP-h-SPA-Ab02: Anti-human SPA mouse monoclonal antibody(mAb) |
Human Staphylococcus protein A (SPA) antigen binding, ELISA validated as capture antibody and detection antibody. Pair recommendation with other Staphylococcus protein A (SPA) antibodies in SPA level test of Biology (N/A) and related syndrome evaluation. | ![]() |